"","X.2","X.1","...1","X","PG.ProteinGroups","PG.Genes","short.name","GO","sub.cell","description","GO.ID","ConditionNorm_P_0_1","ConditionNorm_P_0_2","ConditionNorm_P_0_3","ConditionNorm_P_300_2_1","ConditionNorm_P_300_2_2","ConditionNorm_P_300_2_3","logFC","AveExpr","t","P.Value","adj.P.Val","B","mass","neglog.adj.P.Val.","TotalPeptidesOverallInGene","P0_Undetected","P300_24h_Undetected","medians_.ConditionNorm_P_0_1_ConditionNorm_P_0_2_ConditionNorm_P_0_3","medians_.ConditionNorm_P_300_2_1_ConditionNorm_P_300_2_2_ConditionNorm_P_300_2_3","Ratio","Ratio_log2"
"1",1,1,1,1,"Q96F86","EDC3","EDC3_HUMAN","cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; P-body [GO:0000932]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; phosphodiesterase decapping endonuclease activity [GO:1990174]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]","SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000269|PubMed:16364915}. Note=Processing bodies (PB).","Enhancer of mRNA-decapping protein 3 (LSM16 homolog) (YjeF N-terminal domain-containing protein 2) (YjeF_N2) (hYjeF_N2) (YjeF domain-containing protein 1)","GO:0000932; GO:0003729; GO:0005829; GO:0016020; GO:0031087; GO:0033962; GO:0036464; GO:0042802; GO:0043928; GO:1990174",1e-07,4.38437438448206e-06,9.24919241015426e-08,0.0193977876341387,0.0194618426226633,0.0189859161406415,0.019280323177045,0.00964168721062536,128.800879628291,6.76575298255394e-09,5.79148455306618e-05,10.8470812271437,56078,4.23721009766044,8,1,0,1e-07,0.0193977876341387,193977.876341387,17.5655325932789
"2",2,3,3,3,"P48730","CSNK1D","KC1D_HUMAN","centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cellular response to nerve growth factor stimulus [GO:1990090]; ciliary basal body-plasma membrane docking [GO:0097711]; circadian regulation of gene expression [GO:0032922]; COPII vesicle coating [GO:0048208]; endocytosis [GO:0006897]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation [GO:1905426]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of circadian rhythm [GO:0042752]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, perinuclear region. Cell membrane. Cytoplasm, cytoskeleton, spindle. Golgi apparatus. Note=Localized at mitotic spindle microtubules, and at the centrosomes and interphase in interphase cells. Recruited to the spindle apparatus and the centrosomes in response to DNA-damage. Correct subcellular localization requires kinase activity.","Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26)","GO:0000086; GO:0000139; GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0006468; GO:0006897; GO:0007020; GO:0007030; GO:0008360; GO:0010389; GO:0016055; GO:0018105; GO:0032436; GO:0032922; GO:0033116; GO:0034067; GO:0042277; GO:0042752; GO:0043005; GO:0045296; GO:0048208; GO:0048471; GO:0050321; GO:0051225; GO:0061512; GO:0071539; GO:0090263; GO:0097711; GO:1905426; GO:1905515; GO:1990090; GO:2000052",6.11939112675231e-05,7.04035533733228e-05,0.00011172437840527,0.184997616343177,0.191004438389297,0.183344583109309,0.186367771999579,0.0932649932808049,83.1265230097352,4.46709032271674e-08,0.00010960564457081,8.53659327197659,47330,3.96016707958492,5,0,0,7.04035533733228e-05,0.184997616343177,2627.67442095154,11.3595708158867
"3",3,4,4,4,"Q7Z4K8","TRIM46","TRI46_HUMAN","axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoskeleton [GO:0005856]; main axon [GO:0044304]; proximal neuron projection [GO:1990769]; zinc ion binding [GO:0008270]; anterograde synaptic vesicle transport [GO:0048490]; axonogenesis [GO:0007409]; microtubule bundle formation [GO:0001578]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; positive regulation of anterograde dense core granule transport [GO:1901953]; protein localization to axon [GO:0099612]; regulation of cellular protein localization [GO:1903827]","SUBCELLULAR LOCATION: Cell projection, axon {ECO:0000250|UniProtKB:Q7TNM2}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q7TNM2}. Note=Microtubule-associated. Localizes to the proximal part of the axon. {ECO:0000250|UniProtKB:Q7TNM2}.","Tripartite motif-containing protein 46 (Gene Y protein) (GeneY) (Tripartite, fibronectin type-III and C-terminal SPRY motif protein)","GO:0001578; GO:0001764; GO:0005856; GO:0007409; GO:0008270; GO:0030517; GO:0043194; GO:0044304; GO:0048490; GO:0099612; GO:1901953; GO:1903827; GO:1904115; GO:1990769",2.92357192225913e-05,2.55360427156958e-05,7.95748412680683e-05,0.070412458181699,0.0719859296126172,0.0736219998897587,0.0719620136936229,0.0360257890478802,80.5298645474576,5.12175909209405e-08,0.00010960564457081,8.36877223260556,83424,3.96016707958492,20,0,0,2.92357192225913e-05,0.0719859296126172,2462.2595758476,11.2657671460164
"4",4,6,6,6,"Q9P0J7","KCMF1","KCMF1_HUMAN","cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleic acid binding [GO:0003676]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]",NA,"E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (FGF-induced in gastric cancer) (Potassium channel modulatory factor) (PCMF) (RING-type E3 ubiquitin transferase KCMF1) (ZZ-type zinc finger-containing protein 1)","GO:0003676; GO:0005576; GO:0005829; GO:0008270; GO:0016740; GO:0043312; GO:1904813",0.00014148227843341,0.00152335114328638,0.00022464304483378,0.0380807558941098,0.0371839158493072,0.0390393972425134,0.0374715308397923,0.0193655909087473,55.6286644214978,2.52090204002172e-07,0.00035964869104309,6.4108707477606,41945,3.44412151599379,5,0,0,0.00022464304483378,0.0380807558941098,169.516736751351,7.4052839105472
"5",5,7,7,7,"Q9UPN6","SCAF8","SCAF8_HUMAN","nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus. Nucleus matrix. Note=Detected in granular nuclear foci which correspond to sites of active transcription. {ECO:0000250}.","Protein SCAF8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16) (SR-related and CTD-associated factor 8)","GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380; GO:0016363; GO:0043175",0.00195357993984359,0.00145930398782693,0.00696563229924617,0.179280725185962,0.190758404424643,0.185080666668234,0.181580426683974,0.0942497187509592,50.2520997701013,3.90522677445527e-07,0.00044569716937139,5.87264984770715,140519,3.35096012411505,10,0,0,0.00195357993984359,0.185080666668234,94.7392338002059,6.56589009911495
"6",6,8,8,8,"Q9ULI4","KIF26A","KI26A_HUMAN","cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; enteric nervous system development [GO:0048484]; microtubule-based movement [GO:0007018]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}.","Kinesin-like protein KIF26A","GO:0001560; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0008017; GO:0009968; GO:0019886; GO:0048484",0.00021899555155734,4.0317354040151e-05,9.59695058546089e-05,0.126255850778434,0.128051788969578,0.119380241350074,0.124444199562211,0.0623405272515897,48.8764528070932,4.40093649307728e-07,0.00044569716937139,5.72567980380985,194590,3.35096012411505,18,0,0,9.59695058546089e-05,0.126255850778434,1315.58300372733,10.3614865596106
"7",7,10,10,10,"P51149","RAB7A","RAB7A_HUMAN","alveolar lamellar body [GO:0097208]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of lysosome membrane [GO:0032419]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Rac GTPase binding [GO:0048365]; retromer complex binding [GO:1905394]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; epidermal growth factor catabolic process [GO:0007174]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; multi-organism intracellular transport [GO:1902583]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of intralumenal vesicle formation [GO:1905366]; neutrophil degranulation [GO:0043312]; phagosome acidification [GO:0090383]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; viral release from host cell [GO:0019076]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, phagosome membrane {ECO:0000269|PubMed:12944476, ECO:0000269|PubMed:21255211}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Late endosome membrane {ECO:0000269|PubMed:12944476, ECO:0000269|PubMed:14617358, ECO:0000269|PubMed:16176980, ECO:0000269|PubMed:20028791}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Lysosome membrane {ECO:0000269|PubMed:12944476, ECO:0000269|PubMed:20028791}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Melanosome membrane {ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Cytoplasmic vesicle, autophagosome membrane {ECO:0000269|PubMed:20028791}; Peripheral membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Lipid droplet {ECO:0000250|UniProtKB:P51150}. Endosome membrane {ECO:0000269|PubMed:22431521}. Note=Colocalizes with OSBPL1A at the late endosome (PubMed:16176980). Found in the ruffled border (a late endosomal-like compartment in the plasma membrane) of bone-resorbing osteoclasts. Recruited to phagosomes containing S.aureus or Mycobacterium (PubMed:21255211). Lipid droplet localization is increased upon ADRB2 stimulation (By similarity). {ECO:0000250|UniProtKB:P51150, ECO:0000269|PubMed:16176980, ECO:0000269|PubMed:21255211}.","Ras-related protein Rab-7a","GO:0000045; GO:0000421; GO:0003924; GO:0005525; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005811; GO:0005829; GO:0005886; GO:0006622; GO:0006897; GO:0007174; GO:0008333; GO:0010008; GO:0015031; GO:0016042; GO:0019003; GO:0019076; GO:0019886; GO:0022615; GO:0030667; GO:0030670; GO:0031902; GO:0032419; GO:0033162; GO:0034045; GO:0042147; GO:0043312; GO:0045022; GO:0045335; GO:0045453; GO:0045732; GO:0048365; GO:0048524; GO:0061724; GO:0070062; GO:0090382; GO:0090383; GO:0090385; GO:0097208; GO:1902583; GO:1903542; GO:1903543; GO:1905366; GO:1905394",1e-07,4.64074349419732e-05,2.29701447799555e-05,0.00544276047097283,0.00551807601978047,0.00515296484603829,0.00534810791902322,0.00269721315275225,46.1421119632544,5.63863343491483e-07,0.00044569716937139,5.4208635522649,23490,3.35096012411505,13,1,0,2.29701447799555e-05,0.00544276047097283,236.949332410058,7.88843478604781
"8",8,11,11,11,"O00750","PIK3C2B","P3C2B_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; protein kinase B signaling [GO:0043491]","SUBCELLULAR LOCATION: Microsome {ECO:0000269|PubMed:14563213}. Cell membrane {ECO:0000269|PubMed:14563213}. Cytoplasm, cytosol {ECO:0000269|PubMed:14563213}. Nucleus {ECO:0000269|PubMed:14563213}. Endoplasmic reticulum {ECO:0000269|PubMed:14563213}. Note=Found mostly in the microsome, but also in the plasma membrane and cytosol. Nuclear in testis.","Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)","GO:0001727; GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0009267; GO:0014065; GO:0016303; GO:0016477; GO:0030139; GO:0035005; GO:0035091; GO:0043491; GO:1905037",9.42249184118852e-06,1e-07,1e-07,0.0417314195546033,0.0391834468812481,0.0421628809780588,0.0410227083073564,0.0205145616509586,45.7648086365057,5.84147100122514e-07,0.00044569716937139,5.37739263741519,184768,3.35096012411505,21,2,0,1e-07,0.0417314195546033,417314.195546033,18.6707744712316
"9",9,13,13,13,"P35716","SOX11","SOX11_HUMAN","cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding transcription factor activity [GO:0003700]; enhancer sequence-specific DNA binding [GO:0001158]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription coactivator activity [GO:0001105]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; translation factor activity, RNA binding [GO:0008135]; cardiac ventricle formation [GO:0003211]; closure of optic fissure [GO:0061386]; cornea development in camera-type eye [GO:0061303]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; hard palate development [GO:0060022]; kidney development [GO:0001822]; lens morphogenesis in camera-type eye [GO:0002089]; limb bud formation [GO:0060174]; lung morphogenesis [GO:0060425]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neural crest cell development [GO:0014032]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; noradrenergic neuron differentiation [GO:0003357]; oligodendrocyte development [GO:0014003]; outflow tract morphogenesis [GO:0003151]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lens epithelial cell proliferation [GO:2001111]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; signal transduction involved in cell cycle checkpoint [GO:0072395]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; soft palate development [GO:0060023]; somite development [GO:0061053]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; ventricular septum morphogenesis [GO:0060412]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267, ECO:0000269|PubMed:24886874}.","Transcription factor SOX-11","GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001077; GO:0001105; GO:0001158; GO:0001501; GO:0001822; GO:0001841; GO:0002089; GO:0003151; GO:0003211; GO:0003357; GO:0003700; GO:0005634; GO:0005737; GO:0008135; GO:0008284; GO:0010628; GO:0010629; GO:0014003; GO:0014009; GO:0014032; GO:0017015; GO:0021510; GO:0021782; GO:0030182; GO:0030513; GO:0035332; GO:0035914; GO:0045666; GO:0045669; GO:0045778; GO:0045893; GO:0045944; GO:0046887; GO:0048485; GO:0048557; GO:0048704; GO:0050672; GO:0050769; GO:0060022; GO:0060023; GO:0060174; GO:0060253; GO:0060412; GO:0060425; GO:0060548; GO:0060563; GO:0061029; GO:0061053; GO:0061303; GO:0061386; GO:0072395; GO:2000648; GO:2000678; GO:2001111",0.0180673475878318,0.0251279470539765,0.0386938210718024,0.488956571741226,0.457901564847277,0.465282503345223,0.443417174740038,0.249004959274556,41.2802812947913,9.10475197701095e-07,0.00059951289940933,4.8314346070492,46679,3.2222014679746,3,0,0,0.0251279470539765,0.465282503345223,18.5165346912649,4.21074222310175
"10",10,14,14,14,"Q15771","RAB30","RAB30_HUMAN","cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Golgi organization [GO:0007030]","SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Lipid-anchor {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Golgi apparatus, trans-Golgi network {ECO:0000269|PubMed:22188167}. Cytoplasm {ECO:0000269|PubMed:22188167}. Golgi apparatus {ECO:0000269|PubMed:22188167}.","Ras-related protein Rab-30","GO:0000139; GO:0003924; GO:0005525; GO:0005795; GO:0005801; GO:0005802; GO:0007030; GO:0031985; GO:0043231",1e-07,1e-07,1e-07,0.0809797229034645,0.089219574864441,0.0865998789475897,0.0855996255718317,0.0427999127859159,36.5573879054188,1.53546074174214e-06,0.00093882456780805,4.18845389421122,23058,3.02741555400755,3,3,0,1e-07,0.0865998789475897,865998.789475897,19.7240054827395
"11",11,15,15,15,"Q9UGL1","KDM5B","KDM5B_HUMAN","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; transcription, DNA-templated [GO:0006351]; uterus morphogenesis [GO:0061038]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000255|PROSITE-ProRule:PRU00537, ECO:0000269|PubMed:10336460, ECO:0000269|PubMed:12237901}.","Lysine-specific demethylase 5B (EC 1.14.11.-) (Cancer/testis antigen 31) (CT31) (Histone demethylase JARID1B) (Jumonji/ARID domain-containing protein 1B) (PLU-1) (Retinoblastoma-binding protein 2 homolog 1) (RBP2-H1)","GO:0000981; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006357; GO:0007338; GO:0008270; GO:0009791; GO:0010628; GO:0032452; GO:0032453; GO:0033601; GO:0034647; GO:0034648; GO:0034720; GO:0042393; GO:0044344; GO:0045892; GO:0048511; GO:0051213; GO:0060444; GO:0060763; GO:0060992; GO:0061038; GO:0070306; GO:1990830; GO:1990837; GO:2000864",4.86375926875197e-05,1.68295428394588e-05,0.00011440229959022,0.178801407115803,0.16902567321504,0.161212747365,0.169619986086908,0.0848699495218265,34.610393426094,1.94280290429992e-06,0.00110869285738715,3.89894594511205,175658,2.95518875034936,20,0,0,4.86375926875197e-05,0.16902567321504,3475.20639643852,11.762882948333
"12",12,16,16,16,"Q9H0E2","TOLLIP","TOLIP_HUMAN","azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; interleukin-1 receptor complex [GO:0045323]; interleukin-18 receptor complex [GO:0045092]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; specific granule lumen [GO:0035580]; interleukin-1, Type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; leukocyte activation [GO:0045321]; neutrophil degranulation [GO:0043312]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.","Toll-interacting protein","GO:0005150; GO:0005576; GO:0005737; GO:0005829; GO:0006511; GO:0006914; GO:0006954; GO:0007165; GO:0007267; GO:0016310; GO:0016604; GO:0019900; GO:0030855; GO:0031624; GO:0031625; GO:0032183; GO:0033235; GO:0035325; GO:0035556; GO:0035578; GO:0035580; GO:0036010; GO:0043130; GO:0043312; GO:0045087; GO:0045092; GO:0045321; GO:0045323; GO:0048471; GO:0070062; GO:0070498",1e-07,0.00032969835031174,1e-07,0.0726112316925992,0.0799507946265262,0.0794134258828088,0.0772151846172075,0.0387175584253743,33.8970981728271,2.12472933269412e-06,0.00113673019299136,3.78881089039564,30282,2.94434260444153,5,2,0,1e-07,0.0794134258828088,794134.258828088,19.5990234089729
"13",13,17,17,17,"P16298","PPP3CB","PP2BB_HUMAN","calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722]; axon extension [GO:0048675]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion regulated exocytosis [GO:0017156]; cellular response to drug [GO:0035690]; dephosphorylation [GO:0016311]; Fc-epsilon receptor signaling pathway [GO:0038095]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; social behavior [GO:0035176]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19154138}.","Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform) (CNA beta)","GO:0001915; GO:0001946; GO:0004722; GO:0005509; GO:0005516; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005955; GO:0006468; GO:0006470; GO:0007165; GO:0007223; GO:0007507; GO:0007612; GO:0007613; GO:0008144; GO:0016311; GO:0017156; GO:0019899; GO:0030018; GO:0030217; GO:0030315; GO:0030346; GO:0031987; GO:0033173; GO:0033192; GO:0034097; GO:0035176; GO:0035690; GO:0035774; GO:0038095; GO:0042098; GO:0042110; GO:0043029; GO:0045893; GO:0045944; GO:0046983; GO:0048167; GO:0048675; GO:0050796",1.3395282877886e-05,1e-07,1e-07,0.0191514745972964,0.0204308508278095,0.0213312664551529,0.0202999988657936,0.0101545311938561,33.2461150759818,2.30939695872037e-06,0.00116284929215567,3.68626789178854,59024,2.93447656715145,9,2,0,1e-07,0.0204308508278095,204308.508278095,17.6403897597366
"14",14,21,21,21,"Q8NFT8","DNER","DNER_HUMAN","dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416]","SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein. Note=Present on the membrane of dendrites and cell bodies but excluded from axonal membrane. Also found in early endosomes in the somatodendritic region (By similarity). {ECO:0000250}.","Delta and Notch-like epidermal growth factor-related receptor","GO:0001764; GO:0004888; GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0006897; GO:0007219; GO:0007220; GO:0007416; GO:0007417; GO:0010001; GO:0016021; GO:0030276; GO:0030425; GO:0043025; GO:0048741",0.00299779358766243,0.0103106372202326,0.00596213356547506,0.274134083666569,0.254804307971639,0.246455307844751,0.25204104503653,0.132444043976055,30.9025383354923,3.16154277765173e-06,0.00128870505603328,3.29983656241985,78475,2.88984646759173,8,0,0,0.00596213356547506,0.254804307971639,42.7371016052265,5.41741716382201
"15",15,24,24,24,"Q9UQ35","SRRM2","SRRM2_HUMAN","Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; C2H2 zinc finger domain binding [GO:0070742]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]","SUBCELLULAR LOCATION: Nucleus speckle.","Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803)","GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0015030; GO:0016607; GO:0047485; GO:0070742; GO:0071007; GO:0071013",1.19390649027948e-05,1e-07,1e-07,0.0364795041248153,0.0379008342648204,0.0334803764577727,0.0359495252608352,0.0179788089853852,28.6307528613537,4.38830420442532e-06,0.00153851330023604,2.89642520196188,299615,2.81289874498419,25,2,0,1e-07,0.0364795041248153,364795.041248153,18.4767265931519
"16",16,25,25,25,"Q5H8A4","PIGG","PIGG_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15632136}; Multi-pass membrane protein {ECO:0000269|PubMed:15632136}.","GPI ethanolamine phosphate transferase 2 (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G)","GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016254; GO:0016780; GO:0030176; GO:0051267",1e-07,1e-07,1e-07,0.0386072681990608,0.0423864808211134,0.0436474489124761,0.0415469659775501,0.020773582988775,28.4734505758805,4.49332155442767e-06,0.00153851330023604,2.86732891218632,108173,2.81289874498419,7,3,0,1e-07,0.0423864808211134,423864.808211134,18.69324466464
"17",17,29,29,29,"Q9UHC6","CNTNAP2","CNTP2_HUMAN","axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; voltage-gated potassium channel complex [GO:0008076]; enzyme binding [GO:0019899]; adult behavior [GO:0030534]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cerebral cortex development [GO:0021987]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; striatum development [GO:0021756]; superior temporal gyrus development [GO:0071109]; thalamus development [GO:0021794]; transmission of nerve impulse [GO:0019226]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]","SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q9CPW0}; Single-pass type I membrane protein {ECO:0000305}. Cell projection, axon {ECO:0000250|UniProtKB:Q9CPW0}. Cell junction, paranodal septate junction {ECO:0000250|UniProtKB:Q9CPW0}. Note=Expressed in the juxtaparadonal region. {ECO:0000250|UniProtKB:Q9CPW0}.","Contactin-associated protein-like 2 (Cell recognition molecule Caspr2)","GO:0005769; GO:0005794; GO:0007155; GO:0007420; GO:0007612; GO:0008038; GO:0008076; GO:0009986; GO:0016020; GO:0016021; GO:0019226; GO:0019899; GO:0021756; GO:0021761; GO:0021794; GO:0021987; GO:0030424; GO:0030425; GO:0030534; GO:0030673; GO:0031175; GO:0033010; GO:0035176; GO:0042297; GO:0043025; GO:0043204; GO:0044224; GO:0045163; GO:0048812; GO:0071109; GO:0071205; GO:0071625",0.00017300297063021,2.56850639955827e-05,4.31008021959842e-05,0.0557148466283502,0.0501536758810749,0.0572544159104206,0.0542937165276747,0.0272274545427779,26.1265417880319,6.4992370898479e-06,0.00191839549962407,2.41324481108666,148167,2.71706185305816,20,0,0,4.31008021959842e-05,0.0557148466283502,1292.6637971843,10.3361313848643
"18",18,30,30,30,"Q9HCK4","ROBO2","ROBO2_HUMAN","axolemma [GO:0030673]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; positive regulation of axonogenesis [GO:0050772]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; spinal cord development [GO:0021510]; ureteric bud development [GO:0001657]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.","Roundabout homolog 2","GO:0001656; GO:0001657; GO:0005886; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016021; GO:0016199; GO:0021510; GO:0021891; GO:0030673; GO:0031290; GO:0032870; GO:0035385; GO:0042802; GO:0050772; GO:0050925; GO:0051964; GO:0061364; GO:0070062",5.04911363541428e-05,9.31092081648572e-05,7.91799654529924e-05,0.0118305872829839,0.0111705322669791,0.0103094022527269,0.0110292471642393,0.00558888368544366,25.8630178274216,6.78803854981482e-06,0.00193685366621383,2.3597587938989,151200,2.71290318999671,21,0,0,7.91799654529924e-05,0.0111705322669791,141.077761313382,7.14034677748661
"19",19,31,31,31,"P34059","GALNS","GALNS_HUMAN","azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484]; keratan sulfate catabolic process [GO:0042340]; neutrophil degranulation [GO:0043312]","SUBCELLULAR LOCATION: Lysosome.","N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (GalN6S) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase)","GO:0003943; GO:0005576; GO:0008484; GO:0035578; GO:0042340; GO:0043202; GO:0043312; GO:0043890; GO:0046872; GO:0070062",1e-07,4.73921343167678e-05,1e-07,0.0549456967963855,0.0580782454841861,0.0633936703525616,0.0587900068329388,0.0294108674612417,24.7502059526414,8.19663125795805e-06,0.00226332785703616,2.12779772648426,58026,2.64525253124705,6,2,0,1e-07,0.0580782454841861,580782.454841861,19.1476383453067
"20",20,33,33,33,"Q64LD2","WDR25","WDR25_HUMAN",NA,NA,"WD repeat-containing protein 25",NA,1.43799989263052e-05,1.97490662378097e-05,2.57488528302553e-05,0.041105863248519,0.0414108203018641,0.0468015959139878,0.0430861338487921,0.0215630262303942,24.1753971703026,9.06508974003286e-06,0.00235142933862671,2.0039172792214,60161,2.62866806744122,5,0,0,1.97490662378097e-05,0.0414108203018641,2096.84953218613,11.0340076234655
"21",21,35,35,35,"A6NJT0","UNCX","UNC4_HUMAN","nucleus [GO:0005634]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cartilage condensation [GO:0001502]; common myeloid progenitor cell proliferation [GO:0035726]; dorsal spinal cord development [GO:0021516]; olfactory bulb interneuron differentiation [GO:0021889]; pattern specification process [GO:0007389]; regulation of cell differentiation [GO:0045595]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108}.","Homeobox protein unc-4 homolog (Homeobox protein Uncx4.1)","GO:0000981; GO:0001502; GO:0005634; GO:0006351; GO:0007389; GO:0021516; GO:0021889; GO:0035726; GO:0043565; GO:0045595",0.00537803640388344,0.00041241547426931,0.00088714558675478,0.334408471240156,0.381129939987256,0.38632720773709,0.365062673833198,0.184757202738235,22.854473889411,1.15319207004336e-05,0.00281964330668928,1.70786678535068,53690,2.54980582775668,4,0,0,0.00088714558675478,0.381129939987256,429.613747368622,8.74689634916697
"22",22,36,36,36,"Q9Y2G0","EFR3B","EFR3B_HUMAN","cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:25380825}; Lipid-anchor {ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:25380825}. Cytoplasm, cytosol {ECO:0000269|PubMed:25380825}. Note=Palmitoylation anchors the protein to the plasma membrane (PubMed:23229899, PubMed:25380825). A small amount is observed in the cytosol (PubMed:25380825). {ECO:0000269|PubMed:23229899, ECO:0000269|PubMed:25380825}.","Protein EFR3 homolog B","GO:0005829; GO:0005886; GO:0046854; GO:0072659",0.00337479318072573,0.0092892732908268,0.00678170573385297,0.0477610737827545,0.0483863312307899,0.0507606368268831,0.042487423211674,0.0277256356743055,22.7059846786769,1.18583129720577e-05,0.00281964330668928,1.67353877589545,92487,2.54980582775668,13,0,0,0.00678170573385297,0.0483863312307899,7.13483202157455,2.83487946410971
"23",24,39,39,39,"Q13895","BYSL","BYST_HUMAN","apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; female pregnancy [GO:0007565]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; trophectodermal cell differentiation [GO:0001829]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17381424}. Nucleus, nucleolus {ECO:0000269|PubMed:17381424}. Note=Associated with 40S ribosomal subunits.","Bystin","GO:0000462; GO:0001829; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007155; GO:0007565; GO:0008283; GO:0016020; GO:0043231; GO:0045177",2.63102129302489e-05,6.93716872172458e-05,8.20939472372235e-05,0.127361330270131,0.12715053323096,0.10965016803275,0.121328085228819,0.0607233012302044,21.4627163187625,1.50900058258129e-05,0.00330355055763921,1.37713818239618,49601,2.48101904234871,6,0,0,6.93716872172458e-05,0.12715053323096,1832.8880027492,10.8399029184314
"24",25,41,41,41,"O95870","ABHD16A","ABHGA_HUMAN","integral component of membrane [GO:0016021]; acylglycerol lipase activity [GO:0047372]; monoacylglycerol catabolic process [GO:0052651]; prostaglandin catabolic process [GO:1905344]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","Protein ABHD16A (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5) (Protein G5)","GO:0016021; GO:0047372; GO:0052651; GO:1905344",0.00016045034311505,0.00030523341684851,0.00152533016936801,0.0327136988301347,0.0279452045403436,0.0298585021815948,0.0295087972075805,0.0154180699135675,21.0973629019514,1.62399364375613e-05,0.00339058185135426,1.28682408125278,63243,2.46972576694472,9,0,0,0.00030523341684851,0.0298585021815948,97.8218652789705,6.6120850693061
"25",26,44,44,44,"Q8WUU5","GATAD1","GATD1_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; chromatin assembly [GO:0031497]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21965549}.","GATA zinc finger domain-containing protein 1 (Ocular development-associated gene protein)","GO:0000981; GO:0005634; GO:0005654; GO:0008270; GO:0031497; GO:0043565",3.3912938354281e-05,0.00014372858414311,1e-07,0.040689730275345,0.0358705007225227,0.0345686345424273,0.0369837080059326,0.0185511011771321,20.613605495127,1.79333845414425e-05,0.00348885844715335,1.16485028946337,28690,2.45731665074888,3,1,0,3.3912938354281e-05,0.0358705007225227,1057.72317184054,10.0467463782094
"26",27,45,45,45,"Q8IWT6","LRRC8A","LRC8A_HUMAN","cell surface [GO:0009986]; cytoplasm [GO:0005737]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; volume-sensitive anion channel activity [GO:0005225]; anion transport [GO:0006820]; cell volume homeostasis [GO:0006884]; pre-B cell differentiation [GO:0002329]; response to osmotic stress [GO:0006970]; signal transduction [GO:0007165]; transmembrane transport [GO:0055085]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:24725410, ECO:0000269|PubMed:24782309, ECO:0000269|PubMed:24790029, ECO:0000269|PubMed:26824658}; Multi-pass membrane protein {ECO:0000269|PubMed:24725410, ECO:0000269|PubMed:24782309, ECO:0000269|PubMed:24790029}. Note=The leucine-rich repeat (LRR) domain is on the cytoplasmic side of the cell membrane. {ECO:0000269|PubMed:24782309}.","Volume-regulated anion channel subunit LRRC8A (Leucine-rich repeat-containing protein 8A) (Swelling protein 1)","GO:0002329; GO:0005225; GO:0005737; GO:0005886; GO:0006820; GO:0006884; GO:0006970; GO:0007165; GO:0009986; GO:0016020; GO:0034702; GO:0042802; GO:0055085",1e-07,1e-07,1e-07,0.0436423728186227,0.0379490762218606,0.0371627743628749,0.0395846411344527,0.0197924205672264,20.126916442151,1.98616837930042e-05,0.00372557857652481,1.03927195029159,94199,2.42880627242443,12,3,0,1e-07,0.0379490762218606,379490.762218606,18.5337052415964
"27",28,46,46,46,"O94812","BAIAP3","BAIP3_HUMAN","cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G-protein coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:28626000}. Recycling endosome membrane {ECO:0000269|PubMed:28626000}; Peripheral membrane protein {ECO:0000305|PubMed:28626000}. Late endosome membrane {ECO:0000269|PubMed:28626000}; Peripheral membrane protein {ECO:0000305|PubMed:28626000}. Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:28626000}; Peripheral membrane protein {ECO:0000305|PubMed:28626000}. Cell membrane {ECO:0000269|PubMed:28626000}; Peripheral membrane protein {ECO:0000305|PubMed:28626000}. Note=Rapidly recruited to the plasma membrane and to Golgi structures in response to increased intracellular calcium concentration. {ECO:0000269|PubMed:28626000}.","BAI1-associated protein 3 (BAP3) (Brain-specific angiogenesis inhibitor I-associated protein 3)","GO:0000149; GO:0001956; GO:0005509; GO:0005543; GO:0005783; GO:0005829; GO:0005886; GO:0006887; GO:0007186; GO:0019905; GO:0031902; GO:0032228; GO:0032588; GO:0035774; GO:0042147; GO:0055038; GO:0098793; GO:1905413; GO:1990502",1e-07,1e-07,1e-07,0.225128746846844,0.223270986134075,0.191185228617841,0.213194887199587,0.106597543599793,20.0894098124733,2.00206325373997e-05,0.00372557857652481,1.02947115427705,131901,2.42880627242443,4,3,0,1e-07,0.223270986134075,2232709.86134075,21.0903643557282
"28",29,47,47,47,"Q9NWZ5","UCKL1","UCKL1_HUMAN","cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12199906}. Nucleus {ECO:0000269|PubMed:12199906}. Note=EBNA3 induces isoform 1 translocation to the nucleus, whereas it does change isoform 3 location.","Uridine-cytidine kinase-like 1 (EC 2.7.1.48)","GO:0004849; GO:0005524; GO:0005634; GO:0005829; GO:0006206; GO:0016032; GO:0043097; GO:0044206; GO:0044211",1e-07,1e-07,1e-07,0.0565404586129611,0.049368135137238,0.0478793042579734,0.0512625326693908,0.0256313663346954,19.9033495857207,2.08326683525965e-05,0.0037942051297495,0.980585608548644,61141,2.42087919313369,5,3,0,1e-07,0.049368135137238,493681.35137238,18.9132206232818
"29",30,48,48,48,"Q674X7","KAZN","KAZRN_HUMAN","cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; cornification [GO:0070268]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Cell junction, desmosome. Nucleus. Note=Observed at the apical plasma membrane of keratinocytes. Partially colocalizes with PPL and DP at desmosomes, and with PP at the interdesmosomal plasma membrane. Colocalizes with cortical actin-based membrane structures.; SUBCELLULAR LOCATION: Isoform 3: Cytoplasm. Cell junction, desmosome. Nucleus. Note=Observed at the apical plasma membrane of keratinocytes. Partially colocalizes with PPL and DP at desmosomes, and with PP at the interdesmosomal plasma membrane. Colocalizes with cortical actin-based membrane structures.; SUBCELLULAR LOCATION: Isoform 4: Cytoplasm. Cell junction, desmosome. Nucleus. Note=Observed at the apical plasma membrane of keratinocytes. Partially colocalizes with PPL and DP at desmosomes, and with PP at the interdesmosomal plasma membrane. Colocalizes with cortical actin-based membrane structures.","Kazrin","GO:0001533; GO:0005654; GO:0005829; GO:0005856; GO:0016607; GO:0030057; GO:0070268",1e-07,1e-07,1e-07,0.0480666278056386,0.0558997981167323,0.0570041550015949,0.0536567603079886,0.0268284801539943,19.7997443730697,2.13024077726112e-05,0.00379892938611566,0.953170050217979,86351,2.42033877896577,11,3,0,1e-07,0.0558997981167323,558997.981167323,19.0924835471919
"30",31,49,49,49,"Q52WX2","SBK1","SBK1_HUMAN","cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","Serine/threonine-protein kinase SBK1 (EC 2.7.11.1) (SH3-binding kinase 1)","GO:0004674; GO:0005524; GO:0005737; GO:0018105; GO:0018107",1e-07,1e-07,1.75881143781795e-05,0.177210529218503,0.173617976404089,0.148890844641927,0.16656718738338,0.0832895230631496,19.4268639370513,2.3104554875503e-05,0.00383358125960462,0.853324762389933,46252,2.41639532666264,5,2,0,1e-07,0.173617976404089,1736179.76404089,20.727484901475
"31",32,50,50,50,"Q96DV4","MRPL38","RM38_HUMAN","mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:25278503, ECO:0000269|PubMed:25838379}.","39S ribosomal protein L38, mitochondrial (L38mt) (MRP-L38) (Mitochondrial large ribosomal subunit protein mL38)","GO:0005743; GO:0005762; GO:0070125; GO:0070126",8.01049312210398e-05,7.83132337915905e-05,8.57918948641361e-05,0.0294418057568748,0.0354450087624281,0.0326278524591359,0.0324234856395207,0.0162931461730526,19.4066100459673,2.32077102017359e-05,0.00383358125960462,0.847847890493338,44597,2.41639532666264,6,0,0,8.01049312210398e-05,0.0326278524591359,407.31390641986,8.6699972611268
"32",33,52,52,52,"Q8N608","DPP10","DPP10_HUMAN","membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel binding [GO:0044325]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q6NXK7, ECO:0000269|PubMed:14566338}; Single-pass type II membrane protein {ECO:0000250|UniProtKB:P42658}.","Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase IV-related protein 3) (DPRP-3) (Dipeptidyl peptidase X) (DPP X) (Dipeptidyl peptidase-like protein 2) (DPL2)","GO:0005886; GO:0008076; GO:0008236; GO:0015459; GO:0016020; GO:0044325; GO:0072659; GO:1901379; GO:1903078",1.78235768988502e-05,1e-07,1e-07,0.0314185670931673,0.0260910357673255,0.0292879156543238,0.0289264983126392,0.0144692570152859,19.3909005828671,2.32881104555421e-05,0.00383358125960462,0.843596031160734,90888,2.41639532666264,8,2,0,1e-07,0.0292879156543238,292879.156543238,18.1599459984096
"33",34,53,53,53,"Q8TDN6","BRIX1","BRX1_HUMAN","nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ribosomal large subunit assembly [GO:0000027]","SUBCELLULAR LOCATION: Nucleus, nucleolus.","Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2)","GO:0000027; GO:0003723; GO:0005634; GO:0005730",0.028380946923829,0.0171944847576249,0.025752826835614,0.122190934737919,0.12024279037383,0.134307477185108,0.101804314593263,0.0746782434689875,19.0564380906025,2.50840775382472e-05,0.00405131516466784,0.752263706043356,41401,2.39240397035577,6,0,0,0.025752826835614,0.122190934737919,4.74475813928664,2.24633454875432
"34",35,54,54,54,"Q9Y4F1","FARP1","FARP1_HUMAN","cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; filopodium [GO:0030175]; cytoskeletal protein binding [GO:0008092]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; dendrite morphogenesis [GO:0048813]; negative regulation of phosphatase activity [GO:0010923]; regulation of Rho protein signal transduction [GO:0035023]; synapse assembly [GO:0007416]","SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell junction, synapse. Cell junction, synapse, synaptosome {ECO:0000250}. Cytoplasm, cytosol {ECO:0000250}. Cell projection, filopodium {ECO:0000250}. Cell projection, dendrite {ECO:0000250}. Cell projection, dendritic spine {ECO:0000250}. Note=Recruited to the cell membrane via interaction with CADM1. {ECO:0000250}.","FERM, ARHGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (FERM, RhoGEF and pleckstrin domain-containing protein 1) (Pleckstrin homology domain-containing family C member 2) (PH domain-containing family C member 2)","GO:0005089; GO:0005829; GO:0005856; GO:0007416; GO:0008092; GO:0010923; GO:0030054; GO:0030175; GO:0030425; GO:0030676; GO:0031234; GO:0035023; GO:0043197; GO:0048813",0.00039621386964316,0.0004363854690002,0.00025246158035974,0.0125171958861198,0.0140001554802127,0.0116887725961226,0.0123736876811507,0.00654853081357637,18.8975840238167,2.59966222646392e-05,0.00412094604787614,0.708335115794997,118633,2.38500307129513,28,0,0,0.00039621386964316,0.0125171958861198,31.5920184656663,4.98148821105976
"35",36,56,56,56,"Q9H857","NT5DC2","NT5D2_HUMAN","5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]",NA,"5'-nucleotidase domain-containing protein 2 (EC 3.1.3.-)","GO:0008253; GO:0046872",0.0003023898238355,0.00033268358918251,0.00074489347109395,0.0454595610974561,0.0532721075209981,0.0451972226844515,0.0475163081395979,0.0242181430311696,18.59380927401,2.78581681042831e-05,0.00425831998165471,0.62331768737493,60719,2.37076170761219,10,0,0,0.00033268358918251,0.0454595610974561,136.64503623146,7.09428924323757
"36",37,58,58,58,"Q8IV32","CCDC71","CCD71_HUMAN",NA,NA,"Coiled-coil domain-containing protein 71",NA,0.00229509542347874,0.00510524143082336,0.00461529169232683,0.181296952582033,0.1609673584,0.15029856177223,0.160182414735878,0.0840964168834822,18.2084250074208,3.04618615988588e-05,0.0044957506083833,0.513488483545201,49648,2.34719778827686,3,0,0,0.00461529169232683,0.1609673584,34.8769631760473,5.12420252142443
"37",38,60,60,60,"Q9H6K5","PRR36","PRR36_HUMAN",NA,NA,"Proline-rich protein 36",NA,4.96806427060295e-05,0.00390910994973868,4.97826671642008e-05,0.0335144344820582,0.0291301792694304,0.0323613105565994,0.030332450349493,0.0165024162612828,17.1328710084198,3.94873406899763e-05,0.00562191741744473,0.194552164445934,132748,2.25011553820412,12,0,0,4.97826671642008e-05,0.0323613105565994,650.05176299334,9.34441079290111
"38",39,61,61,61,"Q92738","USP6NL","US6NL_HUMAN","cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; regulation of vesicle fusion [GO:0031338]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]","SUBCELLULAR LOCATION: Golgi apparatus. Cytoplasmic vesicle.","USP6 N-terminal-like protein (Related to the N-terminus of tre) (RN-tre)","GO:0005096; GO:0005829; GO:0005886; GO:0006886; GO:0007030; GO:0012505; GO:0017137; GO:0019068; GO:0031338; GO:0031410; GO:0032588; GO:0035526; GO:0043547; GO:0048227; GO:0090630; GO:1903358",1e-07,0.00057183241756551,1e-07,0.143849156922584,0.164593554352664,0.177639829495616,0.161836836117766,0.081109095531405,17.074774905792,4.00627292598281e-05,0.00562191741744473,0.176775109458225,94104,2.25011553820412,3,2,0,1e-07,0.164593554352664,1645935.54352664,20.6504764088168
"39",40,62,62,62,"Q9H2C0","GAN","GAN_HUMAN","Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeleton organization [GO:0007010]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]","SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton.","Gigaxonin (Kelch-like protein 16)","GO:0005737; GO:0005829; GO:0005856; GO:0007010; GO:0016567; GO:0031463; GO:0043687",1e-07,1e-07,1.23152560632818e-06,0.0281392406446695,0.0265865653037878,0.0325509188253965,0.0290917644160825,0.0145463593832434,16.9019063188554,4.1836853798348e-05,0.00577618497602998,0.123528844282836,67638,2.23835890740816,17,2,0,1e-07,0.0281392406446695,281392.406446695,18.102223871492
"40",41,63,63,63,"Q9GZM8","NDEL1","NDEL1_HUMAN","axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell leading edge [GO:0031252]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; oligopeptidase activity [GO:0070012]; protein-containing complex binding [GO:0044877]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; inner cell mass cell proliferation [GO:0001833]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; nuclear envelope disassembly [GO:0051081]; positive regulation of axon extension [GO:0045773]; positive regulation of axon regeneration [GO:0048680]; positive regulation of GTPase activity [GO:0043547]; positive regulation of ruffle assembly [GO:1900029]; regulation of intracellular protein transport [GO:0033157]; regulation of microtubule motor activity [GO:2000574]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Chromosome, centromere, kinetochore. Cytoplasm, cytoskeleton, spindle. Note=Localizes to the cell body of the motor neurons and colocalizes with assembled neurofilaments within axonal processes. Localizes to the microtubules of the manchette in elongated spermatids. Colocalizes with DISC1 in the perinuclear region, including the centrosome (By similarity). Localizes to the interphase centrosome and the mitotic spindle. Localizes to the kinetochore in a CENPF-dependent manner. {ECO:0000250}.","Nuclear distribution protein nudE-like 1 (Protein Nudel) (Mitosin-associated protein 1)","GO:0000132; GO:0000776; GO:0000777; GO:0001764; GO:0001833; GO:0005635; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0008017; GO:0008021; GO:0008090; GO:0008286; GO:0010975; GO:0016477; GO:0021799; GO:0021955; GO:0031252; GO:0032418; GO:0033157; GO:0042802; GO:0043014; GO:0043203; GO:0043547; GO:0044877; GO:0045773; GO:0047496; GO:0048487; GO:0048680; GO:0051081; GO:0051303; GO:0051642; GO:0060052; GO:0060053; GO:0070012; GO:0090630; GO:0090724; GO:1900029; GO:1904115; GO:1990138; GO:2000574",1.4322491780589e-05,0.0097576804640626,2.01656674090568e-05,0.102123266719463,0.0858322473155243,0.0968820531813671,0.0916817995310342,0.0491049559732678,16.4219487394244,4.72941848955459e-05,0.00642600353501385,-0.0271234673918741,38375,2.19205903987436,8,0,0,2.01656674090568e-05,0.0968820531813671,4804.30680602495,12.2301125700514
"41",42,64,64,64,"Q08629","SPOCK1","TICN1_HUMAN","cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; postsynaptic density [GO:0014069]; sarcoplasm [GO:0016528]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; central nervous system neuron differentiation [GO:0021953]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; regulation of cell growth [GO:0001558]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.","Testican-1 (Protein SPOCK)","GO:0001558; GO:0001764; GO:0004867; GO:0004869; GO:0005509; GO:0005615; GO:0005737; GO:0007155; GO:0007165; GO:0007399; GO:0008191; GO:0010812; GO:0010951; GO:0010977; GO:0014069; GO:0016528; GO:0021953; GO:0022008; GO:0031594; GO:0033268",0.00011162813538108,8.34881965487815e-05,0.0232929921606829,0.216247987786375,0.259327945215955,0.247280991974551,0.23312293882809,0.124390838911582,16.1553595746877,5.07040706258948e-05,0.00678166944621343,-0.112656110989182,49124,2.16866338252964,6,0,0,0.00011162813538108,0.247280991974551,2215.2210204925,11.1132349334472
"42",43,65,65,65,"Q14344","GNA13","GNA13_HUMAN","brush border membrane [GO:0031526]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; type 1 angiotensin receptor binding [GO:0031702]; activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0007189]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G-protein coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10747909}; Lipid-anchor {ECO:0000269|PubMed:10747909}. Melanosome {ECO:0000269|PubMed:17081065}. Cytoplasm {ECO:0000269|PubMed:10747909, ECO:0000269|PubMed:18703424}. Nucleus {ECO:0000269|PubMed:18703424}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV (PubMed:17081065). Detected in the cytoplasm of Leydig cells and in the seminiferous epithelium, including differentiating cells from the spermatogonia to mature spermatozoa stages (PubMed:18703424). In round spermatids, also present in the nuclei (PubMed:18703424). {ECO:0000269|PubMed:17081065, ECO:0000269|PubMed:18703424}.","Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13)","GO:0001569; GO:0001701; GO:0003924; GO:0005085; GO:0005089; GO:0005525; GO:0005634; GO:0005829; GO:0005834; GO:0005886; GO:0005925; GO:0007165; GO:0007186; GO:0007189; GO:0007204; GO:0007266; GO:0008360; GO:0016020; GO:0030154; GO:0030168; GO:0030334; GO:0031526; GO:0031584; GO:0031683; GO:0031702; GO:0031752; GO:0042470; GO:0043065; GO:0046872; GO:0051056; GO:0070062",0.00018598020303809,0.00014588741350679,0.00010078704246661,0.0268584711021707,0.0304280509598935,0.0243603807196826,0.0270714160409118,0.0136799262401264,15.9570188010761,5.34384788634612e-05,0.00703743660109581,-0.177182836913902,44050,2.1525855045979,9,0,0,0.00014588741350679,0.0268584711021707,184.104100940282,7.52437795302046
"43",44,66,66,66,"O94827","PLEKHG5","PKHG5_HUMAN","cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell chemotaxis [GO:0035767]; G-protein coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q66T02}. Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:Q66T02}. Cell membrane {ECO:0000250|UniProtKB:Q66T02}. Cell junction {ECO:0000250|UniProtKB:Q66T02}. Cell projection, lamellipodium {ECO:0000250|UniProtKB:Q66T02}. Note=Predominantly cytoplasmic, however when endothelial cells are stimulated with lysophosphatidic acid, PLEKHG5 is found in perinuclear regions and at the cell membrane. Localizes at cell-cell junctions in quiescent endothelial cells, and relocalizes to cytoplasmic vesicle and the leading edge of lamellipodia in migrating endothelial cells. {ECO:0000250|UniProtKB:Q66T02}.","Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Guanine nucleotide exchange factor 720) (GEF720)","GO:0005085; GO:0005089; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007186; GO:0030027; GO:0030139; GO:0035023; GO:0035767; GO:0043065; GO:0043123; GO:0048471; GO:0051056",5.2574535290573e-05,6.59831100944169e-05,0.00010017029956451,0.075843265506486,0.0687545099649567,0.0604146135363987,0.0682645536876306,0.0342051861587985,15.8947424456821,5.43342161616494e-05,0.00704698318702605,-0.197603457206029,117451,2.15199676465862,3,0,0,6.59831100944169e-05,0.0687545099649567,1042.00165567483,10.0251418546316
"44",45,67,67,67,"Q9NVD7","PARVA","PARVA_HUMAN","cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]","SUBCELLULAR LOCATION: Cell junction, focal adhesion. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm, cytoskeleton. Cytoplasm, myofibril, sarcomere, Z line {ECO:0000250}. Note=Constituent of focal adhesions. Associates with the actin cytoskeleton.","Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2)","GO:0002040; GO:0003148; GO:0003779; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007163; GO:0008360; GO:0030018; GO:0031532; GO:0034113; GO:0034446; GO:0045296; GO:0060271; GO:0070252; GO:0071670",7.21187215775601e-06,1.5909480299096e-05,2.195485362399e-05,0.150660611905356,0.129722163880597,0.121055702180023,0.133797800586632,0.0669139256953427,15.8077543996924,5.56164862862828e-05,0.00710562869568031,-0.226256969495058,42244,2.14839749029311,3,0,0,1.5909480299096e-05,0.129722163880597,8153.76501569118,12.9932506648903
"45",46,68,68,68,"Q13449","LSAMP","LSAMP_HUMAN","anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; locomotory exploration behavior [GO:0035641]; nervous system development [GO:0007399]","SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor, GPI-anchor.","Limbic system-associated membrane protein (LSAMP) (IgLON family member 3)","GO:0005576; GO:0005829; GO:0005886; GO:0007155; GO:0007399; GO:0031225; GO:0035641",0.00012302732462441,4.05665364475448e-05,0.00084350747270184,0.00647451607033328,0.00761791137817669,0.00666184775513951,0.00658239128995856,0.00362689608957055,15.5839112030654,5.9091105544543e-05,0.00743852740384247,-0.300696299989125,37393,2.12851303269144,6,0,0,0.00012302732462441,0.00666184775513951,54.1493345114791,5.75887170228904
"46",47,70,70,70,"Q96C36","PYCR2","P5CR2_HUMAN","mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular amino acid biosynthetic process [GO:0008652]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:2722838}. Mitochondrion {ECO:0000269|PubMed:23024808, ECO:0000269|PubMed:25865492}.","Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2)","GO:0004735; GO:0005739; GO:0005759; GO:0006561; GO:0008652; GO:0034599; GO:0055129",1e-07,1e-07,1e-07,0.0150275357509614,0.0145547760849467,0.0119991795382896,0.0138603971247325,0.00693029856236627,15.282335283054,6.42046332640901e-05,0.00785130943915159,-0.402634567542195,33637,2.10505790570405,6,3,0,1e-07,0.0145547760849467,145547.760849467,17.1511331192137
"47",48,71,71,71,"Q96MH6","TMEM68","TMM68_HUMAN","integral component of membrane [GO:0016021]; transferase activity, transferring acyl groups [GO:0016746]; metabolic process [GO:0008152]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","Transmembrane protein 68","GO:0008152; GO:0016021; GO:0016746",0.0040781044233623,0.00032732723953026,0.00038287444808088,0.0847596046095864,0.092187577421688,0.0734496769130046,0.0818695176111019,0.0425308608425421,15.2124942657889,6.5465439118403e-05,0.00789273463173986,-0.426518676070261,37425,2.10277249872871,4,0,0,0.00038287444808088,0.0847596046095864,221.377020677236,7.79036166539211
"48",49,72,72,72,"O94985","CLSTN1","CSTN1_HUMAN","cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:17332754}; Single-pass type I membrane protein {ECO:0000269|PubMed:17332754}. Golgi apparatus membrane {ECO:0000269|PubMed:17332754}. Cell projection {ECO:0000269|PubMed:17332754}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Nucleus {ECO:0000269|PubMed:17332754}. Note=Neurite tips. Localized in the postsynaptic membrane of both excitatory and inhibitory synapses (By similarity). The AlcICD fragment is translocated to the nucleus upon interaction with APBB1. {ECO:0000250}.","Calsyntenin-1 (Alcadein-alpha) (Alc-alpha) (Alzheimer-related cadherin-like protein) (Non-classical cadherin XB31alpha) [Cleaved into: Soluble Alc-alpha (SAlc-alpha); CTF1-alpha (C-terminal fragment 1-alpha)]","GO:0000139; GO:0001540; GO:0001558; GO:0005509; GO:0005576; GO:0005634; GO:0005789; GO:0007155; GO:0007156; GO:0009986; GO:0014069; GO:0016021; GO:0019894; GO:0030054; GO:0042988; GO:0042995; GO:0045211; GO:0050806; GO:0051965",0.0073028986921557,0.0145606749398158,0.0170814271663615,0.321561008321813,0.382124312372675,0.402718626467457,0.355819648787871,0.190891491326713,15.0584518652499,6.83555391285966e-05,0.00812671409639982,-0.479573532240583,109793,2.09008501876815,3,0,0,0.0145606749398158,0.382124312372675,26.2435851327033,4.71389291468579
"49",50,73,73,73,"Q684P5","RAP1GAP2","RPGP2_HUMAN","centrosome [GO:0005813]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; negative regulation of neuron projection development [GO:0010977]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15632203}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:15632203}.","Rap1 GTPase-activating protein 2 (Rap1GAP2) (GTPase-activating Rap/Ran-GAP domain-like protein 4)","GO:0005096; GO:0005813; GO:0005829; GO:0005886; GO:0008361; GO:0010977; GO:0031965; GO:0043005; GO:0048471; GO:0051056",0.0001313782771069,0.00013230172597983,0.00036920113493788,0.0549896156390295,0.0580571611938915,0.0457886020805129,0.0527341659251365,0.0265780433419098,14.8482773916245,7.2556118227784e-05,0.00841159901018905,-0.552810402731167,80056,2.07512143876901,7,0,0,0.00013230172597983,0.0549896156390295,415.637930886955,8.69918350957375
"50",51,74,74,74,"P82663","MRPS25","RT25_HUMAN","mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:25838379}.","28S ribosomal protein S25, mitochondrial (MRP-S25) (S25mt) (Mitochondrial small ribosomal subunit protein mS25)","GO:0003735; GO:0005739; GO:0005743; GO:0005840; GO:0070125; GO:0070126",1e-07,0.00016271182497805,1e-07,0.0158541119776869,0.0141484719945981,0.0124321030983019,0.0140905917485363,0.0070995998159275,14.7725288848325,7.41473773560323e-05,0.00841159901018905,-0.579450266786917,20116,2.07512143876901,4,2,0,1e-07,0.0141484719945981,141484.719945981,17.110286727858
"51",52,76,76,76,"Q13705","ACVR2B","AVR2B_HUMAN","cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; activin binding [GO:0048185]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; activation of protein kinase activity [GO:0032147]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; determination of left/right symmetry [GO:0007368]; embryonic foregut morphogenesis [GO:0048617]; gastrulation with mouth forming second [GO:0001702]; heart development [GO:0007507]; insulin secretion [GO:0030073]; kidney development [GO:0001822]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; pancreas development [GO:0031016]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; response to glucose [GO:0009749]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; venous blood vessel development [GO:0060841]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.","Activin receptor type-2B (EC 2.7.11.30) (Activin receptor type IIB) (ACTR-IIB)","GO:0000122; GO:0001702; GO:0001822; GO:0001946; GO:0001974; GO:0004674; GO:0004675; GO:0004712; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006355; GO:0007165; GO:0007178; GO:0007368; GO:0007498; GO:0007507; GO:0009749; GO:0009791; GO:0009952; GO:0019838; GO:0030073; GO:0030324; GO:0030501; GO:0030509; GO:0031016; GO:0032147; GO:0032924; GO:0032927; GO:0032991; GO:0035265; GO:0042475; GO:0043235; GO:0045669; GO:0046872; GO:0048185; GO:0048617; GO:0048705; GO:0060021; GO:0060836; GO:0060840; GO:0060841; GO:0061298",1.05682515232934e-05,1e-07,1e-07,0.100204965554687,0.0814328106996523,0.10258671704625,0.0947379083496887,0.0473725435920188,14.7027122263052,7.56521400219349e-05,0.00841159901018905,-0.604120543251256,57724,2.07512143876901,6,2,0,1e-07,0.100204965554687,1002049.65554687,19.9345225709074
"52",53,77,77,77,"O14735","CDIPT","CDIPT_HUMAN","endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi apparatus membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Cell membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Membrane {ECO:0000269|PubMed:8110188}.","CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase)","GO:0000139; GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341",8.96178508335309e-05,0.00134931439068898,0.00024097179690936,0.0217554754037434,0.0173254811956084,0.0201351989970545,0.0191787505193248,0.010149343272473,14.7021190538405,7.56650845542706e-05,0.00841159901018905,-0.604330627554956,23539,2.07512143876901,6,0,0,0.00024097179690936,0.0201351989970545,83.5583219916322,6.38471161555162
"53",54,78,78,78,"P49918","CDKN1C","CDN1C_HUMAN","cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase inhibitor activity [GO:0004860]; protein-containing complex binding [GO:0044877]; cell cycle arrest [GO:0007050]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of kinase activity [GO:0033673]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of mitotic cell cycle [GO:0007346]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Cyclin-dependent kinase inhibitor 1C (Cyclin-dependent kinase inhibitor p57) (p57Kip2)","GO:0004860; GO:0004861; GO:0005634; GO:0005737; GO:0007050; GO:0007346; GO:0030511; GO:0033673; GO:0042326; GO:0044877; GO:0045892; GO:0045893; GO:0050680; GO:1904030",3.84127699176152e-05,0.00372039718029218,6.04525091108705e-05,0.157919694102679,0.185868190455235,0.202182324966481,0.180716982355025,0.0916315786639525,14.4531295448507,8.13474835100589e-05,0.00878928809025613,-0.693242556853907,32177,2.05604630023844,3,0,0,6.04525091108705e-05,0.185868190455235,3074.61498602731,11.5861900471381
"54",55,79,79,79,"O60422","ONECUT3","ONEC3_HUMAN","nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; cell differentiation [GO:0030154]; system development [GO:0048731]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00374}.","One cut domain family member 3 (One cut homeobox 3) (Transcription factor ONECUT-3) (OC-3)","GO:0000977; GO:0000981; GO:0001077; GO:0003677; GO:0005634; GO:0005667; GO:0030154; GO:0048731",0.0851073570504495,0.126629244868213,0.136344708142891,0.530627649392108,0.478869306549605,0.457466923144876,0.372960856341679,0.302507531524691,14.4457483510167,8.15237921965563e-05,0.00878928809025613,-0.695900703164664,50037,2.05604630023844,4,0,0,0.126629244868213,0.478869306549605,3.7816643939398,1.91902133613738
"55",56,81,81,81,"Q9NR28","DIABLO","DBLOH_HUMAN","CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway [GO:0097193]; positive regulation of apoptotic process [GO:0043065]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:14523016}. Note=Released into the cytosol when cells undergo apoptosis.","Diablo homolog, mitochondrial (Direct IAP-binding protein with low pI) (Second mitochondria-derived activator of caspase) (Smac)","GO:0005739; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0008625; GO:0008635; GO:0009898; GO:0035631; GO:0043065; GO:0097193",7.38817101231269e-05,8.08872917274359e-05,0.00040538406310884,0.0172246655484897,0.0201720135016976,0.0158853870759484,0.0175739710203921,0.00897370319851584,14.3487296982189,8.38854000194668e-05,0.00886492622427945,-0.730961137618026,27131,2.05232487433511,4,0,0,8.08872917274359e-05,0.0172246655484897,212.946498524531,7.73434719764923
"56",57,82,82,82,"Q8N5H7","SH2D3C","SH2D3_HUMAN","cytoplasm [GO:0005737]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3/SH2 adaptor activity [GO:0005070]; JNK cascade [GO:0007254]; small GTPase mediated signal transduction [GO:0007264]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=Associated with the membrane when EGF-stimulated. Found at ruffling membranes (By similarity). {ECO:0000250}.","SH2 domain-containing protein 3C (Novel SH2-containing protein 3) (SH2 domain-containing Eph receptor-binding protein 1) (SHEP1)","GO:0005070; GO:0005085; GO:0005737; GO:0007254; GO:0007264; GO:0016020",0.00033030260141081,0.00021042894827093,0.00018833706498173,0.0999539200968129,0.0779864470000564,0.0955168509210917,0.0909093831344325,0.0456977144387707,14.0731922247409,9.10657637690885e-05,0.00950637729101704,-0.831788191759435,94411,2.02198495333232,10,0,0,0.00021042894827093,0.0955168509210917,453.914975605507,8.82627827636601
"57",58,83,83,83,"Q9HCH0","NCKAP5L","NCK5L_HUMAN","centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:26482847, ECO:0000269|PubMed:26485573, ECO:0000269|PubMed:26549230}. Note=Localizes to microtubule plus ends (PubMed:26485573, PubMed:26482847). Associates with centrosomes during interphase, but dissociates from these structures from the onset of mitosis (PubMed:26549230). {ECO:0000269|PubMed:26482847, ECO:0000269|PubMed:26485573, ECO:0000269|PubMed:26549230}.","Nck-associated protein 5-like (NCKAP5-like) (Centrosomal protein of 169 kDa) (Cep169)","GO:0001578; GO:0005737; GO:0005813; GO:0007019; GO:0035371",0.00014764538714357,0.00383746703575343,5.98124714707126e-05,0.0965117597066748,0.0870200409227912,0.0751628533766287,0.0848832430372424,0.0437899298167438,13.9889458039248,9.3410457453342e-05,0.00963365681687479,-0.862994080057955,139013,2.01620882877021,4,0,0,0.00014764538714357,0.0870200409227912,589.385436323677,9.20306760177516
"58",59,84,84,84,"P06241","FYN","FYN_HUMAN","actin filament [GO:0005884]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glial cell projection [GO:0097386]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; disordered domain specific binding [GO:0097718]; ephrin receptor binding [GO:0046875]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein tyrosine kinase activity [GO:0004713]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; T cell receptor binding [GO:0042608]; tau protein binding [GO:0048156]; type 5 metabotropic glutamate receptor binding [GO:0031802]; activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; blood coagulation [GO:0007596]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to glycine [GO:1905430]; cellular response to L-glutamate [GO:1905232]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system development [GO:0007417]; cytokine-mediated signaling pathway [GO:0019221]; dendrite morphogenesis [GO:0048813]; dendritic spine maintenance [GO:0097062]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; leukocyte migration [GO:0050900]; MAPK cascade [GO:0000165]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; neuron migration [GO:0001764]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of defense response to virus by virus [GO:0050690]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to amyloid-beta [GO:1904645]; response to ethanol [GO:0045471]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cell membrane. Note=Present and active in lipid rafts. Palmitoylation is crucial for proper trafficking.","Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn)","GO:0000165; GO:0001764; GO:0002223; GO:0002250; GO:0004713; GO:0004715; GO:0005088; GO:0005524; GO:0005634; GO:0005739; GO:0005768; GO:0005829; GO:0005884; GO:0005886; GO:0006468; GO:0006816; GO:0007169; GO:0007411; GO:0007417; GO:0007596; GO:0007612; GO:0007631; GO:0008360; GO:0010629; GO:0010976; GO:0014068; GO:0014069; GO:0016477; GO:0018108; GO:0019221; GO:0030154; GO:0030168; GO:0030425; GO:0030900; GO:0031234; GO:0031295; GO:0031397; GO:0031802; GO:0035556; GO:0036120; GO:0038083; GO:0038096; GO:0042110; GO:0042127; GO:0042177; GO:0042531; GO:0042608; GO:0042609; GO:0042610; GO:0042802; GO:0042981; GO:0043014; GO:0043123; GO:0043524; GO:0043548; GO:0044297; GO:0044325; GO:0045087; GO:0045121; GO:0045471; GO:0046872; GO:0046875; GO:0046934; GO:0048010; GO:0048013; GO:0048156; GO:0048813; GO:0050690; GO:0050730; GO:0050798; GO:0050852; GO:0050900; GO:0050966; GO:0051428; GO:0051897; GO:0070851; GO:0071375; GO:0071560; GO:0090314; GO:0097062; GO:0097386; GO:0097718; GO:1900182; GO:1900449; GO:1901216; GO:1902951; GO:1903997; GO:1904645; GO:1905232; GO:1905430; GO:1905477; GO:1905664; GO:2001056; GO:2001240",0.00562155266171465,8.80867562504496e-05,0.00017644618958321,0.0355672403440193,0.0306671154371637,0.0327657488500462,0.031038006341227,0.0174810317064629,13.912106167619,9.56139450160655e-05,0.00974351630163715,-0.891613654303159,60762,2.01128428390086,7,0,0,0.00017644618958321,0.0327657488500462,185.69825127674,7.53681641923086
"59",60,85,85,85,"Q96IG2","FBXL20","FXL20_HUMAN","cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; behavioral fear response [GO:0001662]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like)","GO:0000209; GO:0001662; GO:0004842; GO:0005829; GO:0043687",7.09139218819764e-05,5.39277516230444e-05,7.65169294522795e-05,0.0522810866675905,0.0667548953840441,0.0557498894132372,0.0581948376206382,0.0291645383446382,13.8476906668062,9.75104941516008e-05,0.00981988035220827,-0.915722516879832,48423,2.00789380372958,10,0,0,7.09139218819764e-05,0.0557498894132372,786.162828591302,9.61868434153626
"60",61,86,86,86,"P50542","PEX5","PEX5_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular [GO:0005622]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome targeting sequence binding [GO:0000268]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]; negative regulation of protein homotetramerization [GO:1901094]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, translocation [GO:0016561]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; protein ubiquitination [GO:0016567]","SUBCELLULAR LOCATION: Cytoplasm. Peroxisome membrane; Peripheral membrane protein. Note=Its distribution appears to be dynamic. It is probably a cycling receptor found mainly in the cytoplasm and as well associated to the peroxisomal membrane through a docking factor (PEX13).","Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1)","GO:0000268; GO:0005052; GO:0005622; GO:0005737; GO:0005777; GO:0005778; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0008022; GO:0016020; GO:0016558; GO:0016560; GO:0016561; GO:0016567; GO:0019899; GO:0031267; GO:0032991; GO:0045046; GO:0047485; GO:0051262; GO:1901094",0.00224713364208029,0.00013571884492697,0.00021560190382077,0.0451716075327319,0.0449614838598502,0.0359210362151895,0.0411518910723145,0.0214420969997666,13.6646100603912,0.00010315867894097,0.0102678871131952,-0.984834304513486,70865,1.98851891467784,19,0,0,0.00021560190382077,0.0449614838598502,208.539363813905,7.70417592173697
"61",62,87,87,87,"O95071","UBR5","UBR5_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cell proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus, translocation [GO:0033160]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Nucleus.","E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)","GO:0000209; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006511; GO:0006974; GO:0008270; GO:0008283; GO:0010628; GO:0016020; GO:0032991; GO:0033160; GO:0034450; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:2000780",6.52810960475094e-05,9.80347016418348e-05,0.0072888899992658,0.0610608506396599,0.0560116611336936,0.0693789702544553,0.0596664254102846,0.0323172813041273,13.530691823092,0.00010754591957396,0.010398862916066,-1.03594999217749,309352,1.98301414688164,23,0,0,9.80347016418348e-05,0.0610608506396599,622.84935453512,9.28273945776571
"62",63,89,89,89,"P49840","GSK3A","GSK3A_HUMAN","apical dendrite [GO:0097440]; beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; proximal dendrite [GO:1990635]; ATP binding [GO:0005524]; protein kinase A catalytic subunit binding [GO:0034236]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; tau-protein kinase activity [GO:0050321]; aging [GO:0007568]; cardiac left ventricle morphogenesis [GO:0003214]; cell migration [GO:0016477]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-3 [GO:0036016]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; dopamine receptor signaling pathway [GO:0007212]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hypermethylation of CpG island [GO:0044027]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of dendrite development [GO:2000171]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of glycogen synthase activity, transferring glucose-1-phosphate [GO:1904227]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TOR signaling [GO:0032007]; negative regulation of type B pancreatic cell development [GO:2000077]; negative regulation of UDP-glucose catabolic process [GO:0010905]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071879]; positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway [GO:0106071]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of gene expression [GO:0010628]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of heart contraction [GO:0045823]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of systemic arterial blood pressure [GO:0003073]; Wnt signaling pathway [GO:0016055]",NA,"Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1)","GO:0003073; GO:0003214; GO:0004674; GO:0005102; GO:0005524; GO:0005739; GO:0005829; GO:0005874; GO:0005977; GO:0006349; GO:0006468; GO:0007212; GO:0007568; GO:0008286; GO:0010628; GO:0010800; GO:0010905; GO:0016055; GO:0016477; GO:0018105; GO:0018107; GO:0030877; GO:0031398; GO:0032007; GO:0032436; GO:0032869; GO:0033138; GO:0034236; GO:0036016; GO:0036498; GO:0043025; GO:0043161; GO:0043525; GO:0044027; GO:0045719; GO:0045732; GO:0045823; GO:0045944; GO:0046325; GO:0046627; GO:0050321; GO:0060079; GO:0061052; GO:0071285; GO:0071407; GO:0071879; GO:0090090; GO:0097191; GO:0097192; GO:0097440; GO:0098794; GO:0106071; GO:1901030; GO:1902004; GO:1903146; GO:1903955; GO:1904227; GO:1990635; GO:2000077; GO:2000171; GO:2000466; GO:2000467",0.00574576937828337,4.06529481851945e-05,4.39011447126805e-05,0.043186826143253,0.037080779015813,0.0364973983998279,0.0369782266959042,0.0204325545050125,13.4131097719494,0.00011158814564328,0.010398862916066,-1.08122985630318,50981,1.98301414688164,6,0,0,4.39011447126805e-05,0.037080779015813,844.642645618817,9.72219727976213
"63",64,90,90,90,"Q13002","GRIK2","GRIK2_HUMAN","cell junction [GO:0030054]; dendrite cytoplasm [GO:0032839]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; extracellularly glutamate-gated ion channel activity [GO:0005234]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; intracellular protein transport [GO:0006886]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of synaptic transmission [GO:0050806]; receptor clustering [GO:0043113]; regulation of JNK cascade [GO:0046328]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]","SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. Cell junction, synapse, postsynaptic cell membrane; Multi-pass membrane protein.","Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)","GO:0001662; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0006886; GO:0007215; GO:0007268; GO:0014069; GO:0015276; GO:0015277; GO:0019228; GO:0030054; GO:0030165; GO:0031624; GO:0031625; GO:0032839; GO:0032983; GO:0035249; GO:0042734; GO:0042803; GO:0043113; GO:0043195; GO:0043204; GO:0043524; GO:0043525; GO:0045211; GO:0046328; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080",8.128934680792e-05,0.00022751836712052,0.00023787627011116,0.329632670847169,0.272085230787317,0.256894206588254,0.286021808079567,0.143193132034463,13.4049330104401,0.00011187612268265,0.010398862916066,-1.0843927199042,102583,1.98301414688164,3,0,0,0.00022751836712052,0.272085230787317,1195.88248733866,10.2238599156169
"64",65,93,93,93,"Q719H9","KCTD1","KCTD1_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18358072}.","BTB/POZ domain-containing protein KCTD1 (Potassium channel tetramerization domain-containing protein 1)","GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0008134; GO:0042802; GO:0045892; GO:0051260",0.0550905731255052,0.0814253700099528,0.0507403315054204,0.240223840242702,0.261980783812282,0.226846912171026,0.180598420528377,0.152717968477815,13.3689367484157,0.00011315477216429,0.010398862916066,-1.09833838557561,29405,1.98301414688164,3,0,0,0.0550905731255052,0.240223840242702,4.36052534242897,2.12450195685082
"65",66,95,95,95,"Q9ULD9","ZNF608","ZN608_HUMAN","metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription, DNA-templated [GO:0006351]",NA,"Zinc finger protein 608 (Renal carcinoma antigen NY-REN-36)","GO:0000122; GO:0003676; GO:0006351; GO:0046872",0.00011171154118384,0.00536658222503571,0.00018646565345878,0.15078201601581,0.183822619413891,0.196163023947668,0.175034299985897,0.0894054031328411,13.3051672227095,0.00011546431018239,0.010398862916066,-1.12313204934843,162208,1.98301414688164,17,0,0,0.00018646565345878,0.183822619413891,985.825625278098,9.94518867228635
"66",68,97,97,97,"Q9UHG3","PCYOX1","PCYOX_HUMAN","extracellular exosome [GO:0070062]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; very-low-density lipoprotein particle [GO:0034361]; chloride-transporting ATPase activity [GO:0008555]; prenylcysteine oxidase activity [GO:0001735]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328]; prenylcysteine metabolic process [GO:0030329]","SUBCELLULAR LOCATION: Lysosome.","Prenylcysteine oxidase 1 (EC 1.8.3.5) (Prenylcysteine lyase)","GO:0001735; GO:0005764; GO:0005774; GO:0005886; GO:0008555; GO:0030327; GO:0030328; GO:0030329; GO:0034361; GO:0070062",1.3315208450831e-05,8.40083426637238e-06,0.00028308480035278,0.017316822024146,0.0168562392059521,0.0214104233704222,0.0184262279191501,0.00931471424059837,13.1852142294334,0.00011996750689762,0.0105748748512331,-1.17007816818037,56640,1.97572476359741,22,0,0,1.3315208450831e-05,0.017316822024146,1300.52954770417,10.3448834619838
"67",69,98,98,98,"Q5JSZ5","PRRC2B","PRC2B_HUMAN","RNA binding [GO:0003723]; cell differentiation [GO:0030154]",NA,"Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B)","GO:0003723; GO:0030154",0.00276222924459815,0.00010408446583021,9.25004015673208e-05,0.131474702554558,0.138351933838843,0.106205561846304,0.124357794709236,0.0631651687252834,13.156751693304,0.0001210674924557,0.0105748748512331,-1.18127725307956,242967,1.97572476359741,35,0,0,0.00010408446583021,0.131474702554558,1263.15393469981,10.3028147490413
"68",70,99,99,99,"Q9HBE1","PATZ1","PATZ1_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10713105}.","POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein)","GO:0000978; GO:0000981; GO:0001077; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006355; GO:0007283; GO:0008584; GO:0030217; GO:0045892; GO:0046872",0.00015822748959571,0.00015977953885725,0.00016769049806011,0.369633552710407,0.302059890525835,0.287448798103687,0.319552181271139,0.159937989811074,13.1063346484516,0.00012304649507694,0.0106391716955419,-1.20117142973282,74060,1.9730921823848,9,0,0,0.00015977953885725,0.302059890525835,1890.47917327951,10.884536240429
"69",71,101,101,101,"P52292","KPNA2","IMA1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; RNA binding [GO:0003723]; DNA metabolic process [GO:0006259]; modulation by virus of host process [GO:0019054]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of DNA recombination [GO:0000018]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:7604027}. Nucleus {ECO:0000269|PubMed:7604027}.","Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha)","GO:0000018; GO:0003723; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006259; GO:0006607; GO:0008139; GO:0008565; GO:0016020; GO:0019054; GO:0042826; GO:0061608",6.20300138779632e-05,0.00017425386115444,0.00192732484400432,0.165756824199806,0.12689788364378,0.16012551873469,0.150205539286413,0.0758239725495522,12.8468459669639,0.00013388365685951,0.0113263033593921,-1.30472878727428,57862,1.94591181057585,7,0,0,0.00017425386115444,0.16012551873469,918.920921888622,9.84379690492578
"70",72,102,102,102,"Q9BPZ7","MAPKAP1","SIN1_HUMAN","cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; Ras GTPase binding [GO:0017016]; activation of protein kinase B activity [GO:0032148]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; negative regulation of Ras protein signal transduction [GO:0046580]; stress-activated protein kinase signaling cascade [GO:0031098]; substantia nigra development [GO:0021762]; TORC2 signaling [GO:0038203]","SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein. Cytoplasmic vesicle. Nucleus.","Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1) (mSIN1)","GO:0005546; GO:0005547; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0017016; GO:0019901; GO:0021762; GO:0030950; GO:0031098; GO:0031410; GO:0031932; GO:0032148; GO:0038203; GO:0043325; GO:0046580; GO:0070300; GO:0080025",0.00020500552109565,0.00015371851275575,0.00014045676382733,0.0272356905479599,0.0360800967090693,0.0331058765525495,0.0319741610039667,0.0161534741012096,12.7736879428784,0.00013714843806121,0.0113263033593921,-1.33428392766847,59123,1.94591181057585,6,0,0,0.00015371851275575,0.0331058765525495,215.366880404007,7.75065259587469
"71",73,103,103,103,"Q9BQ39","DDX50","DDX50_HUMAN","cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; RNA secondary structure unwinding [GO:0010501]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849}.","ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2)","GO:0003723; GO:0004004; GO:0005524; GO:0005730; GO:0005737; GO:0005886; GO:0010501; GO:0016020",0.0001097295302585,6.35956260735007e-05,7.13287578477646e-05,0.0102192828092321,0.0121965384843921,0.00930972173906442,0.0104936297061696,0.0053283661578114,12.7666355140064,0.00013746829805229,0.0113263033593921,-1.33714152378383,82565,1.94591181057585,7,0,0,7.13287578477646e-05,0.0102192828092321,143.270163642032,7.16259438592429
"72",74,105,105,105,"Q8NFZ8","CADM4","CADM4_HUMAN","cell-cell adherens junction [GO:0005913]; integral component of plasma membrane [GO:0005887]; cell adhesion molecule binding [GO:0050839]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cell recognition [GO:0008037]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.","Cell adhesion molecule 4 (Immunoglobulin superfamily member 4C) (IgSF4C) (Nectin-like protein 4) (NECL-4) (TSLC1-like protein 2)","GO:0005102; GO:0005887; GO:0005913; GO:0007156; GO:0007157; GO:0008037; GO:0042803; GO:0050839",1e-07,1e-07,1e-07,0.134700779873456,0.102226753127241,0.113404177205136,0.116777136735278,0.0583886683676388,12.7287254474918,0.0001392034616512,0.011348396492708,-1.35252812961745,42785,1.94506549913746,6,3,0,1e-07,0.113404177205136,1134041.77205136,20.1130423517749
"73",75,106,106,106,"Q24JP5","TMEM132A","T132A_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; cellular protein metabolic process [GO:0044267]; post-translational protein modification [GO:0043687]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Endoplasmic reticulum membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.","Transmembrane protein 132A (HSPA5-binding protein 1)","GO:0000139; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0016021; GO:0043687; GO:0044267; GO:0070062",0.00409584655272037,0.00819962939744129,0.0106444181199801,0.197760791529678,0.154404424216259,0.162792065671577,0.164005795782457,0.0896495292479426,12.6942171706687,0.00014080633802919,0.0113707759766974,-1.36657187822585,110110,1.94420989671082,13,0,0,0.00819962939744129,0.162792065671577,19.8535882270943,4.31132787049745
"74",76,107,107,107,"Q9HAT8","PELI2","PELI2_HUMAN","cytosol [GO:0005829]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; immune response [GO:0006955]; interleukin-1-mediated signaling pathway [GO:0070498]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; Toll signaling pathway [GO:0008063]",NA,"E3 ubiquitin-protein ligase pellino homolog 2 (Pellino-2) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase pellino homolog 2)","GO:0000209; GO:0001934; GO:0004674; GO:0005829; GO:0006955; GO:0008063; GO:0034450; GO:0043123; GO:0043410; GO:0061630; GO:0070498",1.98075690794172e-06,1.55242091949406e-05,1.10261834899328e-05,0.167799942674517,0.125889450807484,0.148856147460297,0.147505669930902,0.0737623453486485,12.6386884922311,0.00014343340866457,0.0114664318242502,-1.38924640373198,46435,1.94057170678273,4,0,0,1.10261834899328e-05,0.148856147460297,13500.2421822752,13.7206976677169
"75",77,108,108,108,"Q9NUS5","AP5S1","AP5S1_HUMAN","AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:22022230}. Late endosome membrane {ECO:0000305|PubMed:22022230}; Peripheral membrane protein {ECO:0000305|PubMed:22022230}; Cytoplasmic side {ECO:0000305|PubMed:22022230}. Lysosome membrane {ECO:0000305|PubMed:22022230}; Peripheral membrane protein {ECO:0000305|PubMed:22022230}; Cytoplasmic side {ECO:0000305|PubMed:22022230}.","AP-5 complex subunit sigma-1 (Adaptor-related protein complex 5 sigma subunit) (Sigma5)","GO:0000724; GO:0005654; GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016197; GO:0030119; GO:0031902",1e-07,1e-07,1e-07,0.0306511327166337,0.0264918099956981,0.0230422075134518,0.0267282834085945,0.0133642417042973,12.612982013322,0.00014466993423119,0.0114664318242502,-1.39977534963756,22522,1.94057170678273,3,3,0,1e-07,0.0264918099956981,264918.099956981,18.0151868905343
"76",78,109,109,109,"Q86WA8","LONP2","LONP2_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; peroxisome organization [GO:0007031]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070]","SUBCELLULAR LOCATION: Peroxisome matrix {ECO:0000255|HAMAP-Rule:MF_03121, ECO:0000269|PubMed:14561759, ECO:0000269|PubMed:18281296, ECO:0000269|PubMed:22002062}.","Lon protease homolog 2, peroxisomal (EC 3.4.21.53) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease) (pLon)","GO:0002020; GO:0004176; GO:0004252; GO:0005102; GO:0005524; GO:0005634; GO:0005777; GO:0005782; GO:0005829; GO:0006515; GO:0006625; GO:0007031; GO:0008233; GO:0014070; GO:0016020; GO:0016485; GO:0019899; GO:0031998",1e-07,1e-07,1e-07,0.0918465762149333,0.0730087369979509,0.0966487221446982,0.0871679117858608,0.0435840558929304,12.5447419888074,0.00014801639148825,0.0116240395517381,-1.42782424472026,94617,1.93464292098529,11,3,0,1e-07,0.0918465762149333,918465.762149333,19.8088664171147
"77",80,111,111,111,"Q8N350","CBARP","CBARP_HUMAN","cell junction [GO:0030054]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synaptic vesicle membrane [GO:0030672]; ion channel binding [GO:0044325]; negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of voltage-gated calcium channel activity [GO:1901386]","SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {ECO:0000250|UniProtKB:Q66L44}; Single-pass type III membrane protein {ECO:0000250|UniProtKB:Q66L44}. Cell membrane {ECO:0000250|UniProtKB:Q66L44}; Single-pass type III membrane protein {ECO:0000250|UniProtKB:Q66L44}. Cell projection, growth cone {ECO:0000250|UniProtKB:Q66L44}.","Voltage-dependent calcium channel beta subunit-associated regulatory protein","GO:0005886; GO:0016021; GO:0030054; GO:0030141; GO:0030426; GO:0030672; GO:0044325; GO:0045955; GO:1901386; GO:1903170",0.0084531931706784,0.00707743929864754,0.00361837494062206,0.0261197378479641,0.0298368838495453,0.0275644905992908,0.0214573682956174,0.0171116866177914,12.3748077040397,0.00015677172264699,0.0119242724133221,-1.4983054280371,73929,1.92356811094776,11,0,0,0.00707743929864754,0.0275644905992908,3.89469827096337,1.96151156452668
"78",81,112,112,112,"Q15345","LRRC41","LRC41_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]",NA,"Leucine-rich repeat-containing protein 41 (Protein Muf1)","GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0016567; GO:0042803; GO:0043687",1.76369851070422e-05,6.24364175763377e-05,5.56036722566984e-05,0.0370708850786697,0.0348234481058147,0.0456289874696204,0.0391292145263882,0.0196098329548408,12.3399766108709,0.00015864400829835,0.0119242724133221,-1.51286479379512,88650,1.92356811094776,7,0,0,5.56036722566984e-05,0.0370708850786697,666.698503428501,9.38089067840354
"79",82,113,113,113,"Q8IVL1","NAV2","NAV2_HUMAN","interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; heparin binding [GO:0008201]; glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12214280}.","Neuron navigator 2 (EC 3.6.4.12) (Helicase APC down-regulated 1) (Pore membrane and/or filament-interacting-like protein 2) (Retinoic acid inducible in neuroblastoma 1) (Steerin-2) (Unc-53 homolog 2) (unc53H2)","GO:0003025; GO:0004386; GO:0005524; GO:0005614; GO:0005654; GO:0007605; GO:0007608; GO:0007626; GO:0008201; GO:0021554; GO:0021563; GO:0021564",0.00019306217414659,0.00011859167541038,0.00011094686550025,0.0610245077416161,0.0488964630525764,0.0652728004272536,0.058257056835463,0.0292693953227506,12.3267954746313,0.00015935968405043,0.0119242724133221,-1.51838462973073,268167,1.92356811094776,18,0,0,0.00011859167541038,0.0610245077416161,514.576655827183,9.00724219934105
"80",83,117,117,117,"Q96Q11","TRNT1","TRNT1_HUMAN","intracellular [GO:0005622]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 5'-3' RNA polymerase activity [GO:0034062]; ATP binding [GO:0005524]; ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [GO:0052929]; CTP:3'-cytidine-tRNA cytidylyltransferase activity [GO:0052928]; CTP:tRNA cytidylyltransferase activity [GO:0052927]; tRNA binding [GO:0000049]; mitochondrial tRNA 3'-end processing [GO:1990180]; tRNA 3'-end processing [GO:0042780]; tRNA 3'-terminal CCA addition [GO:0001680]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:11256614}.","CCA tRNA nucleotidyltransferase 1, mitochondrial (EC 2.7.7.72) (Mitochondrial tRNA nucleotidyl transferase, CCA-adding) (mt CCA-adding enzyme) (mt tRNA CCA-diphosphorylase) (mt tRNA CCA-pyrophosphorylase) (mt tRNA adenylyltransferase)","GO:0000049; GO:0001680; GO:0005524; GO:0005622; GO:0005654; GO:0005739; GO:0005759; GO:0034062; GO:0042780; GO:0052927; GO:0052928; GO:0052929; GO:1990180",0.0073858171838205,0.00485205977997976,0.00241958568377078,0.0241296338320301,0.0276262927274739,0.0253220381259812,0.020806834012638,0.0152892378888427,12.2481420624034,0.00016371350070459,0.0119242724133221,-1.55143852801824,50128,1.92356811094776,7,0,0,0.00485205977997976,0.0253220381259812,5.21882237116354,2.3837242989497
"81",84,120,120,120,"P56159","GFRA1","GFRA1_HUMAN","anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; MAPK cascade [GO:0000165]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-anchor {ECO:0000250}.","GDNF family receptor alpha-1 (GDNF receptor alpha-1) (GDNFR-alpha-1) (GFR-alpha-1) (RET ligand 1) (TGF-beta-related neurotrophic factor receptor 1)","GO:0000165; GO:0005088; GO:0005102; GO:0005622; GO:0005886; GO:0007166; GO:0007411; GO:0016167; GO:0019898; GO:0031225; GO:0070062",0.00108856425747171,0.00016035150349422,0.00033890948729386,0.104351634379849,0.138312239567869,0.13383826970726,0.124971439468906,0.0630149948172063,12.1750252868678,0.00016789236500484,0.0119763220370121,-1.58234593575784,51456,1.92167653455738,8,0,0,0.00033890948729386,0.13383826970726,394.908595731379,8.62537496016622
"82",85,121,121,121,"Q16774","GUK1","KGUA_HUMAN","cytosol [GO:0005829]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; nucleobase-containing small molecule interconversion [GO:0015949]; purine nucleotide metabolic process [GO:0006163]",NA,"Guanylate kinase (EC 2.7.4.8) (GMP kinase)","GO:0004385; GO:0005524; GO:0005829; GO:0006163; GO:0006185; GO:0015949; GO:0019673; GO:0034436; GO:0046034; GO:0046054; GO:0046060; GO:0046711",3.60671665280267e-06,4.3140169083434e-05,5.13583973482086e-05,0.04916277947272,0.0474470720569416,0.0618786125633286,0.0527967862699686,0.0264310948960124,12.0424876619148,0.0001758061174675,0.0124371931034862,-1.63882042403973,21726,1.90527762263672,6,0,0,4.3140169083434e-05,0.04916277947272,1139.60562782307,10.1543189360525
"83",86,122,122,122,"Q99848","EBNA1BP2","EBP2_HUMAN","nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:19170763, ECO:0000269|PubMed:2879624}. Note=Associated with the nucleolus in an RNA-dependent manner.","Probable rRNA-processing protein EBP2 (EBNA1-binding protein 2) (Nucleolar protein p40)","GO:0003723; GO:0005634; GO:0005730; GO:0006364; GO:0030687; GO:0034399; GO:0042273",1e-07,1e-07,1e-07,0.0470748468265681,0.0363284535362242,0.0368537800416909,0.0400855934681611,0.0200428967340805,11.8972170372446,0.00018501237915125,0.0129811964388095,-1.70139729295107,34852,1.88668527804205,3,3,0,1e-07,0.0368537800416909,368537.800416909,18.4914530765988
"84",87,123,123,123,"P38117","ETFB","ETFB_HUMAN","cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]","SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000305|PubMed:25023281, ECO:0000305|PubMed:8504797}.","Electron transfer flavoprotein subunit beta (Beta-ETF)","GO:0005739; GO:0005759; GO:0005829; GO:0009055; GO:0033539",1e-07,1e-07,1e-07,0.0129464580890367,0.0128106089374607,0.00977124826999344,0.011842671765497,0.00592143588274848,11.8518492407133,0.00018800794042739,0.0130841298378741,-1.72108739396955,27844,1.88325515488698,13,3,0,1e-07,0.0128106089374607,128106.089374607,16.9669795285844
"85",88,124,124,124,"P29372","MPG","3MG_HUMAN","mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; alkylbase DNA N-glycosylase activity [GO:0003905]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA dealkylation involved in DNA repair [GO:0006307]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23290262}. Mitochondrion matrix, mitochondrion nucleoid {ECO:0000269|PubMed:23290262}. Nucleus {ECO:0000269|PubMed:23290262}.","DNA-3-methyladenine glycosylase (EC 3.2.2.21) (3-alkyladenine DNA glycosylase) (3-methyladenine DNA glycosidase) (ADPG) (N-methylpurine-DNA glycosylase)","GO:0003684; GO:0003905; GO:0005654; GO:0006284; GO:0006307; GO:0008725; GO:0019104; GO:0042645; GO:0043916; GO:0045007; GO:0052821; GO:0052822",1e-07,1e-07,0.00489202776428757,0.0718593366810219,0.0570091256542678,0.0564470999143726,0.0601411114951249,0.0317012983356583,11.7735468346505,0.00019331931683778,0.0133452689688017,-1.75523881944754,32869,1.87467266874877,5,2,0,1e-07,0.0570091256542678,570091.256542678,19.1208333495453
"86",89,125,125,125,"Q15048","LRRC14","LRC14_HUMAN","cytoplasm [GO:0005737]; kinase binding [GO:0019900]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:27426725}.","Leucine-rich repeat-containing protein 14","GO:0005737; GO:0019900; GO:0032088; GO:0034122",0.00092194269649173,0.00085033578333437,0.00401540544760616,0.043676179682229,0.0359211768759935,0.0478783077627967,0.0405626601311957,0.0222105580414086,11.5236932649699,0.00021154314573383,0.0144864746198531,-1.86565647445681,54513,1.83903729012753,9,0,0,0.00092194269649173,0.043676179682229,47.3740719986503,5.56602577777937
"87",90,126,126,126,"O94964","SOGA1","SOGA1_HUMAN","extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; insulin receptor signaling pathway [GO:0008286]; negative regulation of gluconeogenesis [GO:0045721]; regulation of autophagy [GO:0010506]","SUBCELLULAR LOCATION: C-terminal 80 kDa form: Secreted {ECO:0000250}. Note=Secreted in primary hepatocyte-conditioned media. {ECO:0000250}.","Protein SOGA1 (SOGA family member 1) (Suppressor of glucose by autophagy) (Suppressor of glucose, autophagy-associated protein 1) [Cleaved into: N-terminal form; C-terminal 80 kDa form (80-kDa SOGA fragment)]","GO:0005615; GO:0008286; GO:0010506; GO:0045721; GO:0070062",1.7405288785706e-05,0.00016292133940051,4.21034897589026e-05,0.106613995515481,0.106478445938619,0.13831911036627,0.117063040567475,0.0586056636563858,11.4754025415663,0.00021530457101738,0.0145168016563522,-1.88725622567257,159760,1.83812905691424,21,0,0,4.21034897589026e-05,0.106613995515481,2532.1890448033,11.3061694002574
"88",91,128,128,128,"Q6PID6","TTC33","TTC33_HUMAN",NA,NA,"Tetratricopeptide repeat protein 33 (TPR repeat protein 33) (Osmosis-responsive factor)",NA,1e-07,1e-07,1e-07,0.122297753898766,0.0978864164520919,0.0913040637274854,0.103829311359448,0.0519147556797239,11.4342094158193,0.00021857811846382,0.0145168016563522,-1.90574872461785,29411,1.83812905691424,3,3,0,1e-07,0.0978864164520919,978864.164520919,19.9007491475767
"89",92,129,129,129,"Q643R3","LPCAT4","LPCT4_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphoethanolamine O-acyltransferase activity [GO:0047166]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; lysophospholipid acyltransferase activity [GO:0071617]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:16243729, ECO:0000269|PubMed:18458083}; Multi-pass membrane protein {ECO:0000269|PubMed:16243729, ECO:0000269|PubMed:18458083}.","Lysophospholipid acyltransferase LPCAT4 (1-acylglycerol-3-phosphate O-acyltransferase 7) (1-AGP acyltransferase 7) (1-AGPAT 7) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (1-alkenylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.121) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 3) (Lysophosphatidylcholine acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase 2) (EC 2.3.1.n7) (Plasmalogen synthase)","GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016021; GO:0036148; GO:0036150; GO:0036151; GO:0036152; GO:0047144; GO:0047166; GO:0047184; GO:0047192; GO:0071617",7.32824240223275e-05,1e-07,1e-07,0.0898073440605833,0.0708376366724365,0.0676808086164734,0.0760841023084903,0.0380665452955859,11.4318238465601,0.00021876955767166,0.0145168016563522,-1.90682156917808,57219,1.83812905691424,8,2,0,1e-07,0.0708376366724365,708376.366724365,19.4341565552755
"90",93,130,130,130,"Q86UL8","MAGI2","MAGI2_HUMAN","bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; phosphatase binding [GO:0019902]; receptor signaling complex scaffold activity [GO:0030159]; SMAD binding [GO:0046332]; type II activin receptor binding [GO:0070699]; cellular response to nerve growth factor stimulus [GO:1990090]; glomerular visceral epithelial cell development [GO:0072015]; mitotic cell cycle arrest [GO:0071850]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; planar cell polarity pathway involved in axis elongation [GO:0003402]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synaptic vesicle clustering [GO:2000809]; protein heterooligomerization [GO:0051291]; receptor clustering [GO:0043113]; SMAD protein signal transduction [GO:0060395]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Late endosome {ECO:0000250}. Cell junction, synapse, synaptosome {ECO:0000250}. Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=Localized diffusely in the cytoplasm before nerve growth factor (NGF) stimulation. Recruted to late endosomes after NGF stimulation. Membrane-associated in synaptosomes (By similarity). {ECO:0000250}.","Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (Atrophin-1-interacting protein 1) (AIP-1) (Atrophin-1-interacting protein A) (Membrane-associated guanylate kinase inverted 2) (MAGI-2)","GO:0002092; GO:0003402; GO:0005634; GO:0005737; GO:0005770; GO:0005886; GO:0005923; GO:0008285; GO:0010976; GO:0014069; GO:0019902; GO:0030159; GO:0030336; GO:0030425; GO:0031697; GO:0032516; GO:0032926; GO:0032991; GO:0036057; GO:0038180; GO:0043113; GO:0045202; GO:0046332; GO:0048471; GO:0051291; GO:0051898; GO:0060395; GO:0070699; GO:0071850; GO:0072015; GO:0097118; GO:1990090; GO:2000809",0.00015553951970633,9.51995879212895e-05,0.00013091022760074,0.0247333577517146,0.024009762540061,0.0316221889484576,0.026661219968335,0.0134578264292436,11.4083227729325,0.00022066651889823,0.0145300415520687,-1.91740175192549,158754,1.83773314373306,14,0,0,0.00013091022760074,0.0247333577517146,188.933731191334,7.56173648535022
"91",94,131,131,131,"Q96P11","NSUN5","NSUN5_HUMAN","nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; rRNA base methylation [GO:0070475]",NA,"Probable 28S rRNA (cytosine-C(5))-methyltransferase (EC 2.1.1.-) (NOL1-related protein) (NOL1R) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein)","GO:0003723; GO:0005634; GO:0005730; GO:0008173; GO:0008757; GO:0070475",0.00014040095359443,6.73536180978727e-05,0.00017672373522214,0.0470930782463102,0.0527089703851222,0.0382896247556273,0.0459023983600484,0.0230793586156624,11.3561090449358,0.00022495376961141,0.0146023115803605,-1.94098156565223,46692,1.83557838893265,6,0,0,0.00014040095359443,0.0470930782463102,335.418507073292,8.38981848310824
"92",95,132,132,132,"Q9Y5I4","PCDHAC2","PCDC2_HUMAN","integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.","Protocadherin alpha-C2 (PCDH-alpha-C2)","GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007267; GO:0007399",9.40089875626644e-05,8.00074178827619e-05,7.07294703593635e-05,0.0644301559111227,0.0744115456293153,0.0540690731515964,0.0642220096054099,0.0321925867613065,11.3534378505278,0.00022517583278126,0.0146023115803605,-1.94219060750311,109450,1.83557838893265,4,0,0,8.00074178827619e-05,0.0644301559111227,805.302278415419,9.65338660494507
"93",96,134,134,134,"Q9GZS1","POLR1E","RPA49_HUMAN","DNA-directed RNA polymerase I complex [GO:0005736]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; RNA polymerase I transcription factor binding [GO:0001179]; positive regulation of gene expression, epigenetic [GO:0045815]; RNA polymerase I transcriptional preinitiation complex assembly [GO:0001188]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849}.","DNA-directed RNA polymerase I subunit RPA49 (RNA polymerase I subunit A49) (DNA-directed RNA polymerase I subunit E) (RNA polymerase I-associated factor 1) (RNA polymerase I-associated factor 53)","GO:0001179; GO:0001188; GO:0001650; GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005730; GO:0005736; GO:0006361; GO:0006363; GO:0045815",5.0347860041441e-05,0.0921938843333735,0.00011321149300929,0.463071492284056,0.487841968322589,0.406971617832272,0.421842544917498,0.24170708702089,11.2521986508994,0.00023379371598911,0.0149348821557226,-1.98821091584314,53962,1.82579819986409,3,0,0,0.00011321149300929,0.463071492284056,4090.32228067213,11.997998803724
"94",97,135,135,135,"O43929","ORC4","ORC4_HUMAN","cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]","SUBCELLULAR LOCATION: Nucleus.","Origin recognition complex subunit 4","GO:0000082; GO:0000166; GO:0000784; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005730; GO:0005829; GO:0006260; GO:0006270",0.0103976926483355,0.0150150671661777,0.00758952658206434,0.122145045592157,0.099035609633022,0.131437049541509,0.106538472790037,0.064269998527211,11.2032850441227,0.00023810211186308,0.0150782817362472,-2.01058437703556,50377,1.82164814619725,5,0,0,0.0103976926483355,0.122145045592157,11.7473221918817,3.55426002607974
"95",98,136,136,136,"Q96KQ7","EHMT2","EHMT2_HUMAN","nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; DNA methylation [GO:0006306]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; regulation of DNA replication [GO:0006275]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11316813}. Chromosome {ECO:0000269|PubMed:11316813}. Note=Associates with euchromatic regions. Does not associate with heterochromatin.","Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a)","GO:0000122; GO:0000790; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006306; GO:0008270; GO:0009267; GO:0016279; GO:0016571; GO:0016607; GO:0018024; GO:0018027; GO:0034968; GO:0046974; GO:0046976; GO:0070317; GO:0070742; GO:1990841",0.00010142354105055,9.41124538548769e-05,9.07504801591312e-05,0.0701505923906499,0.0507203811112411,0.0607681108013454,0.0604509326093906,0.0303208951297168,11.1869619982104,0.00023956148552916,0.0150782817362472,-2.01807096751362,132370,1.82164814619725,12,0,0,9.41124538548769e-05,0.0607681108013454,645.696805388274,9.33471307908409
"96",99,137,137,137,"Q12974","PTP4A2","TP4A2_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; prenylated protein tyrosine phosphatase activity [GO:0004727]; post-translational protein modification [GO:0043687]","SUBCELLULAR LOCATION: Cell membrane. Early endosome. Cytoplasm.","Protein tyrosine phosphatase type IVA 2 (EC 3.1.3.48) (HU-PP-1) (OV-1) (PTP(CAAXII)) (Protein-tyrosine phosphatase 4a2) (Protein-tyrosine phosphatase of regenerating liver 2) (PRL-2)","GO:0004727; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0043687",5.6818645534483e-05,0.00688374264973998,0.00011373740774771,0.028506579676776,0.0276611414562883,0.0264590352497317,0.0251908192265913,0.014946842514303,11.1616567562685,0.00024184564995381,0.0150811860698479,-2.02969743866768,19127,1.82156450174647,5,0,0,0.00011373740774771,0.0276611414562883,243.201792655989,7.92601005279296
"97",100,138,138,138,"Q92845","KIFAP3","KIFA3_HUMAN","axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intraciliary transport particle [GO:0030990]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; kinesin binding [GO:0019894]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]; signal transduction [GO:0007165]",NA,"Kinesin-associated protein 3 (KAP-3) (KAP3) (Smg GDS-associated protein)","GO:0000794; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0005929; GO:0005930; GO:0006890; GO:0007017; GO:0007018; GO:0007165; GO:0008104; GO:0008285; GO:0015630; GO:0016939; GO:0019886; GO:0019894; GO:0030990; GO:0032391; GO:0035735; GO:0036064; GO:0043066; GO:0046587; GO:0065003; GO:0072383; GO:0097542; GO:1990075",7.4307694166774e-05,0.0155740512775207,7.96206183668932e-05,0.154926793312134,0.116973715125942,0.134368011870127,0.130180180239383,0.0703327499830428,11.1475423810143,0.00024313127075222,0.0150811860698479,-2.03619296762059,91205,1.82156450174647,13,0,0,7.96206183668932e-05,0.134368011870127,1687.60321919326,10.7207600293524
"98",101,139,139,139,"O75164","KDM4A","KDM4A_HUMAN","cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; methylated histone binding [GO:0035064]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00537, ECO:0000269|PubMed:15927959, ECO:0000269|PubMed:16024779}.","Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A)","GO:0001650; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0008270; GO:0010507; GO:0010629; GO:0016032; GO:0016577; GO:0031625; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0045892; GO:0051864; GO:0070544",1e-07,1.08922508626597e-05,1e-07,0.152066638621351,0.136443369837931,0.186491085179199,0.15833000046254,0.0791686976482241,11.1193629655139,0.00024572316034888,0.0151323039754418,-2.04918430671114,120662,1.82009494324956,5,2,0,1e-07,0.152066638621351,1520666.38621351,20.53627224918
"99",102,142,142,142,"P35813","PPM1A","PPM1A_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin-dependent protein phosphatase activity [GO:0033192]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; R-SMAD binding [GO:0070412]; cell cycle arrest [GO:0007050]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dephosphorylation [GO:0016311]; N-terminal protein myristoylation [GO:0006499]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; protein dephosphorylation [GO:0006470]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16751101}. Cytoplasm, cytosol {ECO:0000269|PubMed:22781750}. Membrane {ECO:0000269|PubMed:20213681, ECO:0000269|PubMed:25255805}; Lipid-anchor {ECO:0000269|PubMed:20213681, ECO:0000269|PubMed:25255805}. Note=Weakly associates at the membrane and N-myristoylation mediates the membrane localization. {ECO:0000250|UniProtKB:P49443}.","Protein phosphatase 1A (EC 3.1.3.16) (Protein phosphatase 2C isoform alpha) (PP2C-alpha) (Protein phosphatase IA)","GO:0000122; GO:0000287; GO:0004722; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006470; GO:0006499; GO:0007050; GO:0010991; GO:0016020; GO:0016055; GO:0016311; GO:0030145; GO:0030177; GO:0030512; GO:0030514; GO:0033192; GO:0035970; GO:0043123; GO:0043124; GO:0045893; GO:0046827; GO:0070412; GO:0071560; GO:1901223",0.00040670908627361,0.00048926557589205,0.00311355113082661,0.0242904405488689,0.0326511917962657,0.0286904837477402,0.0272075300999608,0.0149402736476445,10.9767170135738,0.00025937522011701,0.0156355766493074,-2.11542193642522,42448,1.80588609708852,9,0,0,0.00048926557589205,0.0286904837477402,58.6398985774351,5.8738107031006
"100",103,143,143,143,"P22694","PRKACB","KAPCB_HUMAN","cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-modulating G-protein coupled receptor signaling pathway [GO:0007188]; blood coagulation [GO:0007596]; cellular response to glucagon stimulus [GO:0071377]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; response to clozapine [GO:0097338]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21423175}. Cell membrane {ECO:0000269|PubMed:21423175}. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}. Nucleus {ECO:0000250}. Note=Translocates into the nucleus (monomeric catalytic subunit). The inactive holoenzyme is found in the cytoplasm. {ECO:0000250}.","cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11)","GO:0000287; GO:0001843; GO:0002223; GO:0003091; GO:0004674; GO:0004691; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007188; GO:0007596; GO:0016301; GO:0031625; GO:0034199; GO:0034380; GO:0045171; GO:0048471; GO:0051447; GO:0070062; GO:0070613; GO:0071377; GO:0097338; GO:0097546; GO:1901621",0.00065028859294236,0.00259694078644515,0.00054718272544193,0.0565500290805973,0.0538304388129956,0.0414639984422684,0.0493500180770107,0.0259398130734485,10.9244074861343,0.00026461338012522,0.0157914208121438,-2.13991292032928,40623,1.80157879316372,5,0,0,0.00065028859294236,0.0538304388129956,82.7793065989811,6.37119825876843
"101",104,144,144,144,"Q8N8A6","DDX51","DDX51_HUMAN","cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; RNA secondary structure unwinding [GO:0010501]; rRNA processing [GO:0006364]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.","ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51)","GO:0003723; GO:0004004; GO:0005524; GO:0005730; GO:0005737; GO:0006364; GO:0010501; GO:0016020",1.30027122639408e-05,1e-07,1e-07,0.0737091529338327,0.0719950150729743,0.0539205314425256,0.0665371655790229,0.0332729836935994,10.913195514654,0.0002657529341768,0.0157914208121438,-2.1451764923994,72457,1.80157879316372,4,2,0,1e-07,0.0719950150729743,719950.150729743,19.4575374924019
"102",105,145,145,145,"Q8WX77","IGFBPL1","IBPL1_HUMAN","extracellular space [GO:0005615]; insulin-like growth factor binding [GO:0005520]; cellular response to tumor cell [GO:0071228]; regulation of cell growth [GO:0001558]","SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15845387}.","Insulin-like growth factor-binding protein-like 1 (IGFBP-related protein 10) (Insulin-like growth factor-binding-related protein 4) (IGFBP-rP4)","GO:0001558; GO:0005520; GO:0005615; GO:0071228",0.0316586847430109,0.0168482077241722,0.0218814467256893,0.0728221031259416,0.080147400822018,0.0825916276649971,0.0550575974733614,0.0509915784676382,10.8961701703222,0.00026749486188794,0.0157914208121438,-2.15317883733543,29005,1.80157879316372,4,0,0,0.0218814467256893,0.080147400822018,3.66280172544182,1.87294760728074
"103",106,146,146,146,"Q9UHV9","PFDN2","PFD2_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17936702}. Cytoplasm {ECO:0000269|PubMed:17936702}. Mitochondrion {ECO:0000269|PubMed:17936702}.","Prefoldin subunit 2","GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0044183; GO:0051082; GO:0051495",1e-07,1e-07,1e-07,0.0196520201483743,0.0225694651400515,0.0161454875004041,0.0194555575962766,0.00972787879813832,10.8741684973826,0.00026976670184064,0.0158164586832597,-2.16353742492152,16648,1.80089074880819,4,3,0,1e-07,0.0196520201483743,196520.201483743,17.5843180977726
"104",107,147,147,147,"O43405","COCH","COCH_HUMAN","extracellular matrix [GO:0031012]; collagen binding [GO:0005518]; defense response to bacterium [GO:0042742]; positive regulation of innate immune response [GO:0045089]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]","SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000269|PubMed:12843317, ECO:0000269|PubMed:22610276}.","Cochlin (COCH-5B2)","GO:0005518; GO:0007605; GO:0008360; GO:0031012; GO:0042742; GO:0045089",1e-07,1e-07,1.28919077911007e-06,0.272637182470655,0.21871864814951,0.306011638249644,0.26578865989301,0.132894826343431,10.8509730166197,0.00027218745878383,0.0158498275319022,-2.17447919070136,59483,1.79997545914659,3,2,0,1e-07,0.272637182470655,2726371.82470655,21.3785509007553
"105",108,148,148,148,"P78509","RELN","RELN_HUMAN","cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]","SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix {ECO:0000250}.","Reelin (EC 3.4.21.-)","GO:0000904; GO:0001764; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007616; GO:0008236; GO:0008306; GO:0010001; GO:0010976; GO:0014068; GO:0016358; GO:0018108; GO:0021511; GO:0021517; GO:0021766; GO:0021800; GO:0021819; GO:0030425; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060291; GO:0061003; GO:0061098; GO:0070325; GO:0070326; GO:0090129; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:1900273; GO:1902078; GO:2000310; GO:2000463; GO:2000969",0.0189778541169099,0.00950415374611199,0.0238481466324389,0.114149581614105,0.128730303903532,0.10000087042053,0.0968502004809024,0.0658684850722714,10.8100620787495,0.00027652225571418,0.0158786864951503,-2.19383077809863,388388,1.79918542580701,5,0,0,0.0189778541169099,0.114149581614105,6.0148835011011,2.58853679492232
"106",109,149,149,149,"Q96KG9","SCYL1","SCYL1_HUMAN","cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]; regulation of transcription, DNA-templated [GO:0006355]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:18556652}. Endoplasmic reticulum-Golgi intermediate compartment {ECO:0000269|PubMed:18556652}. Golgi apparatus, cis-Golgi network {ECO:0000269|PubMed:18556652}. Note=Localized to the Endoplasmic reticulum-Golgi intermediate and cis-Golgi in an ARF1-independent manner.; SUBCELLULAR LOCATION: Isoform 1: Cytoplasm. Note=Cytoplasmic throughout the cell cycle.; SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Note=Cytoplasmic throughout the cell cycle.; SUBCELLULAR LOCATION: Isoform 3: Cytoplasm. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Note=Cytoplasmic during interphase and centrosomal during mitosis, it localizes to the centrosomes in a microtubule-independent manner.; SUBCELLULAR LOCATION: Isoform 6: Nucleus {ECO:0000269|PubMed:15504359}.","N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase)","GO:0003677; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0006890; GO:0016020; GO:0030126; GO:0045296",0.00023446873824051,0.00023232337022533,0.00010438115971477,0.0271064355291336,0.0368807562462233,0.0365623513043956,0.033326123270524,0.0168534527246555,10.7891581697585,0.00027876980417864,0.0158786864951503,-2.20374497176653,89631,1.79918542580701,13,0,0,0.00023232337022533,0.0365623513043956,157.376983938094,7.29808075484917
"107",110,150,150,150,"Q9Y3I1","FBXO7","FBX7_HUMAN","classical Lewy body [GO:0097414]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cytoplasmic inclusion [GO:0097409]; Lewy body core [GO:1990037]; Lewy body corona [GO:1990038]; Lewy neurite [GO:0097462]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; autophagy of mitochondrion [GO:0000422]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of lymphocyte differentiation [GO:0045620]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of autophagy of mitochondrion [GO:1903599]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein targeting to mitochondrion [GO:0006626]; protein ubiquitination [GO:0016567]; regulation of locomotion [GO:0040012]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Mitochondrion. Cytoplasm, cytosol. Note=Predominantly cytoplasmic. A minor proportion is detected in the nucleus. Relocates from the cytosol to depolarized mitochondria.","F-box only protein 7","GO:0000151; GO:0000209; GO:0000422; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006626; GO:0010975; GO:0016567; GO:0019005; GO:0019901; GO:0031625; GO:0031647; GO:0032991; GO:0040012; GO:0043130; GO:0043687; GO:0045620; GO:0045736; GO:0046982; GO:0097409; GO:0097414; GO:0097462; GO:1903204; GO:1903208; GO:1903599; GO:1990037; GO:1990038; GO:2000134",0.0015629129678563,1.32254608741598e-05,1.69098068040687e-05,0.10307234933543,0.0792531690535719,0.0773992156453477,0.0860438952662717,0.0435529637116474,10.7861167187105,0.00027909867689413,0.0158786864951503,-2.2051889412923,58503,1.79918542580701,5,0,0,1.69098068040687e-05,0.0792531690535719,4686.81694426589,12.1943927324005
"108",111,151,151,151,"O60216","RAD21","RAD21_HUMAN","chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear cohesin complex [GO:0000798]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; protein-containing complex binding [GO:0044877]; transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001228]; apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; reciprocal meiotic recombination [GO:0007131]; regulation of transcription by RNA polymerase II [GO:0006357]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10623634}. Chromosome {ECO:0000269|PubMed:11073952}. Chromosome, centromere {ECO:0000269|PubMed:11073952}. Note=Associates with chromatin. Before prophase it is scattered along chromosome arms. During prophase, most of cohesin complexes dissociate from chromatin probably because of phosphorylation by PLK, except at centromeres, where cohesin complexes remain. At anaphase, it is cleaved by separase/ESPL1, leading to the dissociation of the complex from chromosomes, allowing chromosome separation. Once cleaved by caspase-3, the C-terminal 64 kDa cleavage product translocates to the cytoplasm, where it may trigger apoptosis. {ECO:0000269|PubMed:11073952}.","Double-strand-break repair protein rad21 homolog (hHR21) (Nuclear matrix protein 1) (NXP-1) (SCC1 homolog)","GO:0000775; GO:0000785; GO:0000798; GO:0001228; GO:0003682; GO:0005654; GO:0005694; GO:0005829; GO:0006302; GO:0006310; GO:0006357; GO:0006915; GO:0007059; GO:0007131; GO:0008278; GO:0010972; GO:0016020; GO:0016363; GO:0044877; GO:0045841; GO:0045876; GO:0051301; GO:0071168",0.00011856158596556,0.00015166036278295,0.000215128025867,0.0808405810103292,0.0826763987100266,0.060302130695337,0.0744445868136925,0.0373840767317181,10.7768557508497,0.00028010299775323,0.0158786864951503,-2.20958803918321,71690,1.79918542580701,11,0,0,0.00015166036278295,0.0808405810103292,533.036975033647,9.0580918012723
"109",112,152,152,152,"Q6ZN54","DEF8","DEFI8_HUMAN","intracellular [GO:0005622]; metal ion binding [GO:0046872]; intracellular signal transduction [GO:0035556]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]",NA,"Differentially expressed in FDCP 8 homolog (DEF-8)","GO:0005622; GO:0032418; GO:0035556; GO:0045780; GO:0046872; GO:1900029",0.102644429714164,0.118895681223177,0.17717959065577,0.494281199272847,0.60954954049317,0.580494436809415,0.42853515832744,0.347174146361424,10.7592024717423,0.00028202972634722,0.015882726694291,-2.21798334134663,58710,1.79907493725969,4,0,0,0.118895681223177,0.580494436809415,4.88238454784391,2.287585929576
"110",113,154,154,154,"Q6YN16","HSDL2","HSDL2_HUMAN","membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491]","SUBCELLULAR LOCATION: Peroxisome {ECO:0000269|PubMed:19703561}.","Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-) (Short chain dehydrogenase/reductase family 13C member 1)","GO:0005739; GO:0005777; GO:0016020; GO:0016491",1e-07,0.0019339793865708,1e-07,1.02839255038643,1.36570951331921,1.03809040774453,1.14341943068787,0.572354441806124,10.7084151328463,0.00028766403062273,0.015989637026822,-2.24220757856118,45395,1.79616139485523,3,2,0,1e-07,1.03809040774453,10380904.0774453,23.3074287583167
"111",114,155,155,155,"Q14728","MFSD10","MFS10_HUMAN","brush border membrane [GO:0031526]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; organic anion transmembrane transporter activity [GO:0008514]; tetracycline transmembrane transporter activity [GO:0008493]; apoptotic process [GO:0006915]; sodium-independent organic anion transport [GO:0043252]","SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Multi-pass membrane protein {ECO:0000255}.","Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein)","GO:0006915; GO:0008493; GO:0008514; GO:0016021; GO:0030659; GO:0031526; GO:0043252",6.7738305869013e-05,9.65065252411282e-06,6.58595202730473e-05,0.0224752947260784,0.0289968285977533,0.0315090428893847,0.0276126392448501,0.0138540691153138,10.6475001708973,0.00029460488106125,0.0161683909006911,-2.27140339365598,48339,1.79133319949517,4,0,0,6.58595202730473e-05,0.0289968285977533,440.283021764131,8.78228740177843
"112",115,157,157,157,"P51991","HNRNPA3","ROA3_HUMAN","catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA transmembrane transporter activity [GO:0051033]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; RNA metabolic process [GO:0016070]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Component of ribonucleosomes.","Heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3)","GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0016070; GO:0035770; GO:0043005; GO:0051028; GO:0051033; GO:0071013; GO:1990124; GO:1990904",0.00012714796313687,0.00026049965090471,0.00031369990048295,0.00105972093826484,0.00096147182586582,0.00102233948765978,0.00078072824575529,0.00062414662771916,10.6307746380116,0.00029654642189351,0.0161683909006911,-2.27944683682538,39595,1.79133319949517,18,0,0,0.00026049965090471,0.00102233948765978,3.92453304297804,1.97252100644842
"113",116,158,158,158,"Q1L5Z9","LONRF2","LONF2_HUMAN","intracellular [GO:0005622]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]",NA,"LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192)","GO:0000209; GO:0005622; GO:0031624; GO:0032436; GO:0046872; GO:0061630",0.00016125774836465,0.0001048193420994,0.0153737619287478,0.0911769811749857,0.0729674084059302,0.0785146157093998,0.0756730554237013,0.0430498073849213,10.6083642638131,0.0002991724986755,0.0162083328396351,-2.29024256730006,83654,1.79026165361431,8,0,0,0.00016125774836465,0.0785146157093998,486.888949558292,8.92744894731673
"114",117,159,159,159,"Q8WU79","SMAP2","SMAP2_HUMAN","cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]","SUBCELLULAR LOCATION: Cytoplasm. Note=Detected in multiple foci throughout the cytoplasm and in juxtanuclear structures. {ECO:0000250}.","Stromal membrane-associated protein 2 (Stromal membrane-associated protein 1-like)","GO:0005096; GO:0005737; GO:0046872",1e-07,0.00232343195386989,1e-07,0.102642170316034,0.0892101875509905,0.0730694647121425,0.0875327302084323,0.0445409090888394,10.5871083549481,0.00030168965489948,0.0162419084650289,-2.30050169765213,46786,1.78936294140433,5,2,0,1e-07,0.0892101875509905,892101.875509905,19.7668489456816
"115",118,160,160,160,"Q96SB4","SRPK1","SRPK1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm chromatin condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Nucleus. Nucleus matrix. Microsome. Note=Shuttles between the nucleus and the cytoplasm. Inhibition of the Hsp90 ATPase activity, osmotic stress and interaction with HHV-1 ICP27 protein can induce its translocation to the nucleus. KAT5/TIP60 inhibits its nuclear translocation.; SUBCELLULAR LOCATION: Isoform 1: Cytoplasm. Nucleus matrix. Microsome. Note=Mainly localized in the microsomal fraction and the cytoplasm, and to a lesser extent in the nuclear matrix.","SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1)","GO:0000245; GO:0000287; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016032; GO:0016363; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684",0.027060392133547,0.00021091978394305,0.00032749974236098,0.103074429988893,0.102192658791294,0.0984089515787193,0.0920257428996849,0.0552124753364595,10.5637816949949,0.00030448194731046,0.0162897841811097,-2.31178224757807,74325,1.78808466950205,10,0,0,0.00032749974236098,0.102192658791294,312.038898273862,8.285582074147
"116",120,163,163,163,"Q6NXT6","TAPT1","TAPT1_HUMAN","centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; growth hormone-releasing hormone receptor activity [GO:0016520]; cartilage development [GO:0051216]; cell projection organization [GO:0030030]; embryonic skeletal system development [GO:0048706]; in utero embryonic development [GO:0001701]; neural crest cell development [GO:0014032]; ossification [GO:0001503]; positive regulation of bone development [GO:1903012]; positive regulation of cartilage development [GO:0061036]; positive regulation of cilium assembly [GO:0045724]; post-embryonic development [GO:0009791]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:26365339}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000269|PubMed:26365339}. Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","Transmembrane anterior posterior transformation protein 1 homolog (Cytomegalovirus partial fusion receptor)","GO:0001503; GO:0001701; GO:0005737; GO:0005813; GO:0009791; GO:0014032; GO:0016021; GO:0016520; GO:0030030; GO:0036064; GO:0045724; GO:0048706; GO:0051216; GO:0061036; GO:1903012",0.000512692292187,0.00011171089008348,8.49414380729182e-05,0.043613766783763,0.0338274724247237,0.0477255732190114,0.0414858226023849,0.0209793595079736,10.442804255229,0.00031948178504,0.016777693741978,-2.37065810380749,64260,1.77526773742682,10,0,0,0.00011171089008348,0.043613766783763,390.41642897278,8.60886995348201
"117",122,165,165,165,"Q8NDN9","RCBTB1","RCBT1_HUMAN","cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","RCC1 and BTB domain-containing protein 1 (Chronic lymphocytic leukemia deletion region gene 7 protein) (CLL deletion region gene 7 protein) (Regulator of chromosome condensation and BTB domain-containing protein 1)","GO:0005634; GO:0005737; GO:0006325; GO:0006351; GO:0006355; GO:0007049",0.00012309791526117,0.0001176717403842,0.00010178067401328,0.0354204016039801,0.0471490402091544,0.0497454665221553,0.043990786001877,0.0221095764441581,10.3643135418299,0.00032969898485114,0.0169488192770765,-2.40919514371334,58252,1.77086055110757,3,0,0,0.0001176717403842,0.0471490402091544,400.682781228629,8.64631670311263
"118",123,167,167,167,"O60684","KPNA6","IMA7_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of transcription by RNA polymerase II [GO:0045944]",NA,"Importin subunit alpha-7 (Karyopherin subunit alpha-6)","GO:0005643; GO:0005654; GO:0005829; GO:0006607; GO:0008139; GO:0008565; GO:0016020; GO:0045944; GO:0060135; GO:0061608",1e-07,0.0001854954106948,1e-07,0.0294424913024148,0.0285696814651595,0.0211282838798712,0.0263182537455836,0.0132210253430234,10.3537707340521,0.00033110163814732,0.0169488192770765,-2.4143919196555,60030,1.77086055110757,4,2,0,1e-07,0.0285696814651595,285696.814651595,18.124125425615
"119",124,168,168,168,"O60858","TRIM13","TRI13_HUMAN","cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum [GO:0097038]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; anatomical structure morphogenesis [GO:0009653]; endoplasmic reticulum mannose trimming [GO:1904380]; innate immune response [GO:0045087]; negative regulation of viral release from host cell [GO:1902187]; negative regulation of viral transcription [GO:0032897]; positive regulation of cell death [GO:0010942]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; response to gamma radiation [GO:0010332]; ubiquitin-dependent ERAD pathway [GO:0030433]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:17314412, ECO:0000269|PubMed:21333377, ECO:0000269|PubMed:22178386, ECO:0000269|PubMed:25152375}; Single-pass membrane protein {ECO:0000269|PubMed:17314412, ECO:0000269|PubMed:21333377, ECO:0000269|PubMed:22178386}. Note=Concentrates and colocalizes with p62/SQSTM1 and ZFYVE1 at the perinuclear endoplasmic reticulum.","E3 ubiquitin-protein ligase TRIM13 (EC 2.3.2.27) (B-cell chronic lymphocytic leukemia tumor suppressor Leu5) (Leukemia-associated protein 5) (Putative tumor suppressor RFP2) (RING finger protein 77) (RING-type E3 ubiquitin transferase TRIM13) (Ret finger protein 2) (Tripartite motif-containing protein 13)","GO:0004842; GO:0005737; GO:0005789; GO:0008270; GO:0009653; GO:0010332; GO:0010942; GO:0016021; GO:0016239; GO:0030433; GO:0032897; GO:0043123; GO:0043161; GO:0044322; GO:0045087; GO:0051092; GO:0051865; GO:0097038; GO:1902187; GO:1904380",0.00509161676841479,0.0026189212917205,0.0163290439395841,0.10852048216874,0.138735179455584,0.146745896132296,0.123320658585633,0.0696735232927232,10.3422677604328,0.00033264037833514,0.0169488192770765,-2.4200675552665,46988,1.77086055110757,8,0,0,0.00509161676841479,0.138735179455584,27.2477654477474,4.76806601616634
"120",125,170,170,170,"O14775","GNB5","GNB5_HUMAN","cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; dopamine receptor signaling pathway [GO:0007212]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P62881}.","Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5)","GO:0001750; GO:0001917; GO:0003924; GO:0005096; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0007165; GO:0007212; GO:0031682; GO:0043209; GO:0043547; GO:0051087; GO:1901386; GO:1902773",0.00195855459669664,0.00307958464778847,0.00096669654956062,0.0456897361845447,0.037991292355865,0.0330592787237941,0.036911823823386,0.0204575238430416,10.2860552182831,0.00034028702173834,0.0171344523887074,-2.44788718760608,43566,1.76612977091681,4,0,0,0.00195855459669664,0.037991292355865,19.3976172121739,4.27780753867555
"121",126,171,171,171,"Q96S90","LYSMD1","LYSM1_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]",NA,"LysM and putative peptidoglycan-binding domain-containing protein 1","GO:0005634; GO:0005654",4.51956484368904e-05,1e-07,1e-07,0.0739382155199689,0.0527598339496007,0.0585445605106862,0.061732404777273,0.0308813342714488,10.1410325231703,0.00036103110627245,0.0180726682438139,-2.52031115629835,25003,1.74297772358639,3,2,0,1e-07,0.0585445605106862,585445.605106862,19.1591756077797
"122",127,172,172,172,"O15260","SURF4","SURF4_HUMAN","azurophil granule membrane [GO:0035577]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; Golgi organization [GO:0007030]; neutrophil degranulation [GO:0043312]; positive regulation of organelle organization [GO:0010638]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15308636, ECO:0000269|PubMed:18287528}; Multi-pass membrane protein {ECO:0000255}. Endoplasmic reticulum-Golgi intermediate compartment membrane {ECO:0000269|PubMed:18287528}; Multi-pass membrane protein {ECO:0000255}. Golgi apparatus membrane {ECO:0000269|PubMed:18287528}; Multi-pass membrane protein {ECO:0000255}. Note=Cycles between the endoplasmic reticulum and the Golgi. {ECO:0000269|PubMed:18287528}.","Surfeit locus protein 4","GO:0000139; GO:0005789; GO:0005793; GO:0005886; GO:0006890; GO:0007030; GO:0010638; GO:0016021; GO:0030133; GO:0033116; GO:0035577; GO:0043312",7.31357468394752e-05,1e-07,3.28796403900741e-06,0.00796270016086467,0.00884853067030918,0.00616966006217733,0.00763478906082423,0.00384290243403828,10.0396082157573,0.00037646304553821,0.0187356027314365,-2.57153051945181,30394,1.72733233092746,4,1,0,3.28796403900741e-06,0.00796270016086467,2421.77227804125,11.241847497842
"123",128,173,173,173,"Q9NUY8","TBC1D23","TBC23_HUMAN","cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; WASH complex [GO:0071203]; brain development [GO:0007420]; embryonic brain development [GO:1990403]; neuron projection development [GO:0031175]; positive regulation of interleukin-6 production [GO:0032755]; regulation of inflammatory response [GO:0050727]; regulation of tumor necrosis factor production [GO:0032680]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated transport [GO:0016192]","SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network {ECO:0000269|PubMed:28823706, ECO:0000269|PubMed:29084197}. Note=Localization to the trans-Golgi is regulated by ARL1 and ARL5B/ARL8. ARL1 increases Golgi localization, while ARL5B decreases it. Recruitment to the trans-Golgi network requires the presence of GOLGA1 and GOLGA4, but not that of FAM91A1 (PubMed:29084197). {ECO:0000269|PubMed:28823706, ECO:0000269|PubMed:29084197}.","TBC1 domain family member 23 (HCV non-structural protein 4A-transactivated protein 1)","GO:0005794; GO:0005802; GO:0005829; GO:0007420; GO:0016192; GO:0031175; GO:0032680; GO:0032755; GO:0042147; GO:0050727; GO:0071203; GO:1990403",1e-07,1e-07,1e-07,0.0359832408451443,0.0305498399787244,0.0250252934439452,0.0305193580892713,0.0152597790446357,10.0157715402539,0.00038020628269117,0.0188125189585925,-2.58363701280517,78322,1.72555304939521,11,3,0,1e-07,0.0305498399787244,305498.399787244,18.2208052976067
"124",129,174,174,174,"Q6PJG6","BRAT1","BRAT1_HUMAN","cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; glucose metabolic process [GO:0006006]; mitochondrion localization [GO:0051646]; positive regulation of cell growth [GO:0030307]; positive regulation of protein phosphorylation [GO:0001934]; response to ionizing radiation [GO:0010212]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16452482, ECO:0000269|PubMed:25631046}. Cytoplasm {ECO:0000269|PubMed:25631046}. Note=Present at double strand breaks (DSBs)following ionizing radiation treatment. The ubiquitinated form localizes in the nucleus in a NDFIP1-dependent manner. {ECO:0000269|PubMed:16452482, ECO:0000269|PubMed:25631046}.","BRCA1-associated ATM activator 1 (BRCA1-associated protein required for ATM activation protein 1)","GO:0001934; GO:0005634; GO:0005654; GO:0005737; GO:0006006; GO:0006915; GO:0006974; GO:0008283; GO:0010212; GO:0016020; GO:0016477; GO:0030307; GO:0051646",1e-07,1e-07,1e-07,0.081059631035458,0.100164901980325,0.116915441343856,0.0993798914532129,0.0496900457266065,9.96111481879054,0.00038896280453636,0.0191351816484558,-2.61149692043226,88119,1.71816741070378,10,3,0,1e-07,0.100164901980325,1001649.01980325,19.9339456426344
"125",130,175,175,175,"Q9H7F0","ATP13A3","AT133_HUMAN","integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; metal ion binding [GO:0046872]; cellular calcium ion homeostasis [GO:0006874]","SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.","Probable cation-transporting ATPase 13A3 (EC 3.6.3.-) (ATPase family homolog up-regulated in senescence cells 1)","GO:0005388; GO:0005524; GO:0005887; GO:0006874; GO:0016020; GO:0043231; GO:0046872",4.49505441727672e-05,1.73813497441185e-05,0.0100428315319147,0.0414063640921943,0.0514387201857492,0.0449007168560363,0.0425468792360494,0.0246418274266352,9.93134528413813,0.00039383597866551,0.0192642055850106,-2.62673022174656,138043,1.71524889566525,6,0,0,4.49505441727672e-05,0.0449007168560363,998.89150804183,9.96418418179666
"126",131,177,177,177,"Q9GZT9","EGLN1","EGLN1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [GO:0016706]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; peptidyl-proline dioxygenase activity [GO:0031543]; cardiac muscle tissue morphogenesis [GO:0055008]; cellular iron ion homeostasis [GO:0006879]; heart trabecula formation [GO:0060347]; labyrinthine layer development [GO:0060711]; negative regulation of cAMP catabolic process [GO:0030821]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA binding transcription factor activity [GO:0043433]; oxygen homeostasis [GO:0032364]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; regulation of neuron death [GO:1901214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; ventricular septum morphogenesis [GO:0060412]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12615973, ECO:0000269|PubMed:19339211, ECO:0000269|PubMed:19631610}. Nucleus {ECO:0000269|PubMed:12615973, ECO:0000269|PubMed:19339211, ECO:0000269|PubMed:19631610}. Note=Mainly cytoplasmic. Shuttles between the nucleus and cytoplasm (PubMed:19631610). Nuclear export requires functional XPO1. {ECO:0000269|PubMed:19339211, ECO:0000269|PubMed:19631610}.","Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) (SM-20)","GO:0001666; GO:0005506; GO:0005634; GO:0005737; GO:0005829; GO:0006879; GO:0016706; GO:0018401; GO:0019899; GO:0030821; GO:0031418; GO:0031543; GO:0031545; GO:0032364; GO:0043433; GO:0045765; GO:0045944; GO:0051344; GO:0055008; GO:0060347; GO:0060412; GO:0060711; GO:0061418; GO:0071731; GO:1901214",1e-07,1e-07,0.00023423038288962,0.053357885472992,0.0377576845983628,0.0522610413717646,0.04771406035341,0.0239351736376682,9.85240115008012,0.00040712524074091,0.0196892206821595,-2.66733001410785,46021,1.70577147330504,8,2,0,1e-07,0.0522610413717646,522610.413717646,18.9953763470265
"127",132,180,180,180,"Q6NT76","HMBOX1","HMBX1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; telomeric DNA binding [GO:0042162]; transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0001227]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA-dependent DNA biosynthetic process [GO:0006278]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16825764}. Cytoplasm {ECO:0000269|PubMed:16825764}. Note=Predominantly detected in cytoplasm. {ECO:0000269|PubMed:16825764}.; SUBCELLULAR LOCATION: Isoform 5: Nucleus {ECO:0000269|PubMed:19757162}. Cytoplasm {ECO:0000269|PubMed:19757162}.","Homeobox-containing protein 1","GO:0000122; GO:0000784; GO:0000981; GO:0001227; GO:0003691; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006278; GO:0006351; GO:0016604; GO:0032212; GO:0035563; GO:0042162; GO:0042802; GO:0043565; GO:0044877; GO:0045892; GO:0045893; GO:0051973",0.00050238485901315,0.0005917652327168,0.00026274495565716,0.237558535518568,0.164020490644152,0.197422845748304,0.199214992287879,0.100059794493068,9.72933579288104,0.00042895432932026,0.0203991614387859,-2.73121816391826,47278,1.69038768502475,6,0,0,0.00050238485901315,0.197422845748304,392.97132906455,8.61828024799581
"128",133,181,181,181,"Q96I51","RCC1L","RCC1L_HUMAN","RNA binding [GO:0003723]","SUBCELLULAR LOCATION: Mitochondrion membrane {ECO:0000269|PubMed:28608466, ECO:0000269|PubMed:28746876}. Mitochondrion inner membrane {ECO:0000250|UniProtKB:Q9CYF5}.","RCC1-like G exchanging factor-like protein (RCC1-like) (Williams-Beuren syndrome chromosomal region 16 protein)","GO:0003723",2.15234915930862e-05,1e-07,1e-07,0.0838305813000864,0.0578105362088389,0.0692664266144759,0.070295273543936,0.0351548779358324,9.69314938563472,0.00043564371207468,0.0206028186483938,-2.75014442968127,49997,1.68607336022771,3,2,0,1e-07,0.0692664266144759,692664.266144759,19.4017967229986
"129",135,184,184,184,"Q92925","SMARCD2","SMRD2_HUMAN","nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; nucleosome disassembly [GO:0006337]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 (60 kDa BRG-1/Brm-associated factor subunit B) (BRG1-associated factor 60B) (BAF60B)","GO:0000790; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006351; GO:0006357; GO:0016514; GO:0032991; GO:0043044",0.00042730487741304,0.00097743647947195,0.00088735315562849,0.1861521710854,0.127382005799935,0.155365914787401,0.155535999053407,0.0785320310308748,9.51417144512041,0.00047066932813754,0.021896355700312,-2.84471138088498,58921,1.65962816054551,4,0,0,0.00088735315562849,0.155365914787401,175.089155655686,7.45194592136886
"130",136,185,185,185,"Q13569","TDG","TDG_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; RNA polymerase II transcription cofactor activity [GO:0001104]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; embryo development [GO:0009790]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of gene expression, epigenetic [GO:0040029]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8662714}.","G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (Thymine-DNA glycosylase) (hTDG)","GO:0000122; GO:0000287; GO:0001104; GO:0003677; GO:0003684; GO:0003690; GO:0004844; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0006284; GO:0006285; GO:0006298; GO:0006325; GO:0006351; GO:0008134; GO:0008263; GO:0009790; GO:0016605; GO:0019104; GO:0019904; GO:0030983; GO:0031402; GO:0031404; GO:0032091; GO:0032183; GO:0035511; GO:0035562; GO:0040029; GO:0042803; GO:0043621; GO:0043739; GO:0045008; GO:0080111; GO:1902544",0.014080469523151,0.00215523083486056,0.0041968514244679,0.180105541938444,0.13471373789629,0.134199782411311,0.142862170154522,0.0782419356714206,9.47379700504898,0.00047904098986689,0.0221653560716789,-2.86626773737684,46053,1.65432528765708,4,0,0,0.0041968514244679,0.13471373789629,32.0987626845451,5.00444578154101
"131",137,187,187,187,"Q9Y2H5","PLEKHA6","PKHA6_HUMAN",NA,NA,"Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3)",NA,1e-07,3.48140397027661e-06,1e-07,0.16522896741332,0.127058028087184,0.115828772206248,0.136037362100927,0.0680199081851202,9.44680551022153,0.00048473934998143,0.0221847475324012,-2.8807253900845,117128,1.65394550929175,15,2,0,1e-07,0.127058028087184,1270580.28087184,20.2770561034377
"132",138,188,188,188,"Q9ULP9","TBC1D24","TBC24_HUMAN","cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; GTPase activator activity [GO:0005096]; neuron projection development [GO:0031175]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20727515}. Note=Partially expressed at the plasma membrane.","TBC1 domain family member 24","GO:0005096; GO:0005737; GO:0005886; GO:0030054; GO:0031175; GO:0031594; GO:0043195",7.15869373540763e-05,8.76224016150518e-05,0.00013915000974147,0.0079937742303303,0.00756437025100295,0.0055268156982318,0.00692886694361815,0.00356388658804594,9.43510570356173,0.00048723510935647,0.0221847475324012,-2.88700389978136,62919,1.65394550929175,17,0,0,8.76224016150518e-05,0.00756437025100295,86.3291819395137,6.43177641237917
"133",139,190,190,190,"A1L0T0","ILVBL","ILVBL_HUMAN","integral component of membrane [GO:0016021]; membrane [GO:0016020]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; transferase activity [GO:0016740]","SUBCELLULAR LOCATION: Membrane; Single-pass membrane protein.","Acetolactate synthase-like protein (EC 2.2.1.-) (IlvB-like protein)","GO:0000287; GO:0016020; GO:0016021; GO:0016740; GO:0030976",0.00013463481934808,0.00085310873572574,7.69649787491257e-05,0.0349035572391391,0.0237371458154781,0.0312187673955298,0.029598253972108,0.0151540298306616,9.32689372263359,0.00051107946722493,0.0230254749444495,-2.94541120101512,67868,1.63779140288459,8,0,0,0.00013463481934808,0.0312187673955298,231.877366840876,7.85721819759837
"134",140,191,191,191,"Q9H1A3","METTL9","METL9_HUMAN",NA,NA,"Methyltransferase-like protein 9 (DORA reverse strand protein) (DREV) (DREV1)",NA,0.0005182472150884,1e-07,1e-07,0.0501909805715116,0.034154258471975,0.0411422348950949,0.0416563422411644,0.021000986858945,9.30976428541137,0.00051498354427371,0.0230798907800158,-2.95471304270128,36536,1.63676625070472,4,2,0,1e-07,0.0411422348950949,411422.348950949,18.6502606393375
"135",141,193,193,193,"Q9UMN6","KMT2B","KMT2B_HUMAN","histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; zinc ion binding [GO:0008270]; chromatin-mediated maintenance of transcription [GO:0048096]; gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of megakaryocyte differentiation [GO:0045652]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7)","GO:0000981; GO:0001541; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006351; GO:0007613; GO:0008270; GO:0009994; GO:0016458; GO:0018024; GO:0030728; GO:0035097; GO:0042800; GO:0045652; GO:0048096; GO:0051568; GO:0051569; GO:0080182",1e-07,1e-07,1e-07,0.0869061773224839,0.0587162740719823,0.0722130416278233,0.0726117310074298,0.0363059655037149,9.26107483803115,0.00052628143481077,0.0232555793148594,-2.98123784530144,293515,1.63347283739895,7,3,0,1e-07,0.0722130416278233,722130.416278233,19.4618998848552
"136",142,194,194,194,"Q9P2S2","NRXN2","NRX2A_HUMAN","integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888]; adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.","Neurexin-2 (Neurexin II-alpha) (Neurexin-2-alpha)","GO:0004888; GO:0005246; GO:0005886; GO:0007158; GO:0007165; GO:0007268; GO:0007269; GO:0007416; GO:0016021; GO:0030534; GO:0035176; GO:0042297; GO:0046872; GO:0050839; GO:0071625; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:0098793",0.00032730805896553,0.00011722938713364,0.00026843055994615,0.103211962005134,0.0774340770700507,0.0728519060078085,0.0842616590256492,0.0423684855148397,9.25779206401163,0.00052705401718256,0.0232555793148594,-2.98303075547195,184982,1.63347283739895,14,0,0,0.00026843055994615,0.0774340770700507,288.469677541874,8.17227586788615
"137",143,195,195,195,"Q08379","GOLGA2","GOGA2_HUMAN","cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; COPII vesicle coating [GO:0048208]; ER to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306]","SUBCELLULAR LOCATION: Golgi apparatus, cis-Golgi network membrane {ECO:0000269|PubMed:11781572}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q62839}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:26165940}. Note=Peripheral membrane protein associated with cis-Golgi stacks (By similarity). Associates with the mitotic spindle during mitosis (PubMed:26165940). {ECO:0000250|UniProtKB:Q62839, ECO:0000269|PubMed:26165940}.","Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130) (GM130 autoantigen) (Golgin-95)","GO:0000137; GO:0000139; GO:0000922; GO:0005794; GO:0005801; GO:0005874; GO:0006486; GO:0006888; GO:0007020; GO:0007098; GO:0008017; GO:0008356; GO:0010507; GO:0019901; GO:0019905; GO:0030134; GO:0032091; GO:0032580; GO:0033116; GO:0042802; GO:0045296; GO:0048208; GO:0051225; GO:0051289; GO:0060050; GO:0061676; GO:0072686; GO:0090161; GO:0090166; GO:0090306; GO:0090307; GO:1904668",1e-07,1e-07,1e-07,0.0789819522760152,0.0704901272886645,0.102063491964052,0.0838450905095772,0.0419226452547886,9.22797854008966,0.00053413430978789,0.0233793380654392,-2.99933998884565,113086,1.63116778909363,17,3,0,1e-07,0.0789819522760152,789819.522760152,19.591163503214
"138",144,196,196,196,"Q9H832","UBE2Z","UBE2Z_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17160626}. Nucleus {ECO:0000269|PubMed:17160626}.","Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Uba6-specific E2 conjugating enzyme 1) (Use1) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z)","GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0031625; GO:0043065; GO:0061630; GO:0061631",0.00130598590250801,0.0023501895477358,0.00249539396727966,0.169056335075429,0.126535804739014,0.186731153184178,0.158723907860366,0.0814124770693573,9.22302770386552,0.00053532129215257,0.0233793380654392,-3.00205291143287,38210,1.63116778909363,9,0,0,0.0023501895477358,0.169056335075429,71.9330639685211,6.16858315148831
"139",145,197,197,197,"Q8WUD1","RAB2B","RAB2B_HUMAN","endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Endoplasmic reticulum membrane {ECO:0000305}. Golgi apparatus membrane {ECO:0000305}.","Ras-related protein Rab-2B","GO:0000139; GO:0003924; GO:0005525; GO:0005789; GO:0005886; GO:0015031; GO:0016192; GO:0045921; GO:0070062; GO:0098793",1e-07,1e-07,2.83519651078727e-05,0.0126765339135805,0.0185618443446016,0.0177252126709662,0.0163116796546802,0.0081653571490427,9.20991822267151,0.0005384799474069,0.0233979104050919,-3.00924290811142,24214,1.6308229263531,7,2,0,1e-07,0.0177252126709662,177252.126709662,17.4354434117751
"140",147,199,199,199,"P12270","TPR","TPR_HUMAN","cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12802065}. Nucleus membrane {ECO:0000269|PubMed:11514627, ECO:0000269|PubMed:11952838, ECO:0000269|PubMed:18794356, ECO:0000269|PubMed:9024684, ECO:0000269|PubMed:9828100, ECO:0000269|PubMed:9864356}; Peripheral membrane protein {ECO:0000269|PubMed:11514627, ECO:0000269|PubMed:9024684, ECO:0000269|PubMed:9828100, ECO:0000269|PubMed:9864356}; Nucleoplasmic side {ECO:0000269|PubMed:11514627, ECO:0000269|PubMed:9024684, ECO:0000269|PubMed:9828100, ECO:0000269|PubMed:9864356}. Nucleus envelope {ECO:0000269|PubMed:12424524, ECO:0000269|PubMed:7798308}. Nucleus, nuclear pore complex {ECO:0000269|PubMed:11514627, ECO:0000269|PubMed:11839768, ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:18981471, ECO:0000269|PubMed:7798308, ECO:0000269|PubMed:9024684, ECO:0000269|PubMed:9828100, ECO:0000269|PubMed:9864356}. Cytoplasm {ECO:0000269|PubMed:11952838, ECO:0000269|PubMed:12802065}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:19273613}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:18981471}. Nucleus membrane {ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:7798308}; Peripheral membrane protein {ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:7798308}; Cytoplasmic side {ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:7798308}. Note=Detected as discrete intranuclear foci with IFI204 (By similarity). In interphase, localizes to the nucleoplasmic side of the nuclear pore complex (NPC) core structure, forming a fibrous structure called the nuclear basket. Detected exclusively to the cytoplasmic margin of NPC (PubMed:7798308). Docking to the inner nucleoplasmic side of the NPC is mediated through binding to nucleoporins. Anchored by NUP153 to the NPC. The assembly of the NPC is a stepwise process in which Trp-containing peripheral structures assemble after other components, including p62. Detected as filaments that emanate from the nuclear basket of the NPC and extend to the nucleolus to delineate a chromatin-free network extending from the nuclear envelope to the perinucleolar region. Detected in diffuse and discrete spheroidal intranuclear foci. Nucleocytoplasmic shuttling protein imported into the nucleus in a XPO1/CRM1- and Importin alpha/Importin beta receptor-dependent manner. Remains localized to the nuclear membrane after poliovirus (PV) infection. During mitosis, remains associated with the nuclear envelope until prometaphase. Associated with the mitotic spindle from late prometaphase until anaphase. Reorganized during mitosis in a viscous and dynamic nuclear-derived spindle matrix that embeds the microtubule spindle apparatus from pole to pole in a microtubule-independent manner. Recruited to the reforming nuclear envelope during telophase and cytokinesis. Detected at kinetochores during prometaphase (PubMed:18981471). Colocalizes with MAD2L1 in the spindle matrix but not at kinetochore (PubMed:19273613). Colocalizes with dynein, dynactin, tubulin at kinetochore during the metaphase-anaphase transition. Colocalizes with DYNLL1 at the mitotic spindle. {ECO:0000250, ECO:0000269|PubMed:18981471, ECO:0000269|PubMed:19273613, ECO:0000269|PubMed:7798308}.","Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein)","GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0016032; GO:0017056; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673",6.90781279628288e-05,6.58356143329134e-05,4.18504147196662e-05,0.00044697813898265,0.00049140178760042,0.0004684947150192,0.00041003682819562,0.00026393979976961,9.1732774806456,0.00054742990813448,0.0234661245999398,-3.0293879413564,267293,1.62955862765031,66,0,0,6.58356143329134e-05,0.0004684947150192,7.11612885770527,2.83109263492902
"141",148,200,200,200,"Q6IAA8","LAMTOR1","LTOR1_HUMAN","azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; specific granule membrane [GO:0035579]; GTPase binding [GO:0051020]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol esterification [GO:0010872]; regulation of cholesterol import [GO:0060620]; regulation of macroautophagy [GO:0016241]; regulation of receptor recycling [GO:0001919]","SUBCELLULAR LOCATION: Late endosome membrane; Lipid-anchor; Cytoplasmic side. Lysosome membrane; Lipid-anchor; Cytoplasmic side. Cell membrane.","Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18) (Protein associated with DRMs and endosomes) (p27Kip1-releasing factor from RhoA) (p27RF-Rho)","GO:0001558; GO:0001919; GO:0005764; GO:0005765; GO:0005886; GO:0007032; GO:0007040; GO:0007050; GO:0010872; GO:0010874; GO:0016197; GO:0016241; GO:0031902; GO:0032008; GO:0032418; GO:0034613; GO:0035577; GO:0035579; GO:0042632; GO:0043312; GO:0043410; GO:0045121; GO:0051020; GO:0060620; GO:0070062; GO:0071230; GO:0071986; GO:0101003",1e-07,1e-07,1e-07,0.0224507023849146,0.0324695698723194,0.032146552673252,0.0290221749768287,0.0145111874884143,9.16582397149252,0.00054927271416175,0.0234661245999398,-3.03349476104735,17745,1.62955862765031,3,3,0,1e-07,0.032146552673252,321465.52673252,18.2943045087905
"142",149,201,201,201,"P04035","HMGCR","HMDH_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; coenzyme binding [GO:0050662]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; hydroxymethylglutaryl-CoA reductase activity [GO:0042282]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; aging [GO:0007568]; cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; myoblast differentiation [GO:0045445]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of wound healing [GO:0061045]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein tetramerization [GO:0051262]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of lipid metabolic process [GO:0019216]; response to ethanol [GO:0045471]; response to nutrient [GO:0007584]; ubiquinone metabolic process [GO:0006743]; visual learning [GO:0008542]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass membrane protein.","3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34)","GO:0004420; GO:0005778; GO:0005783; GO:0005789; GO:0006695; GO:0006743; GO:0007568; GO:0007584; GO:0008299; GO:0008542; GO:0010664; GO:0010666; GO:0015936; GO:0016021; GO:0019216; GO:0032874; GO:0042282; GO:0042803; GO:0043407; GO:0045445; GO:0045471; GO:0045540; GO:0048643; GO:0048661; GO:0050662; GO:0051262; GO:0051721; GO:0061045; GO:0061179; GO:0070374; GO:0070402; GO:0097756",0.00048239049049747,0.00936860234784105,0.0003126750603652,0.0996204620047004,0.144209031752199,0.135217850346854,0.122961225401683,0.0648685020004095,9.15880384085193,0.00055101530894718,0.0234661245999398,-3.03736554993065,97476,1.62955862765031,12,0,0,0.00048239049049747,0.135217850346854,280.30786885415,8.13086843431465
"143",150,202,202,202,"Q8N806","UBR7","UBR7_HUMAN","transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567]",NA,"Putative E3 ubiquitin-protein ligase UBR7 (EC 2.3.2.27) (N-recognin-7) (RING-type E3 ubiquitin transferase UBR7)","GO:0008270; GO:0016567; GO:0016740",1.04461041838129e-05,2.87803487479666e-05,2.57015003122769e-05,0.154359740189353,0.134891431070228,0.102982901255864,0.130723048187401,0.0653831667447816,9.06285095098332,0.00057552457810769,0.0242614020293663,-3.0905423957275,47999,1.61508410552949,6,0,0,2.57015003122769e-05,0.134891431070228,5248.38742607544,12.3576585055799
"144",151,203,203,203,"Q9Y5R8","TRAPPC1","TPPC1_HUMAN","azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; COPII vesicle coating [GO:0048208]; ER to Golgi vesicle-mediated transport [GO:0006888]; neutrophil degranulation [GO:0043312]","SUBCELLULAR LOCATION: Golgi apparatus, cis-Golgi network {ECO:0000250}. Endoplasmic reticulum {ECO:0000250}.","Trafficking protein particle complex subunit 1 (BET5 homolog) (Multiple myeloma protein 2) (MUM-2)","GO:0000139; GO:0005576; GO:0005783; GO:0005829; GO:0006888; GO:0017112; GO:0030008; GO:0035578; GO:0043312; GO:0048208",2.55597803071783,2.18915380942764,2.29371171992328,3.6547070750213,4.12675021869064,3.839722670804,1.52744546814906,3.11000392076412,9.04174955642162,0.00058109200124295,0.0242614020293663,-3.10230473716107,16832,1.61508410552949,3,0,0,2.29371171992328,3.839722670804,1.6740214724684,0.743318033279536
"145",152,204,204,204,"P20338","RAB4A","RAB4A_HUMAN","cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; vesicle [GO:0031982]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ionotropic glutamate receptor binding [GO:0035255]; protein transporter activity [GO:0008565]; syntaxin binding [GO:0019905]; antigen processing and presentation [GO:0019882]; phosphatidylinositol biosynthetic process [GO:0006661]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]","SUBCELLULAR LOCATION: Membrane; Peripheral membrane protein {ECO:0000269|PubMed:1425574}. Cytoplasm {ECO:0000269|PubMed:1425574}. Early endosome membrane {ECO:0000250|UniProtKB:P05714}; Peripheral membrane protein {ECO:0000250|UniProtKB:P05714}. Recycling endosome membrane {ECO:0000250|UniProtKB:P05714}; Peripheral membrane protein {ECO:0000250|UniProtKB:P05714}. Note=Generally associated with membranes. Cytoplasmic when phosphorylated by CDK1. {ECO:0000269|PubMed:1425574}.","Ras-related protein Rab-4A","GO:0001671; GO:0003924; GO:0005525; GO:0005768; GO:0005829; GO:0005886; GO:0006661; GO:0008565; GO:0019003; GO:0019882; GO:0019905; GO:0030100; GO:0030659; GO:0031901; GO:0031982; GO:0032482; GO:0032593; GO:0035255; GO:0043231; GO:0048471; GO:0051117; GO:0055038; GO:0070062; GO:0098837",0.0453077877702115,0.0472523976055894,0.0502206533365477,0.0708054893773237,0.0769302122944847,0.0688346564010453,0.0245965064535017,0.0598918661308671,9.03815276757312,0.00058204753636845,0.0242614020293663,-3.10431212364061,24390,1.61508410552949,6,0,0,0.0472523976055894,0.0708054893773237,1.49845283975491,0.583473679165223
"146",153,205,205,205,"Q12888","TP53BP1","TP53B_HUMAN","condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; nuclear body [GO:0016604]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription cofactor activity [GO:0001104]; telomeric DNA binding [GO:0042162]; ubiquitin modification-dependent histone binding [GO:0061649]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of DNA binding transcription factor activity [GO:0051091]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11331310, ECO:0000269|PubMed:15525939, ECO:0000269|PubMed:16294045, ECO:0000269|PubMed:16294047, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:19176521, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:28241136, ECO:0000269|PubMed:9748285}. Chromosome {ECO:0000269|PubMed:12824158, ECO:0000269|PubMed:15525939, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:23760478, ECO:0000269|PubMed:24703952, ECO:0000269|PubMed:28241136}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:P70399}. Note=Localizes to the nucleus in absence of DNA damage (PubMed:28241136). Following DNA damage, recruited to sites of DNA damage, such as double stand breaks (DSBs): recognizes and binds histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:23333306, PubMed:23760478, PubMed:24703952, PubMed:28241136, PubMed:17190600). Associated with kinetochores during mitosis (By similarity). {ECO:0000250|UniProtKB:P70399, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:23760478, ECO:0000269|PubMed:28241136}.","TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1)","GO:0000077; GO:0000777; GO:0000784; GO:0001102; GO:0001104; GO:0002039; GO:0003684; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006303; GO:0006351; GO:0006974; GO:0016604; GO:0035064; GO:0035861; GO:0042162; GO:0045830; GO:0045893; GO:0045944; GO:0051091; GO:0051260; GO:0061649; GO:0071481; GO:1990391; GO:2000042",1e-07,5.69577953339532e-05,1e-07,0.00173286755465751,0.00235529777161983,0.00255608472033116,0.00219569741709152,0.00111690130699041,9.0331958466798,0.00058336755689013,0.0242614020293663,-3.10707978512328,213574,1.61508410552949,38,2,0,1e-07,0.00235529777161983,23552.9777161983,14.523621845537
"147",154,207,207,207,"Q00403","GTF2B","TF2B_HUMAN","chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor TFIID complex [GO:0005669]; transcriptional preinitiation complex [GO:0097550]; acetyltransferase activity [GO:0016407]; core promoter binding [GO:0001047]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II core binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of core promoter binding [GO:1904798]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of viral transcription [GO:0050434]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II transcriptional preinitiation complex assembly [GO:0051123]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Nucleus.","Transcription initiation factor IIB (General transcription factor TFIIB) (S300-II)","GO:0000979; GO:0000993; GO:0001047; GO:0001174; GO:0005634; GO:0005654; GO:0005669; GO:0005694; GO:0006366; GO:0006367; GO:0006473; GO:0008134; GO:0008270; GO:0016032; GO:0016407; GO:0016604; GO:0017025; GO:0032993; GO:0042795; GO:0043923; GO:0046966; GO:0050434; GO:0051123; GO:0060261; GO:0090575; GO:0097550; GO:1904798; GO:1990114; GO:1990841",1e-07,2.62046290435162e-05,1e-07,0.0500894830940219,0.0543309883850821,0.036337770764377,0.0469106125381459,0.0234641078120874,8.96806133127948,0.00060105729742168,0.0248553162605294,-3.14357463090036,34833,1.60458070650088,9,2,0,1e-07,0.0500894830940219,500894.830940219,18.9341481980003
"148",155,209,209,209,"Q96CT7","CCDC124","CC124_HUMAN","cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:23894443}. Midbody {ECO:0000269|PubMed:23894443}. Note=Colocalizes with gamma-tubulin at interphase, prophase, metaphase, and anaphase. Relocates from centrosome to midbody at telophase.","Coiled-coil domain-containing protein 124","GO:0003723; GO:0005815; GO:0005829; GO:0005886; GO:0007049; GO:0030496; GO:0051301",1e-07,1e-07,1e-07,0.00041180795909083,0.00037621626913188,0.00044264792943838,0.0004101240525537,0.00020516202627685,8.90995616723951,0.00061739386270675,0.0251366681146434,-3.17633245451547,25835,1.59969228891427,9,3,0,1e-07,0.00041180795909083,4118.0795909083,12.0077559981434
"149",156,210,210,210,"Q13526","PIN1","PIN1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; motor activity [GO:0003774]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; cell cycle [GO:0007049]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of type I interferon production [GO:0032480]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]; regulation of cytokinesis [GO:0032465]; regulation of mitotic nuclear division [GO:0007088]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein localization to nucleus [GO:1900180]; regulation of signal transduction by p53 class mediator [GO:1901796]; synapse organization [GO:0050808]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16476580, ECO:0000269|PubMed:23623683}. Nucleus speckle {ECO:0000269|PubMed:21497122}. Cytoplasm {ECO:0000269|PubMed:21497122}. Note=Colocalizes with NEK6 in the nucleus (PubMed:16476580). Mainly localized in the nucleus but phosphorylation at Ser-71 by DAPK1 results in inhibition of its nuclear localization (PubMed:21497122). {ECO:0000269|PubMed:16476580}.","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1)","GO:0000413; GO:0001934; GO:0003755; GO:0003774; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0007049; GO:0007088; GO:0008013; GO:0016607; GO:0030182; GO:0030496; GO:0030512; GO:0031434; GO:0032091; GO:0032465; GO:0032480; GO:0032794; GO:0035307; GO:0042177; GO:0043005; GO:0043524; GO:0043525; GO:0043547; GO:0045944; GO:0050808; GO:0050815; GO:0050816; GO:0050821; GO:0051219; GO:0051443; GO:0060393; GO:0061051; GO:0070373; GO:0090263; GO:1900180; GO:1901796; GO:2000146",1e-07,1e-07,1e-07,0.0394438993773619,0.0290099588935616,0.0276138013647041,0.0320224532118759,0.0160113266059379,8.90675425038519,0.00061830976770354,0.0251366681146434,-3.17814316045509,18243,1.59969228891427,3,3,0,1e-07,0.0290099588935616,290099.588935616,18.1461887257088
"150",157,212,212,212,"P49721","PSMB2","PSB2_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; post-translational protein modification [GO:0043687]; protein deubiquitination [GO:0016579]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12181345}. Nucleus {ECO:0000269|PubMed:12181345}.","Proteasome subunit beta type-2 (EC 3.4.25.1) (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I)","GO:0000502; GO:0004298; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0010243; GO:0014070; GO:0016020; GO:0016032; GO:0016579; GO:0019774; GO:0043687; GO:0051603; GO:0070062",2.43865718210025e-05,1e-07,3.34341351632625e-05,0.00849697321432334,0.0103637825312889,0.0127586756909524,0.0105205035765268,0.00527955869059148,8.84997944019476,0.00063482918168365,0.0256175090478744,-3.21034701328119,22836,1.59146310173249,7,1,0,2.43865718210025e-05,0.0103637825312889,424.979066650249,8.73124796941645
"151",158,213,213,213,"Q9C0D0","PHACTR1","PHAR1_HUMAN","cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; synapse [GO:0045202]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; stress fiber assembly [GO:0043149]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell junction, synapse {ECO:0000250}. Nucleus {ECO:0000250}. Note=Enriched at synapses (By similarity). Cytoplasmic in resting cells, and is imported into the nucleus upon serum stimulation. Interaction with actin prevents nuclear import (By similarity). {ECO:0000250}.","Phosphatase and actin regulator 1","GO:0003779; GO:0004864; GO:0005634; GO:0005829; GO:0008157; GO:0030054; GO:0031032; GO:0031532; GO:0043149; GO:0045202; GO:0048870",0.0025913699411814,3.83329714692081e-05,1.75864881178154e-05,0.0280506317765593,0.0268018168589848,0.0194820285345421,0.0238957292564393,0.0128302944284758,8.84115472052375,0.00063744502654173,0.0256175090478744,-3.21536919254107,66308,1.59146310173249,5,0,0,3.83329714692081e-05,0.0268018168589848,699.184431358629,9.44952925068337
"152",160,215,215,215,"O60293","ZFC3H1","ZC3H1_HUMAN","exosome (RNase complex) [GO:0000178]; extracellular space [GO:0005615]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA processing [GO:0006396]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:27871484}. Note=Excluded from the nucleolus. {ECO:0000269|PubMed:27871484}.","Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2)","GO:0000178; GO:0003723; GO:0005615; GO:0005634; GO:0006396; GO:0046872",0.0313783166203283,0.0456785965478899,0.0772714900778404,0.213881723114603,0.180170810644385,0.217514481078223,0.152412870530384,0.127649236347212,8.77531756099363,0.00065738186707412,0.0261729710797882,-3.25297960786963,226356,1.58214697471137,8,0,0,0.0456785965478899,0.213881723114603,4.68231818134708,2.22722297440176
"153",161,217,217,217,"Q8N8R5","C2orf69","CB069_HUMAN","extracellular region [GO:0005576]","SUBCELLULAR LOCATION: Secreted {ECO:0000305}.","UPF0565 protein C2orf69","GO:0005576",8.41066734596107e-05,0.00011926102820501,6.6214069944205e-05,0.0440743449643249,0.0291133111974568,0.0361541235847445,0.0363573993249725,0.0182685602530225,8.73455864244448,0.00067010660944381,0.026433698510779,-3.276390379122,43448,1.5778420676497,6,0,0,8.41066734596107e-05,0.0361541235847445,429.86034398455,8.74772421292282
"154",162,218,218,218,"P36894","BMPR1A","BMR1A_HUMAN","dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; cardiac conduction system development [GO:0003161]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to BMP stimulus [GO:0071773]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; fibrous ring of heart morphogenesis [GO:1905285]; heart formation [GO:0060914]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm structural organization [GO:0048352]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somitogenesis [GO:0001756]; stem cell population maintenance [GO:0019827]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular trabecula myocardium morphogenesis [GO:0003222]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292)","GO:0000981; GO:0001701; GO:0001707; GO:0001756; GO:0001880; GO:0002053; GO:0002062; GO:0003148; GO:0003151; GO:0003161; GO:0003183; GO:0003186; GO:0003203; GO:0003215; GO:0003222; GO:0003223; GO:0003272; GO:0004674; GO:0004675; GO:0005524; GO:0005886; GO:0006468; GO:0006955; GO:0007179; GO:0007398; GO:0009897; GO:0009950; GO:0010862; GO:0014032; GO:0014912; GO:0016021; GO:0019827; GO:0021983; GO:0021998; GO:0030324; GO:0030425; GO:0030501; GO:0030509; GO:0035137; GO:0035912; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0048352; GO:0048368; GO:0048378; GO:0048382; GO:0048568; GO:0048589; GO:0050679; GO:0050768; GO:0060021; GO:0060043; GO:0060045; GO:0060391; GO:0060914; GO:0061312; GO:0061626; GO:0071773; GO:0098821; GO:1902895; GO:1904414; GO:1904707; GO:1905285; GO:1990712; GO:2000772",1e-07,1e-07,1e-07,0.0630396352440231,0.0490745526869193,0.0421848030265875,0.0514328969858433,0.0257165484929217,8.70427430990066,0.00067975636708406,0.0266913509277044,-3.29384811164661,60198,1.57362944473629,4,3,0,1e-07,0.0490745526869193,490745.526869193,18.904615592066
"155",163,219,219,219,"Q8IVU1","IGDCC3","IGDC3_HUMAN","integral component of plasma membrane [GO:0005887]; neuromuscular process controlling balance [GO:0050885]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","Immunoglobulin superfamily DCC subclass member 3 (Putative neuronal cell adhesion molecule)","GO:0005887; GO:0050885",8.52905447622209e-06,8.30925063834818e-05,6.35141566997862e-05,0.111714996011502,0.121264600937861,0.0799839241861229,0.104269461805975,0.0521864428088408,8.67637850839457,0.00068879557328372,0.0269227858781217,-3.30997697672754,86724,1.56988000281004,5,0,0,6.35141566997862e-05,0.111714996011502,1758.89914652489,10.7804570471878
"156",164,221,221,221,"Q9UI30","TRMT112","TR112_HUMAN","cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488]","SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:25851604}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:25851604}. Note=Localizes to a polarized perinuclear structure, overlapping partially with the Golgi and lysosomes (PubMed:25851604). {ECO:0000269|PubMed:25851604}.","Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog)","GO:0005654; GO:0005829; GO:0008276; GO:0018364; GO:0030488; GO:0032991; GO:0046982; GO:0048471; GO:0070476; GO:2000234",1e-07,1e-07,1e-07,0.0629764051473924,0.052475895027868,0.0411113449515998,0.0521877817089534,0.0260939908544767,8.58182233894071,0.00072054701081582,0.0277637217023409,-3.36499369652859,14199,1.55652231752366,6,3,0,1e-07,0.052475895027868,524758.95027868,19.0012953427433
"157",165,222,222,222,"P36915","GNL1","GNL1_HUMAN","extracellular space [GO:0005615]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural molecule activity [GO:0005198]; cellular response to DNA damage stimulus [GO:0006974]; ribosome biogenesis [GO:0042254]; signal transduction [GO:0007165]; T cell mediated immunity [GO:0002456]",NA,"Guanine nucleotide-binding protein-like 1 (GTP-binding protein HSR1)","GO:0002456; GO:0003924; GO:0005198; GO:0005525; GO:0005615; GO:0005634; GO:0006974; GO:0007165; GO:0042254",1e-07,1e-07,1e-07,0.0166059015139433,0.0128407455610801,0.0110632903288093,0.0135032124679442,0.00675170623397212,8.57702529718626,0.00072220494872176,0.0277637217023409,-3.36779917372126,68661,1.55652231752366,12,3,0,1e-07,0.0128407455610801,128407.455610801,16.9703694452807
"158",166,225,225,225,"O75976","CPD","CBPD_HUMAN","extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q90240}; Single-pass type I membrane protein {ECO:0000255}.","Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180)","GO:0004181; GO:0004185; GO:0005615; GO:0005886; GO:0006518; GO:0008270; GO:0016020; GO:0016021; GO:0016485; GO:0070062",0.00018876433979146,0.00020206302604892,0.00021730027379275,0.00091753719205279,0.00102864069483885,0.00124001107360425,0.00085935377362091,0.0006323861000215,8.53466563343546,0.00073704913897328,0.0279379408394455,-3.39263331013024,152931,1.5538056066335,11,0,0,0.00020206302604892,0.00102864069483885,5.09069231987951,2.34786187212344
"159",167,226,226,226,"Q92900","UPF1","RENT1_HUMAN","chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome, telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]","SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, P-body. Nucleus. Note=Hyperphosphorylated form is targeted to the P-body, while unphosphorylated protein is distributed throughout the cytoplasm.","Regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1)","GO:0000184; GO:0000294; GO:0000784; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0004004; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0009048; GO:0032201; GO:0032204; GO:0035145; GO:0042162; GO:0044530; GO:0044770; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347",3.90543635999334e-06,8.01586008661876e-06,2.91188492904728e-05,0.00051516638332925,0.00066187148808686,0.00071949817467685,0.00061849863345196,0.00032292936530501,8.52325550778411,0.00074111111513879,0.0279379408394455,-3.39934142991553,124345,1.5538056066335,32,0,0,8.01586008661876e-06,0.00066187148808686,82.5702396168007,6.36754998677687
"160",168,227,227,227,"Q9NYY8","FASTKD2","FAKD2_HUMAN","intercellular bridge [GO:0045171]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; cellular respiration [GO:0045333]; mitochondrial large ribosomal subunit assembly [GO:1902775]","SUBCELLULAR LOCATION: Mitochondrion matrix, mitochondrion nucleoid {ECO:0000269|PubMed:20869947, ECO:0000269|PubMed:25683715}. Note=Localizes to mitochondrial RNA granules found in close proximity to the mitochondrial nucleoids. {ECO:0000269|PubMed:25683715}.","FAST kinase domain-containing protein 2, mitochondrial","GO:0003723; GO:0004672; GO:0005634; GO:0005739; GO:0019843; GO:0035770; GO:0042645; GO:0045171; GO:0045333; GO:1902775",0.00010881467812941,0.00022219349123034,0.00014090458130257,0.040331562531501,0.0601525854185365,0.045597923907946,0.0485367197024404,0.024425664101441,8.50100669902348,0.00074911051415456,0.0279379408394455,-3.41244467832362,81463,1.5538056066335,8,0,0,0.00014090458130257,0.045597923907946,323.608526326279,8.33810580967669
"161",170,233,233,233,"Q9UBI9","HECA","HDC_HUMAN","cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; negative regulation of mitotic cell cycle [GO:0045930]; respiratory tube development [GO:0030323]",NA,"Headcase protein homolog (hHDC)","GO:0005634; GO:0005737; GO:0016020; GO:0030323; GO:0045930",7.20395133730241e-05,0.00027796172257744,2.64078092979973e-05,0.0776801756559839,0.0586472792400777,0.0519461143472715,0.0626323867326949,0.0314416630480969,8.43588569494859,0.0007731374904362,0.0281859545353916,-3.45097274360549,58837,1.54996725293413,5,0,0,7.20395133730241e-05,0.0586472792400777,814.098770162414,9.66906002920368
"162",171,234,234,234,"Q8N158","GPC2","GPC2_HUMAN","anchored component of plasma membrane [GO:0046658]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; heparan sulfate proteoglycan binding [GO:0043395]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; neuron differentiation [GO:0030182]; regulation of signal transduction [GO:0009966]; retinoid metabolic process [GO:0001523]; smoothened signaling pathway [GO:0007224]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-anchor {ECO:0000250}; Extracellular side {ECO:0000250}.; SUBCELLULAR LOCATION: Secreted glypican-2: Secreted, extracellular space {ECO:0000250}.","Glypican-2 [Cleaved into: Secreted glypican-2]","GO:0001523; GO:0005615; GO:0005783; GO:0005796; GO:0005886; GO:0006024; GO:0006027; GO:0007224; GO:0009966; GO:0030182; GO:0043202; GO:0043395; GO:0046658",0.00014424352208074,2.65922863606958e-05,8.55327468534331e-06,0.0599603762540966,0.0405469697740796,0.0443488183855432,0.0482255917768642,0.0241725922494744,8.42906386776573,0.0007757085253274,0.0281859545353916,-3.45502403592887,62830,1.54996725293413,18,0,0,2.65922863606958e-05,0.0443488183855432,1667.73243127722,10.7036721279806
"163",172,235,235,235,"Q9NY72","SCN3B","SCN3B_HUMAN","integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]; ion channel binding [GO:0044325]; sodium channel regulator activity [GO:0017080]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; atrial cardiac muscle cell action potential [GO:0086014]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; membrane depolarization [GO:0051899]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; nervous system development [GO:0007399]; positive regulation of heart rate [GO:0010460]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; SA node cell action potential [GO:0086015]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; ventricular cardiac muscle cell action potential [GO:0086005]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","Sodium channel subunit beta-3","GO:0001518; GO:0005244; GO:0005248; GO:0005886; GO:0006814; GO:0007399; GO:0010460; GO:0010765; GO:0016021; GO:0017080; GO:0019233; GO:0030018; GO:0035725; GO:0044325; GO:0051899; GO:0060048; GO:0060371; GO:0060373; GO:0072659; GO:0086002; GO:0086005; GO:0086006; GO:0086010; GO:0086012; GO:0086014; GO:0086015; GO:0086091; GO:2000649",0.0606826540634144,0.0417875311711335,0.0208947593896991,0.255649315822757,0.345806931102767,0.266856940351079,0.248316080884119,0.165279688650142,8.42283254021818,0.00077806613407399,0.0281859545353916,-3.45872718556731,24702,1.54996725293413,3,0,0,0.0417875311711335,0.266856940351079,6.3860422684033,2.67492210195499
"164",173,236,236,236,"Q9NPZ5","B3GAT2","B3GA2_HUMAN","Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate metabolic process [GO:0030204]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan metabolic process [GO:0030203]; protein glycosylation [GO:0006486]","SUBCELLULAR LOCATION: Golgi apparatus membrane; Single-pass type II membrane protein.","Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 2) (GlcAT-D) (UDP-glucuronosyltransferase S) (GlcAT-S) (Glucuronosyltransferase S)","GO:0000139; GO:0005975; GO:0006486; GO:0015018; GO:0016021; GO:0030203; GO:0030204; GO:0046872; GO:0050650",2.47809962434634e-05,2.20330505715254e-05,1.28393215257828e-05,0.078227194942588,0.120995217530522,0.107067738333842,0.102076832479537,0.0510583006958821,8.41517039833865,0.00078097708660566,0.0281859545353916,-3.46328396553326,36919,1.54996725293413,4,0,0,2.20330505715254e-05,0.107067738333842,4859.41508581712,12.2465669557822
"165",174,237,237,237,"Q9BRD0","BUD13","BUD13_HUMAN","nucleus [GO:0005634]; RES complex [GO:0070274]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]",NA,"BUD13 homolog","GO:0000398; GO:0003723; GO:0005634; GO:0070274",0.0278791161533569,0.0304006265735806,0.0140187216522198,0.0990603678513296,0.0798158240488948,0.0832732156215739,0.0632836477142136,0.0557413119834926,8.41084605082786,0.00078262583245238,0.0281859545353916,-3.46585733559948,70521,1.54996725293413,5,0,0,0.0278791161533569,0.0832732156215739,2.98693886719745,1.5786677107342
"166",175,238,238,238,"O95819","MAP4K4","M4K4_HUMAN","cytoplasm [GO:0005737]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of neuron projection regeneration [GO:0070571]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; regulation of mitotic cell cycle [GO:0007346]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14966141}.","Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase)","GO:0004111; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007346; GO:0008349; GO:0035556; GO:0043066; GO:0046328; GO:0048812; GO:0061179; GO:0070571",0.00086722821665776,0.00011402066189348,6.2439275014296e-05,0.0267104589821053,0.0259562247728385,0.0178196077784712,0.0231475344599498,0.0119216632811634,8.407541215925,0.00078388873236897,0.0281859545353916,-3.46782479496399,142101,1.54996725293413,23,0,0,0.00011402066189348,0.0259562247728385,227.644922786777,7.83064147275573
"167",176,239,239,239,"Q96BX8","MOB3A","MOB3A_HUMAN","intracellular [GO:0005622]; metal ion binding [GO:0046872]",NA,"MOB kinase activator 3A (MOB-LAK) (Mob1 homolog 2A) (Mps one binder kinase activator-like 2A)","GO:0005622; GO:0046872",0.0001847110682741,0.00019955312361705,0.00015088473267744,0.0830045662898937,0.0841611014509459,0.0560737823393583,0.0742347670518765,0.0372957665007944,8.3995112531594,0.00078696765583628,0.0281859545353916,-3.4726081068135,25464,1.54996725293413,4,0,0,0.0001847110682741,0.0830045662898937,449.375162330391,8.81177657647984
"168",177,240,240,240,"Q96Q42","ALS2","ALS2_HUMAN","centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of Rho protein signal transduction [GO:0035023]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]",NA,"Alsin (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein) (Amyotrophic lateral sclerosis 2 protein)","GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0008219; GO:0014069; GO:0016020; GO:0016197; GO:0016601; GO:0017112; GO:0017137; GO:0030027; GO:0030425; GO:0030426; GO:0030676; GO:0031982; GO:0032991; GO:0035022; GO:0035023; GO:0035249; GO:0042803; GO:0043025; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036",4.74363000177913e-05,7.01012029420113e-05,0.00012907699012042,0.0301331380124073,0.0461802144756837,0.0366364700408377,0.0375677360119495,0.0188660728370015,8.36942934622745,0.00079863392713076,0.0284179780265941,-3.49056342648009,183634,1.5464068258854,19,0,0,7.01012029420113e-05,0.0366364700408377,522.622558576404,9.02962558853121
"169",178,242,242,242,"O75688","PPM1B","PPM1B_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:22781750}. Membrane {ECO:0000250|UniProtKB:P36993}; Lipid-anchor {ECO:0000250|UniProtKB:P36993}. Note=Weakly associates at the membrane and N-myristoylation mediates the membrane localization. {ECO:0000250|UniProtKB:P36993}.","Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta)","GO:0000287; GO:0004722; GO:0005730; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:1901223",9.93273981491254e-05,0.00020112695499819,0.00013769421642829,0.0326807365175173,0.0344167716233367,0.0225639178470939,0.0297410924727908,0.0150165957595873,8.35418841636324,0.00080462513925401,0.0284486953345452,-3.49968223892196,52643,1.54593764568367,9,0,0,0.00013769421642829,0.0326807365175173,237.342841008411,7.89082872406944
"170",179,244,244,244,"Q9Y2I1","NISCH","NISCH_HUMAN","cytosol [GO:0005829]; early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission, GABAergic [GO:0032228]","SUBCELLULAR LOCATION: Cell membrane. Cytoplasm. Early endosome. Recycling endosome. Note=Enriched in the early/sorting and recycling endosomes. Colocalized in early/sorting endosomes with EEA1 and SNX2 and in recycling endosomes with transferrin receptor. Detected in the perinuclear region partially associated with punctate structures (By similarity). Colocalizes with PAK1 in cytoplasm, vesicular structures in the perinuclear area and membrane ruffles (By similarity). Colocalizes with RAC1 in the cytoplasm and vesicles structures (By similarity). Colocalized with MAPK1 and MAPK3 in RVLM neurons (By similarity). {ECO:0000250}.","Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor antisera-selected protein) (hIRAS) (Imidazoline-1 receptor) (I1R) (Imidazoline-1 receptor candidate protein) (I-1 receptor candidate protein) (I1R candidate protein)","GO:0005178; GO:0005769; GO:0005829; GO:0005886; GO:0006006; GO:0006915; GO:0008217; GO:0016020; GO:0016601; GO:0030036; GO:0030336; GO:0032228; GO:0035091; GO:0042802; GO:0048243; GO:0055037",1e-07,1e-07,1e-07,0.0829802982991267,0.0673649901142867,0.103908899073008,0.0847512958288072,0.0423757479144036,8.31165790472599,0.0008216362820861,0.0288246171092502,-3.52520665658583,166629,1.54023645292985,12,3,0,1e-07,0.0829802982991267,829802.982991267,19.6624093178828
"171",181,247,247,247,"Q9NXH9","TRMT1","TRM1_HUMAN","mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]; tRNA modification [GO:0006400]; tRNA N2-guanine methylation [GO:0002940]",NA,"tRNA (guanine(26)-N(2))-dimethyltransferase (EC 2.1.1.216) (tRNA 2,2-dimethylguanosine-26 methyltransferase) (tRNA(guanine-26,N(2)-N(2)) methyltransferase) (tRNA(m(2,2)G26)dimethyltransferase)","GO:0000049; GO:0002940; GO:0003723; GO:0004809; GO:0005634; GO:0005654; GO:0005739; GO:0006400; GO:0046872",7.96527139651101e-05,0.230931633916881,8.74528437222076e-05,0.686675285376802,0.804400099280757,0.799901233435319,0.686625959539437,0.420345892927908,8.28449816983542,0.00083272929230201,0.0288589584700619,-3.54156678585423,72234,1.53971934679995,7,0,0,8.74528437222076e-05,0.799901233435319,9146.65778023401,13.1590289586898
"172",182,250,250,250,"Q8IVL0","NAV3","NAV3_HUMAN","nuclear outer membrane [GO:0005640]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of invadopodium disassembly [GO:1905929]; positive regulation of microtubule polymerization [GO:0031116]","SUBCELLULAR LOCATION: Nucleus outer membrane {ECO:0000250}.","Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1) (Steerin-3) (Unc-53 homolog 3) (unc53H3)","GO:0005524; GO:0005640; GO:0007026; GO:0008017; GO:0030336; GO:0031116; GO:0032703; GO:1905929",0.00016725532415681,0.00012518347178537,7.50758177953905e-05,0.0506088079133387,0.0491325968592507,0.0331790958001479,0.0441843286529999,0.0222146691977458,8.22047890051485,0.00085960851923208,0.029316026724918,-3.58031775132246,255648,1.53289489106957,19,0,0,0.00012518347178537,0.0491325968592507,392.484695930863,8.61649259018636
"173",183,255,255,255,"Q8NFP4","MDGA1","MDGA1_HUMAN","anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; brain development [GO:0007420]; neuron migration [GO:0001764]; spinal cord association neuron differentiation [GO:0021527]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15922729}; Lipid-anchor, GPI-anchor {ECO:0000269|PubMed:15922729}. Note=Associated with lipid rafts.","MAM domain-containing glycosylphosphatidylinositol anchor protein 1 (GPI and MAM protein) (GPIM) (Glycosylphosphatidylinositol-MAM) (MAM domain-containing protein 3)","GO:0001764; GO:0005576; GO:0005615; GO:0005886; GO:0007420; GO:0021527; GO:0046658",5.67772885844096e-05,6.78960913219683e-05,8.32366234636109e-05,0.0176652027793279,0.0189318918965487,0.0122057550744614,0.0161983132489893,0.00816845995895133,8.14780621599629,0.0008914153454998,0.0299235896371698,-3.62462982104949,105790,1.52398630966772,19,0,0,6.78960913219683e-05,0.0176652027793279,260.179966701738,8.02336607168931
"174",184,256,256,256,"Q9BYD1","MRPL13","RM13_HUMAN","mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:25278503, ECO:0000269|PubMed:25838379}.","39S ribosomal protein L13, mitochondrial (L13mt) (MRP-L13) (Mitochondrial large ribosomal subunit protein uL13m)","GO:0003723; GO:0003729; GO:0003735; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0070125; GO:0070126",1.19247985199888e-05,0.00174138406584881,2.12110518353213e-05,0.0151620614932486,0.0119313175198474,0.0179986909468229,0.0144391833479049,0.00781109831268718,8.12470052191919,0.00090182761405145,0.0301548608448454,-3.63879124563567,20692,1.52064267132021,6,0,0,2.12110518353213e-05,0.0151620614932486,714.818935475904,9.48143404149514
"175",185,257,257,257,"Q5T3F8","TMEM63B","CSCL2_HUMAN","actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ion transport [GO:0006811]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","CSC1-like protein 2 (Transmembrane protein 63B)","GO:0005886; GO:0006811; GO:0015629; GO:0016021",0.00290839866116431,0.00582150223364754,0.00767603217695318,0.0968199887604492,0.0728285539501907,0.066211930251167,0.0731515132966806,0.0420444010055953,8.07849833649592,0.0009230964416423,0.03074593595509,-3.66721472821402,94958,1.51221228180477,7,0,0,0.00582150223364754,0.0728285539501907,12.5102681450934,3.64504080744869
"176",186,258,258,258,"Q9ULJ6","ZMIZ1","ZMIZ1_HUMAN","cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; artery morphogenesis [GO:0048844]; cell aging [GO:0007569]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296]","SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:14609956}. Cytoplasm {ECO:0000269|PubMed:14609956}.","Zinc finger MIZ domain-containing protein 1 (PIAS-like protein Zimp10) (Retinoic acid-induced protein 17)","GO:0001570; GO:0001701; GO:0003007; GO:0005654; GO:0005737; GO:0006351; GO:0007296; GO:0007569; GO:0008270; GO:0016607; GO:0043231; GO:0045582; GO:0045747; GO:0045944; GO:0048146; GO:0048589; GO:0048844",0.0140619241085673,0.0374207020784961,0.0281242265826822,0.3888049638183,0.454443650955336,0.298748520941432,0.354130094315108,0.203600664747469,8.0563613631455,0.00093350361162474,0.0307555173635658,-3.68088385847595,115483,1.51207696295817,5,0,0,0.0281242265826822,0.3888049638183,13.824556656705,3.78916130992754
"177",187,259,259,259,"Q9UPU3","SORCS3","SORC3_HUMAN","integral component of membrane [GO:0016021]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; neuropeptide receptor activity [GO:0008188]; learning [GO:0007612]; memory [GO:0007613]; neuropeptide signaling pathway [GO:0007218]; regulation of long term synaptic depression [GO:1900452]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","VPS10 domain-containing receptor SorCS3","GO:0007218; GO:0007612; GO:0007613; GO:0008188; GO:0014069; GO:0016020; GO:0016021; GO:1900452",0.0143589680030575,0.0286692414857313,0.0428389994919556,0.167422034043441,0.238614034755292,0.226619730429419,0.182262863415803,0.119753834701483,8.05532483950386,0.00093399440526144,0.0307555173635658,-3.68152469644375,135755,1.51207696295817,3,0,0,0.0286692414857313,0.226619730429419,7.90462944554036,2.98269783328427
"178",188,260,260,260,"Q9UHR5","SAP30BP","S30BP_HUMAN","intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of cell death [GO:0010942]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15496587}.","SAP30-binding protein (Transcriptional regulator protein HCNGP)","GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0006915; GO:0010942; GO:0045111",1e-07,1e-07,1e-07,0.0358811883517335,0.0341901375050794,0.0231047074655607,0.0310585777741245,0.0155293888870623,8.04726915549303,0.000937819512869,0.0307555173635658,-3.68650764126008,33870,1.51207696295817,4,3,0,1e-07,0.0341901375050794,341901.375050794,18.3832206994163
"179",189,261,261,261,"P51812","RPS6KA3","KS6A3_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}.","Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2)","GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007417; GO:0016301; GO:0018105; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045597; GO:0045944",1e-07,1e-07,1e-07,0.0605298526328697,0.0455875399691802,0.0394383984729754,0.0485184970250084,0.0242593485125042,8.04350031037584,0.00093961564361221,0.0307555173635658,-3.6888404071611,83736,1.51207696295817,7,3,0,1e-07,0.0455875399691802,455875.399691802,18.7982800338913
"180",190,262,262,262,"Q9NQG5","RPRD1B","RPR1B_HUMAN","centrosome [GO:0005813]; cytosol [GO:0005829]; DNA-directed RNA polymerase II, holoenzyme [GO:0016591]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA polymerase II core binding [GO:0000993]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle process [GO:0010564]; snRNA transcription by RNA polymerase II [GO:0042795]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22264791}.","Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor)","GO:0000993; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0008284; GO:0010564; GO:0016591; GO:0042795; GO:0042802; GO:0045944; GO:0070940",1e-07,1e-07,1e-07,0.0702997982919452,0.0500913215583987,0.047417335619635,0.0559360518233263,0.0279681259116631,8.03987196675982,0.00094134877911848,0.0307555173635658,-3.69108711208003,36900,1.51207696295817,9,3,0,1e-07,0.0500913215583987,500913.215583987,18.934201149131
"181",191,264,264,264,"Q658Y4","FAM91A1","F91A1_HUMAN","trans-Golgi network [GO:0005802]","SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network {ECO:0000269|PubMed:29084197}. Note=Recruitment to the TGN requires the presence of GOLGA1, GOLGA4 and TBC1D23. {ECO:0000269|PubMed:29084197}.","Protein FAM91A1","GO:0005802",1.86004701927316e-05,1e-07,1e-07,0.0278828964044215,0.0221546957190474,0.0177159857791409,0.022578259144139,0.0112953963954671,7.96482073525521,0.00097808804833735,0.0317137639915445,-3.73775951165661,93909,1.49875221007803,9,2,0,1e-07,0.0221546957190474,221546.957190474,17.7572529868785
"182",192,265,265,265,"O95758","PTBP3","PTBP3_HUMAN","nucleus [GO:0005634]; RNA binding [GO:0003723]; anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; RNA splicing [GO:0008380]",NA,"Polypyrimidine tract-binding protein 3 (Regulator of differentiation 1) (Rod1)","GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0009653; GO:0033119; GO:0043249; GO:0045595",0.0100718756323954,0.0307616493865374,0.0195689994583763,0.0873079037750252,0.0858231258465246,0.109325532619712,0.0740180125879843,0.0571431811197618,7.94761224019213,0.00098675691225386,0.0318741100712946,-3.74851513355128,59690,1.49656193193905,9,0,0,0.0195689994583763,0.0873079037750252,4.46154152953661,2.15754226906225
"183",193,266,266,266,"O75182","SIN3B","SIN3B_HUMAN","autosome [GO:0030849]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]; chromatin binding [GO:0003682]; RNA polymerase II transcription corepressor activity [GO:0001106]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00810}.","Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b)","GO:0000122; GO:0000805; GO:0000806; GO:0001106; GO:0001741; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0016575; GO:0016580; GO:0019216; GO:0030849",1.4858747767043e-06,1e-07,1e-07,0.0634402453002452,0.0398381915365996,0.0548103746910772,0.0526957085510484,0.0263484162337831,7.93481301004715,0.00099326537216811,0.0319637277660116,-3.7565280666845,133066,1.49534257686117,19,2,0,1e-07,0.0548103746910772,548103.746910772,19.064089471614
"184",194,267,267,267,"O43526","KCNQ2","KCNQ2_HUMAN","axon initial segment [GO:0043194]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; voltage-gated potassium channel activity [GO:0005249]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10788442, ECO:0000269|PubMed:9836639}; Multi-pass membrane protein {ECO:0000255}.","Potassium voltage-gated channel subfamily KQT member 2 (KQT-like 2) (Neuroblastoma-specific potassium channel subunit alpha KvLQT2) (Voltage-gated potassium channel subunit Kv7.2)","GO:0005249; GO:0005516; GO:0005886; GO:0005887; GO:0007268; GO:0007399; GO:0008076; GO:0016021; GO:0030506; GO:0033268; GO:0034765; GO:0043194; GO:0071805",0.0146164008314944,0.0213728194919574,0.0161100316066065,0.239515291797169,0.15768218217154,0.196227836980909,0.180442019673187,0.107587427146613,7.89630528340252,0.0010131646971295,0.0324113035025161,-3.78070387499915,95848,1.48930350236594,10,0,0,0.0161100316066065,0.196227836980909,12.1804749843221,3.60649848791526
"185",196,269,269,269,"Q13485","SMAD4","SMAD4_HUMAN","activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; collagen binding [GO:0005518]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; proximal promoter sequence-specific DNA binding [GO:0000987]; R-SMAD binding [GO:0070412]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; RNA polymerase II transcription factor binding [GO:0001085]; sulfate binding [GO:0043199]; transcription regulatory region DNA binding [GO:0044212]; transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0001077]; transforming growth factor beta receptor, common-partner cytoplasmic mediator activity [GO:0030616]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endoderm development [GO:0007492]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesoderm development [GO:0007498]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; protein deubiquitination [GO:0016579]; protein homotrimerization [GO:0070207]; regulation of binding [GO:0051098]; regulation of hair follicle development [GO:0051797]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15799969, ECO:0000269|PubMed:17327236}. Nucleus {ECO:0000269|PubMed:15799969}. Note=Cytoplasmic in the absence of ligand. Migrates to the nucleus when complexed with R-SMAD (PubMed:15799969). PDPK1 prevents its nuclear translocation in response to TGF-beta (PubMed:17327236). {ECO:0000269|PubMed:15799969, ECO:0000269|PubMed:17327236}.","Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4)","GO:0000122; GO:0000790; GO:0000978; GO:0000981; GO:0000987; GO:0001077; GO:0001085; GO:0001541; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0003148; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006879; GO:0007179; GO:0007183; GO:0007283; GO:0007338; GO:0007411; GO:0007492; GO:0007498; GO:0008283; GO:0008285; GO:0010614; GO:0010718; GO:0010862; GO:0014033; GO:0016579; GO:0017015; GO:0030308; GO:0030509; GO:0030511; GO:0030513; GO:0030616; GO:0032444; GO:0032525; GO:0032909; GO:0033686; GO:0035019; GO:0035556; GO:0036302; GO:0042118; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0044212; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0046982; GO:0048589; GO:0048663; GO:0048733; GO:0048859; GO:0051098; GO:0051571; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060548; GO:0060956; GO:0061040; GO:0061614; GO:0062009; GO:0070102; GO:0070207; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071559; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:1901522; GO:1905305; GO:2000617",0.00272856723611486,0.00511533841694915,0.0013484836459544,0.0871221553604209,0.0560245668649346,0.0782027477550136,0.0707190268937836,0.0384236432132312,7.88607501176392,0.00101853278530103,0.0324113035025161,-3.78714387680679,60439,1.48930350236594,6,0,0,0.00272856723611486,0.0782027477550136,28.6607369317989,4.8410037998881
"186",197,272,272,272,"Q9BY43","CHMP4A","CHM4A_HUMAN","cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; membrane coat [GO:0030117]; midbody [GO:0030496]; nucleus [GO:0005634]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; cell separation after cytokinesis [GO:0000920]; endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane invagination [GO:0010324]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of neuron death [GO:1901215]; nucleus organization [GO:0006997]; plasma membrane tubulation [GO:0097320]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; vacuolar transport [GO:0007034]; vesicle budding from membrane [GO:0006900]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058]","SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane. Late endosome membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305}. Note=Membrane-associated. Localizes to large vesicle-like structures. Localizes to the midbody of dividing cells. Localized in two distinct rings on either side of the Fleming body.","Charged multivesicular body protein 4a (Chromatin-modifying protein 4a) (CHMP4a) (SNF7 homolog associated with Alix-2) (SNF7-1) (hSnf-1) (Vacuolar protein sorting-associated protein 32-1) (Vps32-1) (hVps32-1)","GO:0000815; GO:0000920; GO:0005634; GO:0005737; GO:0005829; GO:0006620; GO:0006900; GO:0006997; GO:0007034; GO:0007080; GO:0008289; GO:0009898; GO:0010324; GO:0016197; GO:0016236; GO:0019058; GO:0030117; GO:0030496; GO:0030659; GO:0031902; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0051117; GO:0051258; GO:0051260; GO:0097320; GO:1901215; GO:1902902",0.00054571691340506,5.23473192116233e-05,9.94143873345089e-05,0.0219910981798728,0.0155651597539717,0.014824189263963,0.0172276561926188,0.00884632096962646,7.84007476505601,0.00104310296714912,0.0328270639661636,-3.81619136430222,25098,1.48376795858392,4,0,0,9.94143873345089e-05,0.0155651597539717,156.568482402835,7.29065001378644
"187",198,273,273,273,"Q96CX2","KCTD12","KCD12_HUMAN","cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; protein homooligomerization [GO:0051260]","SUBCELLULAR LOCATION: Cell junction, synapse, presynaptic cell membrane. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250}.","BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain)","GO:0003723; GO:0030054; GO:0042734; GO:0042802; GO:0045211; GO:0051260",1e-07,1e-07,3.71722704243115e-05,0.116283137193006,0.0811293231849253,0.078190449763371,0.0918551792902926,0.0459400470686211,7.79314905247564,0.00106891578207228,0.0335161871594824,-3.84597624893691,35701,1.47474539307821,11,2,0,1e-07,0.0811293231849253,811293.231849253,19.6298639273177
"188",199,276,276,276,"Q6ZT07","TBC1D9","TBCD9_HUMAN","endomembrane system [GO:0012505]; intracellular [GO:0005622]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of vesicle fusion [GO:0031338]",NA,"TBC1 domain family member 9 (TBC1 domain family member 9A)","GO:0005096; GO:0005509; GO:0005622; GO:0006886; GO:0012505; GO:0017137; GO:0031338; GO:0090630",2.79546199010969e-06,3.67031723705617e-07,3.19244808952018e-05,0.225562593305225,0.143106956432956,0.21627594544874,0.194970136070771,0.0974967636935884,7.76295608419625,0.00108593625682167,0.0336797621680924,-3.86522283518467,143229,1.47263098396128,8,0,0,2.79546199010969e-06,0.21627594544874,77366.798838232,16.2394269610654
"189",200,278,278,278,"Q96HE7","ERO1A","ERO1A_HUMAN","dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; disulfide oxidoreductase activity [GO:0015036]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; 4-hydroxyproline metabolic process [GO:0019471]; animal organ senescence [GO:0010260]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular protein modification process [GO:0006464]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; response to temperature stimulus [GO:0009266]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:10671517, ECO:0000269|PubMed:14517240}; Peripheral membrane protein {ECO:0000269|PubMed:10671517, ECO:0000269|PubMed:14517240}; Lumenal side {ECO:0000269|PubMed:10671517, ECO:0000269|PubMed:14517240}. Note=The association with ERP44 is essential for its retention in the endoplasmic reticulum.","ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic oxidoreductin-1-like protein) (Endoplasmic reticulum oxidoreductase alpha) (Oxidoreductin-1-L-alpha)","GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006464; GO:0009266; GO:0010260; GO:0015035; GO:0015036; GO:0016020; GO:0016491; GO:0016671; GO:0019471; GO:0022417; GO:0030198; GO:0030425; GO:0030968; GO:0034599; GO:0034975; GO:0034976; GO:0043231; GO:0045454; GO:0050873; GO:0051085; GO:0051209; GO:0070059; GO:0071456",0.00015378714209052,5.03783923745316e-05,6.69668133274309e-05,0.00388818541878582,0.0039075224397274,0.00255030202789557,0.0033582925128721,0.00176952370570021,7.70566812930344,0.00111914780931318,0.0344600908191396,-3.90192012110058,54393,1.46268358230879,11,0,0,6.69668133274309e-05,0.00388818541878582,58.0613773538055,5.85950689141162
"190",201,279,279,279,"Q76G19","PDZD4","PDZD4_HUMAN","cell cortex [GO:0005938]","SUBCELLULAR LOCATION: Cytoplasm, cell cortex {ECO:0000269|PubMed:15077175}. Note=Mainly localized under the plasma membrane.","PDZ domain-containing protein 4 (PDZ domain-containing RING finger protein 4-like protein)","GO:0005938",5.97118980484613e-05,6.96384118236157e-05,5.43691982173314e-05,0.243139079908413,0.170465226361988,0.275742918443509,0.22972116840194,0.114921824037,7.66493685842614,0.00114351537796269,0.0350841994098948,-3.92815538324713,86171,1.45488842923441,8,0,0,5.97118980484613e-05,0.243139079908413,4071.86989284924,11.9914757488409
"191",202,280,280,280,"P53804","TTC3","TTC3_HUMAN","cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20059950}.","E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3)","GO:0004842; GO:0005634; GO:0005730; GO:0005829; GO:0006511; GO:0046872; GO:0070936",7.41727254843433e-05,0.0154320673814301,0.00012607598919293,0.156933949810922,0.10927474857825,0.111414537937183,0.120663640076749,0.0655425920704103,7.65712552481784,0.00114826210546824,0.0351040129386006,-3.93320046633623,229869,1.45464323403354,14,0,0,0.00012607598919293,0.111414537937183,883.709409304645,9.78742823509731
"192",203,282,282,282,"Q9Y4P1","ATG4B","ATG4B_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; macroautophagy [GO:0016236]; positive regulation of protein catabolic process [GO:0045732]; protein delipidation [GO:0051697]; protein targeting to membrane [GO:0006612]; proteolysis [GO:0006508]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","Cysteine protease ATG4B (EC 3.4.22.-) (AUT-like 1 cysteine endopeptidase) (Autophagin-1) (Autophagy-related cysteine endopeptidase 1) (Autophagy-related protein 4 homolog B) (hAPG4B)","GO:0000045; GO:0000422; GO:0004175; GO:0004197; GO:0005737; GO:0005829; GO:0006501; GO:0006508; GO:0006612; GO:0006914; GO:0008234; GO:0016236; GO:0044804; GO:0045732; GO:0051697",1e-07,1e-07,1e-07,0.00778862933048096,0.0118919518281124,0.00843661970849094,0.00937230028902811,0.00468625014451405,7.63581134670346,0.00116133673849993,0.0352519236934731,-3.94698921879877,44294,1.45281717862536,14,3,0,1e-07,0.00843661970849094,84366.1970849094,16.3643774511545
"193",204,283,283,283,"O43301","HSPA12A","HS12A_HUMAN","extracellular exosome [GO:0070062]; ATP binding [GO:0005524]",NA,"Heat shock 70 kDa protein 12A","GO:0005524; GO:0070062",0.00012653028035575,0.00012320176373781,0.0002374670338069,0.00131275278362079,0.00157610747164305,0.00106830982072082,0.0011566569993614,0.00074072819231419,7.6220012801266,0.0011699050181279,0.0353865263433738,-3.95594107853473,74978,1.45116206703037,27,0,0,0.00012653028035575,0.00131275278362079,10.3750088905982,3.37504066762803
"194",205,285,285,285,"Q9HCK5","AGO4","AGO4_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; micro-ribonucleoprotein complex [GO:0035068]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; single-stranded RNA binding [GO:0003727]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; posttranscriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of cell morphogenesis [GO:0022604]; regulation of megakaryocyte differentiation [GO:0045652]; RNA secondary structure unwinding [GO:0010501]; synaptonemal complex assembly [GO:0007130]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]","SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000255|HAMAP-Rule:MF_03033, ECO:0000269|PubMed:16081698, ECO:0000269|PubMed:19167051}.","Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4)","GO:0000932; GO:0003725; GO:0003727; GO:0005654; GO:0005737; GO:0005829; GO:0006402; GO:0007130; GO:0007140; GO:0007223; GO:0008584; GO:0010501; GO:0010586; GO:0016020; GO:0016442; GO:0016604; GO:0022604; GO:0031054; GO:0035068; GO:0035194; GO:0035196; GO:0035198; GO:0035278; GO:0035280; GO:0043066; GO:0045652; GO:0070578",1e-07,1e-07,0.00858000752301531,0.0712233225553425,0.0719427234163445,0.0481324139089623,0.0609060841192113,0.0333131112339441,7.59452767172727,0.00118718075633067,0.035539301659424,-3.97379145850725,97097,1.44929111025155,8,2,0,1e-07,0.0712233225553425,712233.225553425,19.441990213175
"195",206,286,286,286,"Q6P995","FAM171B","F171B_HUMAN","integral component of membrane [GO:0016021]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.","Protein FAM171B","GO:0016021",8.32486480853905e-05,0.00017391161595246,0.00015475419808053,0.0412816153616405,0.0339772851910505,0.0541005497199577,0.0429825119368435,0.0216285607891279,7.58739082893878,0.00119171921893613,0.035539301659424,-3.97843756541178,92181,1.44929111025155,15,0,0,0.00015475419808053,0.0412816153616405,266.756029068489,8.05937706816806
"196",207,287,287,287,"Q9H6U8","ALG9","ALG9_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,2-mannosyltransferase activity [GO:0000026]; dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052926]; dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052918]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:15148656}; Multi-pass membrane protein {ECO:0000305}.","Alpha-1,2-mannosyltransferase ALG9 (EC 2.4.1.259) (EC 2.4.1.261) (Asparagine-linked glycosylation protein 9 homolog) (Disrupted in bipolar disorder protein 1) (Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase) (Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase)","GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006488; GO:0016020; GO:0016021; GO:0052918; GO:0052926",0.00019641623052523,1e-07,1e-07,0.0366031701735221,0.0313282877521068,0.0224965030549358,0.0300771149166799,0.0151040962018483,7.586882807398,0.00119204308487812,0.035539301659424,-3.97876843241808,69863,1.44929111025155,8,2,0,1e-07,0.0313282877521068,313282.877521068,18.257106395788
"197",208,288,288,288,"Q5T8D3","ACBD5","ACBD5_HUMAN","integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; autophagy of peroxisome [GO:0030242]; fatty acid catabolic process [GO:0009062]","SUBCELLULAR LOCATION: Peroxisome membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}.","Acyl-CoA-binding domain-containing protein 5","GO:0000062; GO:0005634; GO:0005654; GO:0005777; GO:0005778; GO:0008289; GO:0009062; GO:0016020; GO:0016021; GO:0030242",1e-07,0.00122927782189865,1e-07,0.0501518286122082,0.0309667875133351,0.0428795140887941,0.0409228841308129,0.0208712680060393,7.57737019881335,0.00119812725308623,0.035539301659424,-3.98496737910697,60092,1.44929111025155,8,2,0,1e-07,0.0428795140887941,428795.140887941,18.7099290316863
"198",209,289,289,289,"Q14318","FKBP8","FKBP8_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; FK506 binding [GO:0005528]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; chaperone-mediated protein folding [GO:0061077]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:16176796}. Mitochondrion membrane {ECO:0000305}; Single-pass membrane protein; Cytoplasmic side {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 1: Mitochondrion membrane {ECO:0000269|PubMed:12510191, ECO:0000269|PubMed:18385096}; Single-pass membrane protein; Cytoplasmic side {ECO:0000305}.; SUBCELLULAR LOCATION: Isoform 3: Mitochondrion membrane {ECO:0000269|PubMed:18385096}; Single-pass membrane protein; Cytoplasmic side {ECO:0000305}.","Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase)","GO:0001708; GO:0001933; GO:0003755; GO:0005528; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006915; GO:0007224; GO:0016020; GO:0016032; GO:0021904; GO:0030176; GO:0030513; GO:0031966; GO:0032991; GO:0035264; GO:0035556; GO:0042802; GO:0043010; GO:0043066; GO:0046872; GO:0061077; GO:0097718",0.00103262810879975,0.00041218841173132,0.00038041899589778,0.192681523188906,0.125634505414983,0.136984537246184,0.151158443444548,0.0761876335610836,7.57449779656654,0.00119997184084803,0.035539301659424,-3.98684051296016,44562,1.44929111025155,9,0,0,0.00041218841173132,0.136984537246184,332.334760870171,8.37649339075596
"199",210,290,290,290,"Q06136","KDSR","KDSR_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3-dehydrosphinganine reductase activity [GO:0047560]; 3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15328338}; Multi-pass membrane protein {ECO:0000269|PubMed:15328338}.","3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1) (FVT-1) (Short chain dehydrogenase/reductase family 35C member 1)","GO:0005615; GO:0005783; GO:0005789; GO:0006666; GO:0016020; GO:0016021; GO:0030148; GO:0047560",0.00018419618288138,0.00117117439172889,0.00023994754357895,0.0137069403170585,0.0203393399679609,0.014329851208382,0.0155936044584041,0.00832857493526512,7.56821526765783,0.0012040183973403,0.035539301659424,-3.99093956907421,36187,1.44929111025155,4,0,0,0.00023994754357895,0.014329851208382,59.7207664418829,5.90016077567811
"200",211,291,291,291,"P51116","FXR2","FXR2_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]","SUBCELLULAR LOCATION: Cytoplasm.","Fragile X mental retardation syndrome-related protein 2","GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0016020; GO:0017148; GO:0022625; GO:0042802; GO:0042803; GO:0046982",0.00091167787473095,0.00232950903605502,0.0006930938619805,0.100098347105463,0.0695301681449476,0.0669081730108991,0.0775341358295143,0.0400784948390127,7.54737434907607,0.00121756147776537,0.0356061187080492,-4.00455827779232,74223,1.44847536458874,11,0,0,0.00091167787473095,0.0695301681449476,76.2661572383415,6.25297110455921
"201",212,292,292,292,"Q16512","PKN1","PKN1_HUMAN","cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; GTP-Rho binding [GO:0017049]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone kinase activity (H3-T11 specific) [GO:0035402]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; activation of JUN kinase activity [GO:0007257]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; epithelial cell migration [GO:0010631]; histone H3-T11 phosphorylation [GO:0035407]; hyperosmotic response [GO:0006972]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of transcription by RNA polymerase II [GO:0006357]; renal system process [GO:0003014]; signal transduction [GO:0007165]; spleen development [GO:0048536]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:9478917}. Nucleus {ECO:0000269|PubMed:12514133}. Endosome {ECO:0000269|PubMed:9478917}. Cell membrane {ECO:0000250|UniProtKB:Q63433}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q63433}. Cleavage furrow {ECO:0000269|PubMed:17332740}. Midbody {ECO:0000269|PubMed:17332740}. Note=Associates with chromatin in a ligand-dependent manner. Localization to endosomes is mediated via its interaction with RHOB. Association to the cell membrane is dependent on Ser-377 phosphorylation. Accumulates during telophase at the cleavage furrow and finally concentrates around the midbody in cytokinesis. {ECO:0000250|UniProtKB:Q63433, ECO:0000269|PubMed:17332740}.","Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N)","GO:0001782; GO:0001783; GO:0002634; GO:0002637; GO:0003014; GO:0003682; GO:0004672; GO:0004674; GO:0004697; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0006351; GO:0006357; GO:0006468; GO:0006469; GO:0006972; GO:0007165; GO:0007257; GO:0010631; GO:0017049; GO:0018105; GO:0030374; GO:0030496; GO:0030889; GO:0032154; GO:0032991; GO:0035402; GO:0035407; GO:0042393; GO:0042826; GO:0048365; GO:0048536; GO:0050681; GO:2000145",0.00518253617581034,0.00291669232800672,0.053381613109123,0.223342675487399,0.173740989986506,0.244152545209459,0.193251789690141,0.117119508716051,7.5457897763787,0.00121859875083721,0.0356061187080492,-4.00559505457276,103932,1.44847536458874,10,0,0,0.00518253617581034,0.223342675487399,43.095246788601,5.42945685021863
"202",213,294,294,294,"Q9NYB0","TERF2IP","TE2IP_HUMAN","chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nuclear chromosome, telomeric region [GO:0000784]; nuclear envelope [GO:0005635]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; G-rich strand telomeric DNA binding [GO:0098505]; phosphatase binding [GO:0019902]; telomeric DNA binding [GO:0042162]; negative regulation of DNA recombination at telomere [GO:0048239]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomere maintenance [GO:0032205]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of telomere maintenance [GO:0032204]; regulation of transcription, DNA-templated [GO:0006355]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomere maintenance via telomere lengthening [GO:0010833]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q91VL8}. Cytoplasm {ECO:0000250|UniProtKB:Q91VL8}. Chromosome {ECO:0000250|UniProtKB:Q91VL8}. Chromosome, telomere {ECO:0000250|UniProtKB:Q91VL8}. Note=Associates with chromosomes, both at telomeres and in extratelomeric sites. Also exists as a cytoplasmic form, where it associates with the IKK complex. {ECO:0000250|UniProtKB:Q91VL8}.","Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (TRF2-interacting telomeric protein 1) (Dopamine receptor-interacting protein 5) (Repressor/activator protein 1 homolog) (RAP1 homolog) (hRap1)","GO:0000228; GO:0000723; GO:0000781; GO:0000783; GO:0000784; GO:0001933; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006351; GO:0006355; GO:0007004; GO:0010569; GO:0010833; GO:0016233; GO:0016604; GO:0019902; GO:0031848; GO:0032204; GO:0032205; GO:0033138; GO:0042162; GO:0043123; GO:0048239; GO:0051092; GO:0070187; GO:0070198; GO:0098505; GO:1901224; GO:1901985",3.99495553226072e-05,3.29248487676805e-05,3.0160023258021e-05,0.0375353154927675,0.0409663655328906,0.0577677833222691,0.0453888099735263,0.0227287497958792,7.53812771360804,0.00122362959991693,0.0356061187080492,-4.01061093878251,44260,1.44847536458874,15,0,0,3.29248487676805e-05,0.0409663655328906,1244.23853308944,10.2810473758512
"203",214,295,295,295,"Q9BUN8","DERL1","DERL1_HUMAN","Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; ATPase binding [GO:0051117]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; establishment of protein localization [GO:0045184]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein folding [GO:0006457]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral process [GO:0016032]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15215855, ECO:0000269|PubMed:15215856, ECO:0000269|PubMed:16186509, ECO:0000269|PubMed:16449189}; Multi-pass membrane protein {ECO:0000269|PubMed:15215855, ECO:0000269|PubMed:15215856, ECO:0000269|PubMed:16186509, ECO:0000269|PubMed:16449189}.","Derlin-1 (Degradation in endoplasmic reticulum protein 1) (DERtrin-1) (Der1-like protein 1)","GO:0002020; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0006457; GO:0006986; GO:0016020; GO:0016021; GO:0016032; GO:0016567; GO:0030176; GO:0030433; GO:0030968; GO:0030970; GO:0031398; GO:0031625; GO:0031648; GO:0032092; GO:0036502; GO:0036503; GO:0036513; GO:0038023; GO:0042288; GO:0045184; GO:0051117; GO:0051260; GO:0055085; GO:0071712; GO:1990381",0.00937353752691873,0.00969442466057331,0.0098150019698545,0.0374645320672007,0.0357498167954793,0.0269101007383145,0.0237471618145493,0.0215012356263902,7.53289479984187,0.00122708002556945,0.0356061187080492,-4.01403912520874,28801,1.44847536458874,3,0,0,0.00969442466057331,0.0357498167954793,3.68766771078967,1.88270866292728
"204",215,297,297,297,"Q86VS8","HOOK3","HOOK3_HUMAN","centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein transport [GO:0015031]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000269|PubMed:11238449}. Golgi apparatus {ECO:0000269|PubMed:11238449}. Note=Enriched at the cis-face of the Golgi complex. Localizes to microtubule asters in prophase (PubMed:11238449). Localizes to the manchette in elongating spermatids (By similarity). {ECO:0000250|UniProtKB:Q8BUK6, ECO:0000269|PubMed:11238449}.","Protein Hook homolog 3 (h-hook3) (hHK3)","GO:0000242; GO:0005801; GO:0005813; GO:0005829; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0022027; GO:0030705; GO:0031122; GO:0034451; GO:0034452; GO:0034454; GO:0042802; GO:0045022; GO:0045503; GO:0045505; GO:0050768; GO:0051645; GO:0051959; GO:0070695; GO:0071539; GO:0097150",0.00013933251202092,0.00034255032090201,0.00023726990032476,0.0119530740852252,0.0186086023001886,0.0136152941561967,0.0144859392694543,0.00748268721247636,7.51525572193997,0.00123879829600724,0.0356850429641896,-4.02560992173386,83126,1.44751377602351,20,0,0,0.00023726990032476,0.0136152941561967,57.3831494747583,5.84255524749937
"205",216,299,299,299,"Q9Y6I4","USP3","UBP3_HUMAN","cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17980597}. Note=Localizes preferentially with monoubiquitinated H2A to chromatin.","Ubiquitin carboxyl-terminal hydrolase 3 (EC 3.4.19.12) (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3)","GO:0000122; GO:0000278; GO:0000790; GO:0000978; GO:0004843; GO:0005634; GO:0005654; GO:0006281; GO:0006355; GO:0006511; GO:0008270; GO:0016578; GO:0016579; GO:0031647; GO:0036459; GO:0036464; GO:0042393; GO:0090543; GO:1990841",3.42453050870006e-05,4.35348452132402e-05,1.89135246938989e-05,0.025134525850777,0.0198192650402094,0.0320745389570644,0.0256438787243522,0.0128541705871741,7.50314013552351,0.00124692608978968,0.0356850429641896,-4.03357095593378,58897,1.44751377602351,5,0,0,3.42453050870006e-05,0.025134525850777,733.955378318939,9.51954854516632
"206",217,300,300,300,"O75190","DNAJB6","DNJB6_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]; intermediate filament organization [GO:0045109]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034]; regulation of protein localization [GO:0032880]","SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:10954706}. Nucleus {ECO:0000269|PubMed:10954706}. Cytoplasm, myofibril, sarcomere, Z line {ECO:0000269|PubMed:22366786}.","DnaJ homolog subfamily B member 6 (HHDJ1) (Heat shock protein J2) (HSJ-2) (MRJ) (MSJ-1)","GO:0001671; GO:0005634; GO:0005654; GO:0005829; GO:0006457; GO:0016020; GO:0030018; GO:0031072; GO:0032880; GO:0042802; GO:0043154; GO:0045109; GO:0048471; GO:0051082; GO:0051087; GO:0090084; GO:1900034",1e-07,1e-07,1e-07,0.140653127916725,0.085827298679252,0.121256620187966,0.115912248927981,0.0579562244639905,7.49763004352974,0.00125064402911879,0.0356850429641896,-4.03719523258437,36087,1.44751377602351,3,3,0,1e-07,0.121256620187966,1212566.20187966,20.2096320848847
"207",218,301,301,301,"Q9H4L4","SENP3","SENP3_HUMAN","cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; protein desumoylation [GO:0016926]; rRNA processing [GO:0006364]","SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:19680224}. Nucleus, nucleoplasm {ECO:0000269|PubMed:19015314, ECO:0000269|PubMed:19680224}. Cytoplasm {ECO:0000250|UniProtKB:Q9EP97}. Note=Redistributes between the nucleolus and the nucleoplasm in response to mild oxidative stress (PubMed:19680224). Mainly found in the nucleoplasm, with low levels detected in the cytoplasmic and chromatin fractions (By similarity). {ECO:0000250|UniProtKB:Q9EP97, ECO:0000269|PubMed:19680224}.","Sentrin-specific protease 3 (EC 3.4.22.-) (SUMO-1-specific protease 3) (Sentrin/SUMO-specific protease SENP3)","GO:0004175; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0008234; GO:0016926; GO:0071339",0.00587899532767547,0.00121073997257914,0.00066352796166637,0.0731017255591619,0.0460404403945039,0.061939535482769,0.0577761460581713,0.0314724941163926,7.47539570222599,0.00126578445151232,0.0359616828562735,-4.05184316507704,65010,1.44415999329886,9,0,0,0.00121073997257914,0.061939535482769,51.1584129421483,5.6768996039074
"208",219,302,302,302,"Q9HCD6","TANC2","TANC2_HUMAN","in utero embryonic development [GO:0001701]",NA,"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)","GO:0001701",0.00077948014173808,0.00934722749592745,0.00047999277371524,0.0956862421179499,0.0608286579895461,0.081187960713643,0.0756987201365861,0.0413849268720866,7.4710907697225,0.00126874161478909,0.0359616828562735,-4.05468355823081,219650,1.44415999329886,29,0,0,0.00077948014173808,0.081187960713643,104.156547891792,6.70260972828027
"209",220,303,303,303,"Q9P2N5","RBM27","RBM27_HUMAN","cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus speckle. Note=Incorporated into the nuclear speckles and to speckles proximal to the nuclear periphery. Also localizes to punctate structures in the cytoplasm termed cytospeckles (By similarity). {ECO:0000250}.","RNA-binding protein 27 (RNA-binding motif protein 27)","GO:0003723; GO:0005737; GO:0006397; GO:0016607; GO:0046872",1e-07,1e-07,1e-07,0.0691661881712943,0.0906843954820959,0.0561823127594669,0.0720108654709524,0.0360055327354762,7.43103334326756,0.00129666518931901,0.0365525937015081,-4.08118083879424,118718,1.43708180091441,5,3,0,1e-07,0.0691661881712943,691661.881712943,19.399707424456
"210",221,305,305,305,"Q9Y2G5","POFUT2","OFUT2_HUMAN","endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; peptide-O-fucosyltransferase activity [GO:0046922]; fucose metabolic process [GO:0006004]; mesoderm formation [GO:0001707]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046]","SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000269|PubMed:15233996}. Golgi apparatus {ECO:0000269|PubMed:15233996}. Note=Mainly located in the endoplasmic reticulum.","GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2)","GO:0001707; GO:0005789; GO:0005794; GO:0006004; GO:0010468; GO:0010717; GO:0036066; GO:0046922; GO:0051046",0.124277987687812,0.131014765703865,0.169381735783788,0.243866149799797,0.266998694052655,0.24982013769036,0.112003497455783,0.19755991178638,7.42293692390396,0.00130239965875701,0.0365525937015081,-4.08655131878041,49976,1.43708180091441,5,0,0,0.131014765703865,0.24982013769036,1.90680902528981,0.931160359086431
"211",222,307,307,307,"Q7L523","RRAGA","RRAGA_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cell death [GO:0008219]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; modulation by virus of host morphology or physiology [GO:0019048]; negative regulation of autophagy [GO:0010507]; positive regulation of cytolysis [GO:0045919]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein ubiquitination [GO:0016567]; regulation of macroautophagy [GO:0016241]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:8995684, ECO:0000269|PubMed:9394008}. Nucleus {ECO:0000269|PubMed:8995684, ECO:0000269|PubMed:9394008}. Lysosome {ECO:0000269|PubMed:20381137}. Note=Predominantly cytoplasmic. May shuttle between the cytoplasm and nucleus, depending on the bound nucleotide state (PubMed:8995684, PubMed:9394008). Colocalizes in vivo with adenovirus E3-14.7K mainly to the cytoplasm especially near the nuclear membrane and in discrete foci on or near the plasma membrane (PubMed:8995684). {ECO:0000269|PubMed:20381137, ECO:0000269|PubMed:8995684, ECO:0000269|PubMed:9394008}.","Ras-related GTP-binding protein A (Rag A) (RagA) (Adenovirus E3 14.7 kDa-interacting protein 1) (FIP-1)","GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006915; GO:0007050; GO:0008219; GO:0010507; GO:0016241; GO:0016567; GO:0019048; GO:0031625; GO:0032008; GO:0034198; GO:0034448; GO:0034613; GO:0042803; GO:0045919; GO:0046982; GO:0051219; GO:0071230; GO:1904263; GO:1990131",1e-07,1e-07,1e-07,0.0429300335674951,0.0261186377945902,0.034630608885489,0.0345596600825248,0.0172799300412624,7.39300938686029,0.00132386619952766,0.0368990515167398,-4.10644626994801,36566,1.43298479715639,3,3,0,1e-07,0.034630608885489,346306.08885489,18.4016882280809
"212",223,309,309,309,"Q7Z460","CLASP1","CLAP1_HUMAN","basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; spindle microtubule [GO:0005876]; dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Chromosome, centromere, kinetochore. Cytoplasm, cytoskeleton, spindle. Golgi apparatus, trans-Golgi network {ECO:0000305}. Note=Localizes to microtubule plus ends. Localizes to centrosomes, kinetochores and the mitotic spindle from prometaphase. Subsequently localizes to the spindle midzone from anaphase and to the midbody from telophase. In migrating cells localizes to the plus ends of microtubules within the cell body and to the entire microtubule lattice within the lamella. Localizes to the cell cortex and this requires ERC1 and PHLDB2.","CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1)","GO:0000086; GO:0000226; GO:0000776; GO:0000777; GO:0001578; GO:0002162; GO:0005794; GO:0005813; GO:0005828; GO:0005829; GO:0005876; GO:0005881; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010389; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030953; GO:0030981; GO:0031023; GO:0031111; GO:0031116; GO:0031592; GO:0034453; GO:0035371; GO:0040001; GO:0043515; GO:0045180; GO:0045921; GO:0051010; GO:0051294; GO:0051301; GO:0051497; GO:0051893; GO:0070507; GO:0090091; GO:0090162; GO:0090307; GO:0097711; GO:1903690; GO:1904261",6.86349770831876e-06,1e-07,1e-07,0.0052156864203371,0.00467452877872622,0.00731440458349089,0.0057325187616153,0.00286861388004375,7.38184167333113,0.00133198678956455,0.0368990515167398,-4.11388786431166,169451,1.43298479715639,46,2,0,1e-07,0.0052156864203371,52156.864203371,15.670569513416
"213",224,310,310,310,"Q5VSG8","MANEAL","MANEL_HUMAN","Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; hydrolase activity, acting on glycosyl bonds [GO:0016798]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.","Glycoprotein endo-alpha-1,2-mannosidase-like protein (EC 3.2.1.-)","GO:0000139; GO:0016021; GO:0016798",3.50121302224723e-05,3.54519015364178e-05,0.00226015002267359,0.13965210198664,0.171933297595556,0.225826584820152,0.178360456782638,0.0899570997427967,7.3639263779176,0.00134514088611085,0.0371432451132543,-4.1258457944543,51317,1.43012015570629,4,0,0,3.54519015364178e-05,0.171933297595556,4849.76235813299,12.2436983405922
"214",225,311,311,311,"P05165","PCCA","PCCA_HUMAN","cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; biotin metabolic process [GO:0006768]","SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000269|PubMed:16023992}.","Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)","GO:0004658; GO:0005524; GO:0005759; GO:0005829; GO:0006768; GO:0009374; GO:0019899; GO:0046872",0.00039221059392447,0.00036755871339452,0.00020410625002272,0.0008277265326617,0.00089235375559139,0.00093328723157614,0.00056316398749584,0.00060287384619516,7.34121501983975,0.00136204442151784,0.0374890683221632,-4.14104066261135,80059,1.42609535252513,17,0,0,0.00036755871339452,0.00089235375559139,2.42778561103945,1.27964102804076
"215",226,312,312,312,"O43310","CTIF","CTIF_HUMAN","cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]","SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:19648179}.","CBP80/20-dependent translation initiation factor","GO:0000184; GO:0003723; GO:0005829; GO:0006446; GO:0048471",0.00156689402269719,0.00164863565379805,0.00153732300835655,0.185966773045934,0.132168735814563,0.119218863349974,0.14420050650854,0.0736845374825539,7.32600576363334,0.00137350892111751,0.0375730494264675,-4.1512387109983,67587,1.42512355619176,11,0,0,0.00156689402269719,0.132168735814563,84.350781801473,6.39832953501705
"216",227,313,313,313,"O94953","KDM4B","KDM4B_HUMAN","nucleoplasm [GO:0005654]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00537, ECO:0000269|PubMed:15927959}.","Lysine-specific demethylase 4B (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3B) (Jumonji domain-containing protein 2B)","GO:0005654; GO:0006351; GO:0006355; GO:0032452; GO:0032454; GO:0033169; GO:0046872; GO:0051864; GO:0070544",3.64620111503343e-05,2.89017174544432e-05,3.96236606926757e-05,0.170569833909523,0.118007302184311,0.110657359982451,0.133043169562329,0.0665565805775971,7.32177941930582,0.00137671549680126,0.0375730494264675,-4.15407574271878,121897,1.42512355619176,8,0,0,3.64620111503343e-05,0.118007302184311,3236.44523330768,11.6601943756501
"217",228,315,315,315,"Q8IYB1","MB21D2","M21D2_HUMAN","cadherin binding [GO:0045296]; protein-containing complex binding [GO:0044877]",NA,"Protein MB21D2 (Mab-21 domain-containing protein 2)","GO:0044877; GO:0045296",2.26384155758377e-05,1e-07,0.00065675739259015,0.0235115073548327,0.017875176189378,0.0293292336228298,0.0233454737862915,0.0118992354958677,7.31398503968098,0.00138265310389454,0.0375730494264675,-4.15931155856933,55800,1.42512355619176,11,1,0,2.26384155758377e-05,0.0235115073548327,1038.56682355133,10.0203783298332
"218",229,316,316,316,"O43252","PAPSS1","PAPS1_HUMAN","cytosol [GO:0005829]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103]",NA,"Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPS synthase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK 1) (SK1) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)]","GO:0000103; GO:0001501; GO:0004020; GO:0004781; GO:0005524; GO:0005829; GO:0016779; GO:0042803; GO:0050428",2.39545729325481e-05,1.97495995909339e-05,3.43353749080633e-05,0.0862322511173894,0.0572530665025309,0.0579305754778758,0.0671126178501215,0.0335823221075379,7.29700004489653,0.00139570022602315,0.0376848734731202,-4.17073756436815,70833,1.42383293853251,11,0,0,2.39545729325481e-05,0.0579305754778758,2418.3514204573,11.2398081883528
"219",230,317,317,317,"A2RRP1","NBAS","NBAS_HUMAN","cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; SNARE binding [GO:0000149]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20577004}. Endoplasmic reticulum {ECO:0000269|PubMed:19369418}. Endoplasmic reticulum membrane; Peripheral membrane protein {ECO:0000305}.","Neuroblastoma-amplified sequence (Neuroblastoma-amplified gene protein)","GO:0000149; GO:0000956; GO:0005783; GO:0005789; GO:0005829; GO:0006890; GO:0015031; GO:0016020; GO:0070939; GO:2000623",0.00014679308148681,0.00377591710227832,9.16956091928225e-05,0.0154211358605085,0.0112374750893405,0.0145573730863166,0.0124005260810692,0.00753839830485393,7.29581054537397,0.00139661954706503,0.0376848734731202,-4.171538601868,268571,1.42383293853251,27,0,0,0.00014679308148681,0.0145573730863166,99.1693405361522,6.63182225689843
"220",231,318,318,318,"P23743","DGKA","DGKA_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; NAD+ kinase activity [GO:0003951]; phospholipid binding [GO:0005543]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205]",NA,"Diacylglycerol kinase alpha (DAG kinase alpha) (EC 2.7.1.107) (80 kDa diacylglycerol kinase) (Diglyceride kinase alpha) (DGK-alpha)","GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005543; GO:0005829; GO:0005886; GO:0006654; GO:0007205; GO:0016020; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834",0.00021614112612629,5.57013325310305e-05,5.73957115234899e-05,0.1165130529385,0.0710303102661094,0.090419306693167,0.0925444772425317,0.0463819846779928,7.29147646371324,0.00139997543977246,0.0376848734731202,-4.17445821598624,82630,1.42383293853251,9,0,0,5.73957115234899e-05,0.090419306693167,1575.36694455233,10.6214721941805
"221",232,319,319,319,"Q9UI08","EVL","EVL_HUMAN","cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; cellular response to interferon-gamma [GO:0071346]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; nervous system development [GO:0007399]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:P70429}. Cell projection, lamellipodium {ECO:0000250|UniProtKB:P70429}. Note=Targeted to the leading edge of lamellipodia and the dital tip of stress fibers through interaction with a number of proteins. In activated T-cells, localizes to the F-actin collar and the distal tip of microspikes. {ECO:0000250|UniProtKB:P70429}.","Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like)","GO:0003779; GO:0005522; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0007015; GO:0007166; GO:0007399; GO:0007411; GO:0008154; GO:0009887; GO:0010633; GO:0016020; GO:0017124; GO:0030027; GO:0045010; GO:0045335; GO:0051289; GO:0051496; GO:0071346; GO:1900028",0.0136291542249659,0.00027021190985797,0.0002879059264531,0.0559734392478906,0.0442186497718273,0.0632182144206952,0.049741010459712,0.0295995959169483,7.27061146944656,0.00141626923309891,0.0379427786506293,-4.1885344010952,44620,1.42087086774236,13,0,0,0.0002879059264531,0.0559734392478906,194.415724391171,7.60300109896396
"222",233,320,320,320,"Q96S55","WRNIP1","WRIP1_HUMAN","membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; innate immune response [GO:0045087]; regulation of DNA-dependent DNA replication initiation [GO:0030174]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18842586}. Cytoplasm {ECO:0000269|PubMed:29053956}. Note=Colocalizes with WRN in granular structures in the nucleus. {ECO:0000269|PubMed:18842586, ECO:0000269|PubMed:29053956}.","ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1)","GO:0000731; GO:0003677; GO:0005524; GO:0005634; GO:0006260; GO:0016020; GO:0016887; GO:0030174; GO:0042802; GO:0045087; GO:0046872; GO:0048471",0.00033238318972098,0.00042024309462495,0.0016231156265449,0.119111041658888,0.0920266855016464,0.0729008847867415,0.0938876233454619,0.0477357256430279,7.26787706187895,0.00141842163179923,0.0379427786506293,-4.1903816612882,72133,1.42087086774236,5,0,0,0.00042024309462495,0.0920266855016464,218.984408497602,7.77468434460601
"223",234,321,321,321,"O95983","MBD3","MBD3_HUMAN","cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase activity [GO:0004407]; methyl-CpG binding [GO:0008327]; aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; brain development [GO:0007420]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; histone acetylation [GO:0016573]; in utero embryonic development [GO:0001701]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to nutrient levels [GO:0031667]; tissue development [GO:0009888]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Nuclear, in discrete foci. Detected on chromatin, at promoter regions of active genes.","Methyl-CpG-binding domain protein 3 (Methyl-CpG-binding protein MBD3)","GO:0000122; GO:0000790; GO:0000792; GO:0001701; GO:0003677; GO:0003682; GO:0004407; GO:0005654; GO:0005737; GO:0006346; GO:0006351; GO:0007420; GO:0007507; GO:0007568; GO:0008327; GO:0009888; GO:0016573; GO:0016581; GO:0031667; GO:0032355; GO:0032991; GO:0043044; GO:0044030; GO:0048568",2.00504063546186e-05,1.2779789430328e-05,1.73060741808933e-05,0.0324745261209568,0.0484576029218338,0.0321131466566044,0.0376650464764764,0.0188492353282268,7.25630652243118,0.00142757358384582,0.0380686289025551,-4.19820480804041,32844,1.41943276465602,7,0,0,1.73060741808933e-05,0.0324745261209568,1876.48138922288,10.8738142664356
"224",235,323,323,323,"A7MD48","SRRM4","SRRM4_HUMAN","nucleus [GO:0005634]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; sensory perception of sound [GO:0007605]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Serine/arginine repetitive matrix protein 4 (Medulloblastoma antigen MU-MB-2.76) (Neural-specific serine/arginine repetitive splicing factor of 100 kDa) (Neural-specific SR-related protein of 100 kDa) (nSR100)","GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0007399; GO:0007605; GO:0008380; GO:0030154; GO:0043484",0.00029677335087821,0.00030468037784044,0.00661847084004464,0.255800253373082,0.154285175576976,0.215156788166101,0.206007430849132,0.105410356947487,7.23231933817719,0.00144677661805161,0.0383418199706556,-4.21445695187817,68559,1.41632727631832,5,0,0,0.00030468037784044,0.215156788166101,706.172119422728,9.46387605255365
"225",236,324,324,324,"P09471","GNAO1","GNAO_HUMAN","cell body [GO:0044297]; dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G-protein coupled serotonin receptor binding [GO:0031821]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; adenylate cyclase-modulating G-protein coupled receptor signaling pathway [GO:0007188]; aging [GO:0007568]; dopamine receptor signaling pathway [GO:0007212]; forebrain development [GO:0030900]; locomotory behavior [GO:0007626]; muscle contraction [GO:0006936]; negative regulation of calcium ion transport [GO:0051926]; neuron projection development [GO:0031175]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; regulation of heart contraction [GO:0008016]; response to cytokine [GO:0034097]; response to hydrogen peroxide [GO:0042542]; response to morphine [GO:0043278]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P18872}. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}.","Guanine nucleotide-binding protein G(o) subunit alpha","GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0006457; GO:0006936; GO:0007188; GO:0007212; GO:0007223; GO:0007568; GO:0007626; GO:0008016; GO:0030425; GO:0030900; GO:0031175; GO:0031683; GO:0031821; GO:0031852; GO:0032794; GO:0034097; GO:0042475; GO:0042542; GO:0043209; GO:0043278; GO:0043547; GO:0044297; GO:0046872; GO:0051430; GO:0051926",0.00017418395176706,0.00016924700359986,0.00035475980566785,0.00865402091318114,0.0139974470415813,0.013430213849817,0.0117944970145149,0.0061299787609357,7.21933799580349,0.00145729990183866,0.0385015035794412,-4.22327132731829,40051,1.41452230988101,23,0,0,0.00017418395176706,0.013430213849817,77.1036235747913,6.26872675775839
"226",237,325,325,325,"Q9NP72","RAB18","RAB18_HUMAN","cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; import into nucleus [GO:0051170]; lipid particle organization [GO:0034389]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}.","Ras-related protein Rab-18","GO:0001654; GO:0003924; GO:0005525; GO:0005622; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0007264; GO:0007420; GO:0015031; GO:0019003; GO:0030667; GO:0034389; GO:0043312; GO:0051170; GO:0071782; GO:0071786",0.00260721953807314,0.00148084060077253,0.00581571477569092,0.0698969993271787,0.0486282198720229,0.0470562874082076,0.0518925772309575,0.0292475469203243,7.20341489082162,0.00147033534522965,0.0386857537499301,-4.23410152504154,22977,1.41244893696726,6,0,0,0.00260721953807314,0.0486282198720229,18.6513713793206,4.22120980630124
"227",238,326,326,326,"P0CK96","SLC35E2B","S352B_HUMAN","integral component of membrane [GO:0016021]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","Solute carrier family 35 member E2B","GO:0016021",0.254018421523396,0.278771809029365,0.229409245896164,0.714190556844618,0.996887390332633,0.807059682596388,0.585312717774904,0.546722851037094,7.19980219857512,0.00147331258440154,0.0386857537499301,-4.23656154100981,43777,1.41244893696726,3,0,0,0.254018421523396,0.807059682596388,3.17716989876679,1.66774224005283
"228",239,327,327,327,"Q9H6T3","RPAP3","RPAP3_HUMAN","cytosol [GO:0005829]; R2TP complex [GO:0097255]",NA,"RNA polymerase II-associated protein 3","GO:0005829; GO:0097255",0.00468130587555167,0.00930745959742742,0.0218214239454779,0.108140650118058,0.102005401483914,0.0729690641524632,0.0824349754453261,0.0531542175288154,7.13550658998038,0.00152754594420252,0.0399871354201028,-4.28051835875946,75719,1.39807970653921,19,0,0,0.00930745959742742,0.102005401483914,10.959532020113,3.45411429038683
"229",240,328,328,328,"Q8NEY1","NAV1","NAV1_HUMAN","axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule bundle formation [GO:0001578]; neuron migration [GO:0001764]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Note=Associates with a subset of microtubule plus ends. Enriched in neuronal growth cones (By similarity). {ECO:0000250}.","Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1) (unc53H1)","GO:0001578; GO:0001764; GO:0005737; GO:0005874; GO:0043194",0.00024684328305591,0.00037582096286843,0.00028156498416616,0.0673068229487912,0.078456000006292,0.0466942315377749,0.0638509417542559,0.0322268806204914,7.12535407630417,0.00153633001338097,0.0400944662028693,-4.28748985973238,202472,1.39691556412297,41,0,0,0.00028156498416616,0.0673068229487912,239.045430837634,7.90114101976116
"230",241,329,329,329,"Q86V59","PNMA8A","PNM8A_HUMAN",NA,NA,"Paraneoplastic antigen-like protein 8A (PNMA-like protein 1)",NA,0.0599985019489594,0.0119686445202688,0.0239771107821384,0.392128040512983,0.273761302933822,0.426650582810892,0.332198556335443,0.198080697251511,7.11251471637648,0.0015475268907428,0.0401827053742371,-4.29631836492463,48161,1.39596082693198,5,0,0,0.0239771107821384,0.392128040512983,16.3542657026507,4.03159507956477
"231",242,330,330,330,"Q9BSV6","TSEN34","SEN34_HUMAN","nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]; mRNA processing [GO:0006397]; tRNA-type intron splice site recognition and cleavage [GO:0000379]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15109492}. Nucleus, nucleolus {ECO:0000269|PubMed:15109492}. Note=May be transiently localized in the nucleolus.","tRNA-splicing endonuclease subunit Sen34 (EC 4.6.1.16) (Leukocyte receptor cluster member 5) (tRNA-intron endonuclease Sen34) (HsSen34)","GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0016829",0.00287028846383489,0.00572209051316637,0.00754586944486633,0.28355666466033,0.175518272070345,0.210968345783525,0.217968344697444,0.114363588489345,7.1107203262926,0.00154909962307222,0.0401827053742371,-4.29755328006751,33652,1.39596082693198,4,0,0,0.00572209051316637,0.210968345783525,36.8691032233924,5.20434042070616
"232",243,331,331,331,"P18669","PGAM1","PGAM1_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; protein kinase binding [GO:0019901]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312]; regulation of glycolytic process [GO:0006110]; regulation of pentose-phosphate shunt [GO:0043456]; respiratory burst [GO:0045730]",NA,"Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B)","GO:0004082; GO:0004619; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006094; GO:0006096; GO:0006110; GO:0016020; GO:0016787; GO:0019901; GO:0034774; GO:0043209; GO:0043312; GO:0043456; GO:0045730; GO:0046538; GO:0061621; GO:0070062; GO:1904813",0.00098647459235748,0.00127602103867613,0.00112344590059572,0.00239281988239949,0.00230669826432913,0.00196776819724569,0.00109378160411499,0.00167553797926727,7.07819905634666,0.00157794323815098,0.0408072329866234,-4.31998033089468,28804,1.38926285240589,5,0,0,0.00112344590059572,0.00230669826432913,2.05323484033007,1.03789864624994
"233",244,334,334,334,"Q86Y82","STX12","STX12_HUMAN","early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]","SUBCELLULAR LOCATION: Endosome membrane; Single-pass type IV membrane protein {ECO:0000250|UniProtKB:G3V7P1}. Golgi apparatus membrane; Single-pass type IV membrane protein {ECO:0000250|UniProtKB:G3V7P1}. Endomembrane system {ECO:0000305}; Single-pass type IV membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Early endosome membrane {ECO:0000250|UniProtKB:G3V7P1}; Single-pass type IV membrane protein {ECO:0000305}. Recycling endosome membrane {ECO:0000250|UniProtKB:G3V7P1}; Single-pass type IV membrane protein {ECO:0000250|UniProtKB:G3V7P1}.","Syntaxin-12","GO:0000045; GO:0000139; GO:0000149; GO:0000407; GO:0005484; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0031201; GO:0031901; GO:0031982; GO:0033344; GO:0045121; GO:0045335; GO:0048278; GO:0050821; GO:0055038",1e-07,1e-07,1e-07,0.10826300178165,0.0681430754264867,0.0751235197139134,0.0838430989740166,0.0419216494870083,7.0341443798326,0.0016180647059951,0.0414689637225091,-4.35049963780902,31642,1.38227681718528,3,3,0,1e-07,0.0751235197139134,751235.197139134,19.5189051326741
"234",245,335,335,335,"Q8WZA1","POMGNT1","PMGT1_HUMAN","Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000269|PubMed:17034757, ECO:0000303|PubMed:11709191}; Single-pass type II membrane protein {ECO:0000305|PubMed:11709191}.","Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-) (UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2) (GnT I.2)","GO:0000139; GO:0006493; GO:0008375; GO:0016021; GO:0016266; GO:0030145; GO:0030173; GO:0047223",0.0730558928720827,0.097827062777415,0.0742773665539345,0.319689065699327,0.225177095563097,0.291529435789588,0.197078424949526,0.180259319875907,7.01866494090127,0.00163245582794606,0.0416159144104299,-4.36126130091302,75252,1.38074055834111,3,0,0,0.0742773665539345,0.291529435789588,3.92487576384257,1.97264698834187
"235",246,337,337,337,"P51784","USP11","UBP11_HUMAN","chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12084015, ECO:0000269|PubMed:15314155, ECO:0000269|PubMed:20233726}. Cytoplasm {ECO:0000269|PubMed:15314155}. Chromosome {ECO:0000269|PubMed:20233726, ECO:0000269|PubMed:20601937}. Note=Predominantly nuclear (PubMed:12084015, PubMed:15314155). Associates with chromatin (PubMed:20601937, PubMed:20233726). {ECO:0000269|PubMed:12084015, ECO:0000269|PubMed:15314155, ECO:0000269|PubMed:20233726, ECO:0000269|PubMed:20601937}.","Ubiquitin carboxyl-terminal hydrolase 11 (EC 3.4.19.12) (Deubiquitinating enzyme 11) (Ubiquitin thioesterase 11) (Ubiquitin-specific-processing protease 11)","GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006511; GO:0016579; GO:0036459",0.00075834735020277,0.00060179288076604,0.0004240866361353,0.0795880663215968,0.133380852509997,0.10359142493833,0.10492537230094,0.0530574284395047,7.00156891974467,0.00164853107865104,0.041732230781804,-4.37317001716936,109817,1.37952839960812,22,0,0,0.00060179288076604,0.10359142493833,172.138003371634,7.42742182999517
"236",247,340,340,340,"P25705","ATP5F1A","ATPA_HUMAN","extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]; transmembrane transporter activity [GO:0022857]; ATP biosynthetic process [GO:0006754]; cristae formation [GO:0042407]; lipid metabolic process [GO:0006629]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]","SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250|UniProtKB:P19483}; Peripheral membrane protein {ECO:0000250|UniProtKB:P19483}; Matrix side {ECO:0000250|UniProtKB:P19483}. Cell membrane {ECO:0000269|PubMed:10077593}; Peripheral membrane protein {ECO:0000269|PubMed:10077593}; Extracellular side {ECO:0000269|PubMed:10077593}. Note=Colocalizes with HRG on the cell surface of T-cells (PubMed:19285951). {ECO:0000269|PubMed:19285951}.","ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)","GO:0001937; GO:0003723; GO:0005524; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0005886; GO:0006629; GO:0006754; GO:0016020; GO:0022857; GO:0042288; GO:0042407; GO:0042776; GO:0043209; GO:0043532; GO:0043536; GO:0045259; GO:0045261; GO:0046933; GO:0070062",1e-07,1e-07,1e-07,0.024630612423048,0.0154737872637956,0.0170332282453699,0.0190457759774045,0.00952298798870226,6.99031175157851,0.00165922120006443,0.0417733337427986,-4.38102483464239,59751,1.37910086425301,18,3,0,1e-07,0.0170332282453699,170332.282453699,17.3779923640751
"237",248,341,341,341,"Q9Y5V3","MAGED1","MAGD1_HUMAN","chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; transcription coactivator activity [GO:0003713]; circadian regulation of gene expression [GO:0032922]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Nucleus {ECO:0000250}. Note=Expression shifts from the cytoplasm to the plasma membrane upon stimulation with NGF. {ECO:0000250}.","Melanoma-associated antigen D1 (MAGE tumor antigen CCF) (MAGE-D1 antigen) (Neurotrophin receptor-interacting MAGE homolog)","GO:0000785; GO:0003713; GO:0005634; GO:0005737; GO:0005886; GO:0006355; GO:0006357; GO:0032922; GO:0032991; GO:0042752; GO:0042802; GO:0042981; GO:0043406; GO:0045892; GO:0045893; GO:0050680; GO:0090190; GO:2001235",0.00092553785804158,0.00141352912941564,0.00110907797718682,0.176204133803323,0.143970467767901,0.238051073263701,0.184925843290094,0.0936123032999281,6.95537308957937,0.00169294064981673,0.0423622324167293,-4.4054713390646,86161,1.37302116138985,4,0,0,0.00110907797718682,0.176204133803323,158.874432120873,7.31174315825995
"238",249,344,344,344,"Q5VTL8","PRPF38B","PR38B_HUMAN","precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27)","GO:0003723; GO:0006397; GO:0008380; GO:0071011",1e-07,1e-07,1e-07,0.0500911697607851,0.0402455850312194,0.0294247111841358,0.0399203886587134,0.0199602943293567,6.94449511422648,0.00170360862252998,0.0423622324167293,-4.41310360982606,64468,1.37302116138985,4,3,0,1e-07,0.0402455850312194,402455.850312194,18.6184710016909
"239",250,345,345,345,"O15270","SPTLC2","SPTC2_HUMAN","endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Single-pass membrane protein {ECO:0000250}.","Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2)","GO:0004758; GO:0005789; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:1904504",1e-07,1e-07,1e-07,0.0643937033870184,0.0464658689771415,0.0392158441866475,0.0500250388502692,0.0250126194251346,6.94069326130711,0.00170735632987986,0.0423622324167293,-4.4157734459508,62924,1.37302116138985,8,3,0,1e-07,0.0464658689771415,464658.689771415,18.8258118629672
"240",251,347,347,347,"Q9H1B7","IRF2BPL","I2BPL_HUMAN","extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; development of secondary female sexual characteristics [GO:0046543]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Interferon regulatory factor 2-binding protein-like (Enhanced at puberty protein 1)","GO:0000122; GO:0005615; GO:0005634; GO:0005654; GO:0045944; GO:0046543; GO:0046872",3.5225985899605e-05,1e-07,7.04674132796062e-06,0.104503017777289,0.0671348116553194,0.0697097534214827,0.080435070042288,0.0402316592635532,6.93034043174303,0.00171761260915151,0.0423710776205675,-4.42304987946464,82659,1.37293049047825,12,1,0,7.04674132796062e-06,0.0697097534214827,9892.48081874139,13.2721166475153
"241",252,349,349,349,"Q10471","GALNT2","GALT2_HUMAN","endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]","SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane {ECO:0000269|PubMed:9394011}; Single-pass type II membrane protein {ECO:0000269|PubMed:9394011}. Secreted {ECO:0000269|PubMed:9394011}. Note=Resides preferentially in the trans and medial parts of the Golgi stack. A secreted form also exists.","Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form]","GO:0000139; GO:0002378; GO:0004653; GO:0005576; GO:0005789; GO:0005794; GO:0005795; GO:0006493; GO:0016020; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030173; GO:0030246; GO:0032580; GO:0048471",0.0107360089164569,0.0361714623015637,0.00901863933816956,0.133107905951359,0.0949340989130981,0.130956191462783,0.10102402859035,0.0691540511472383,6.91042435594535,0.00173755428299881,0.0425336036328625,-4.43707335914172,64733,1.37126782039986,13,0,0,0.0107360089164569,0.130956191462783,12.1978467493674,3.60855459036547
"242",253,350,350,350,"O43312","MTSS1","MTSS1_HUMAN","actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.","Metastasis suppressor protein 1 (Metastasis suppressor YGL-1) (Missing in metastasis protein)","GO:0001726; GO:0003785; GO:0005102; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013",1e-07,1e-07,1e-07,0.0988285594848135,0.0589977280503732,0.0739692658992114,0.0772650844781327,0.0386326422390663,6.90605856639646,0.00174196320265944,0.0425336036328625,-4.44015194374276,82251,1.37126782039986,5,3,0,1e-07,0.0739692658992114,739692.658992114,19.4965664324068
"243",254,351,351,351,"Q8IZD9","DOCK3","DOCK3_HUMAN","cytosol [GO:0005829]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; SH3 domain binding [GO:0017124]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; small GTPase mediated signal transduction [GO:0007264]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP)","GO:0005829; GO:0007264; GO:0017124; GO:0030676; GO:1903997",0.00012590662530732,9.89873782024281e-05,0.0001518152900681,0.0115256878913146,0.00705807915502881,0.00832635207352748,0.00884446994209767,0.00454780473557479,6.90397069480166,0.00174407650410453,0.0425336036328625,-4.44162480334813,233103,1.37126782039986,29,0,0,0.00012590662530732,0.00832635207352748,66.1311670708674,6.04725845710744
"244",255,352,352,352,"P60510","PPP4C","PP4C_HUMAN","cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289]; metal ion binding [GO:0046872]; NF-kappaB-inducing kinase activity [GO:0004704]; protein serine/threonine phosphatase activity [GO:0004722]; regulation of double-strand break repair via homologous recombination [GO:0010569]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome.","Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X)","GO:0004704; GO:0004722; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0010569; GO:0030289; GO:0046872",0.00152654744672122,0.00012930155942225,0.00014664335284335,0.0646899847018716,0.0391816030443912,0.047683821407354,0.0499176389315433,0.0255596502521006,6.89800477064268,0.0017501322796127,0.0425600349814907,-4.44583542894355,35080,1.37099802375196,3,0,0,0.00014664335284335,0.047683821407354,325.168652262688,8.34504437152638
"245",256,354,354,354,"Q5VWQ0","RSBN1","RSBN1_HUMAN","nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Lysine-specific demethylase 9 (KDM9) (EC 1.14.11.-) (Round spermatid basic protein 1)","GO:0005634; GO:0006325; GO:0046872; GO:0051213",0.0227797500778044,0.0124526123110922,0.0421725287180707,0.0837300016803653,0.0817852113063599,0.0854880230311751,0.057866114970311,0.0547346878541446,6.84503750017287,0.00180503292531037,0.0436471238436632,-4.48335228834992,90072,1.36004436914009,10,0,0,0.0227797500778044,0.0837300016803653,3.67563302469891,1.87799273510479
"246",257,355,355,355,"Q9P0K1","ADAM22","ADA22_HUMAN","axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; adult locomotory behavior [GO:0008344]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell adhesion [GO:0007162]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}. Cell projection, axon {ECO:0000250|UniProtKB:Q9R1V6}.","Disintegrin and metalloproteinase domain-containing protein 22 (ADAM 22) (Metalloproteinase-disintegrin ADAM22-3) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2)","GO:0004222; GO:0005178; GO:0005886; GO:0007155; GO:0007162; GO:0007417; GO:0008344; GO:0016021; GO:0022011; GO:0030424",0.00111531907716711,5.04114066898491e-06,5.56274102471947e-05,0.0158029302245899,0.0237867470083426,0.0155196884376948,0.017977792680848,0.00938089221645177,6.82670602717274,0.00182451930701224,0.0439940430085206,-4.49639279151764,100433,1.35660612496091,7,0,0,5.56274102471947e-05,0.0158029302245899,284.085312517076,8.15018043451398
"247",258,356,356,356,"O75376","NCOR1","NCOR1_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; transcriptional repressor complex [GO:0017053]; histone deacetylase binding [GO:0042826]; ligand-dependent nuclear receptor binding [GO:0016922]; nuclear hormone receptor binding [GO:0035257]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; circadian rhythm [GO:0007623]; negative regulation of JNK cascade [GO:0046329]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of fatty acid transport [GO:2000191]; regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter [GO:0072362]; regulation of lipid metabolic process [GO:0019216]; regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter [GO:0072368]; spindle assembly [GO:0051225]; transcription by RNA polymerase II [GO:0006366]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00624}.","Nuclear receptor corepressor 1 (N-CoR) (N-CoR1)","GO:0000122; GO:0000790; GO:0000981; GO:0001102; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0005876; GO:0006325; GO:0006366; GO:0007623; GO:0016020; GO:0016922; GO:0017053; GO:0019216; GO:0035257; GO:0042826; GO:0044212; GO:0046329; GO:0046966; GO:0051225; GO:0072362; GO:0072368; GO:1903799; GO:2000191",0.054698829286835,0.0336725595595308,0.0607374128553977,0.285554127111328,0.250166786493199,0.189442105815728,0.192018072572831,0.145711970187003,6.81829946413909,0.00183354090028012,0.0439977892907614,-4.50238272045485,270210,1.3565691444898,19,0,0,0.054698829286835,0.250166786493199,4.57353091016538,2.19330840154255
"248",259,357,357,357,"Q8N3C0","ASCC3","ASCC3_HUMAN","activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; intracellular [GO:0005622]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; RNA binding [GO:0003723]; cell proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12077347}.","Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12) (ASC-1 complex subunit p200) (ASC1p200) (Helicase, ATP binding 1) (Trip4 complex subunit p200)","GO:0003723; GO:0005524; GO:0005622; GO:0005634; GO:0005654; GO:0005829; GO:0006307; GO:0006351; GO:0006355; GO:0008283; GO:0016020; GO:0032508; GO:0043140; GO:0099053",9.36148919255932e-05,7.39750536803627e-05,6.96595871999388e-05,0.00038566549675578,0.00042477858851846,0.00036555265931725,0.00031291573726187,0.0002355410462329,6.81559680173446,0.0018364527930806,0.0439977892907614,-4.50430975141852,251460,1.3565691444898,17,0,0,7.39750536803627e-05,0.00038566549675578,5.21345342204406,2.38223933879204
"249",260,360,360,360,"Q14202","ZMYM3","ZMYM3_HUMAN","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]","SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.","Zinc finger MYM-type protein 3 (Zinc finger protein 261)","GO:0000981; GO:0003677; GO:0005654; GO:0005737; GO:0007010; GO:0007275; GO:0008270; GO:0022604",4.10738776026946e-06,1.44915348058863e-06,0.00115456636021851,0.0766508244121246,0.0658795738263489,0.0444897908176916,0.0619533553849019,0.0313633853262707,6.79996179353329,0.00185340885993464,0.0439977892907614,-4.51547016503166,152379,1.3565691444898,11,0,0,4.10738776026946e-06,0.0658795738263489,16039.2876620022,13.9693224496891
"250",261,363,363,363,"Q9Y2B0","CNPY2","CNPY2_HUMAN","endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; enzyme linked receptor protein signaling pathway [GO:0007167]; negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of low-density lipoprotein particle clearance [GO:0010988]; tissue development [GO:0009888]","SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000255|PROSITE-ProRule:PRU10138}.","Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4)","GO:0005783; GO:0005887; GO:0007167; GO:0009888; GO:0010629; GO:0010988; GO:0045716",0.00027366365865498,1e-07,1e-07,0.0143601302319104,0.0119020152945013,0.00833418338977705,0.0114408217525112,0.00581169876247395,6.77877159916072,0.00187669399296142,0.04417175356979,-4.53062994009476,20652,1.35485535938851,6,2,0,1e-07,0.0119020152945013,119020.152945013,16.8608463512657
"251",262,364,364,364,"O14522","PTPRT","PTPRT_HUMAN","cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein tyrosine phosphatase activity [GO:0004725]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho)","GO:0004725; GO:0005886; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0045294; GO:0045295; GO:0045296; GO:0070097",0.00059891588966614,5.06331194754731e-05,8.55811407224879e-05,0.119554599194439,0.159514674899857,0.0941649555731236,0.124166366505852,0.062328226636214,6.7772933740234,0.00187833157703313,0.04417175356979,-4.53168894877997,162134,1.35485535938851,21,0,0,8.55811407224879e-05,0.119554599194439,1396.97365780758,10.4480891013231
"252",263,366,366,366,"P48634","PRRC2A","PRC2A_HUMAN","cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15752841}. Nucleus {ECO:0000269|PubMed:15752841}.","Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2)","GO:0003723; GO:0005654; GO:0005829; GO:0005886; GO:0016020; GO:0030154; GO:0070062",0.00026755833299417,0.00039544508483622,0.00042645004558821,0.0528934909146833,0.0437014510540737,0.030547531795401,0.0420176734335798,0.0213719878712628,6.72716746157234,0.0019349025322227,0.045253458130673,-4.56771309301351,228863,1.34434822773647,28,0,0,0.00039544508483622,0.0437014510540737,110.512060283094,6.78806001062379
"253",264,368,368,368,"Q9NZ94","NLGN3","NLGN3_HUMAN","asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; carboxylic ester hydrolase activity [GO:0052689]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon extension [GO:0048675]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; oligodendrocyte differentiation [GO:0048709]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by neurological system process [GO:0002087]; regulation of terminal button organization [GO:2000331]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; visual learning [GO:0008542]; vocalization behavior [GO:0071625]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Cell junction, synapse {ECO:0000250}. Note=Detected at both glutamatergic and GABAergic synapses. {ECO:0000250}.","Neuroligin-3 (Gliotactin homolog)","GO:0002087; GO:0005886; GO:0005887; GO:0006898; GO:0007158; GO:0007416; GO:0007612; GO:0008542; GO:0009986; GO:0030054; GO:0030139; GO:0030534; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0048675; GO:0048709; GO:0050804; GO:0050808; GO:0050839; GO:0051965; GO:0051968; GO:0052689; GO:0060024; GO:0060076; GO:0060079; GO:0060080; GO:0060291; GO:0061002; GO:0071625; GO:0089717; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0098983; GO:0098985; GO:0099054; GO:0099055; GO:1900271; GO:2000310; GO:2000331; GO:2000463; GO:2000809; GO:2000969",9.75982063861821e-05,2.53464971716829e-05,2.51217127361251e-05,0.0588661842036274,0.0484051946312794,0.0813538415282719,0.0628257179822949,0.0314622144632455,6.7103185459197,0.00195438089855047,0.0453231656318959,-4.57987178359363,93895,1.34367976411203,8,0,0,2.53464971716829e-05,0.0588661842036274,2322.45835804849,11.1814370138102
"254",265,369,369,369,"O43913","ORC5","ORC5_HUMAN","cytosol [GO:0005829]; nuclear chromosome, telomeric region [GO:0000784]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]","SUBCELLULAR LOCATION: Nucleus.","Origin recognition complex subunit 5","GO:0000082; GO:0000166; GO:0000784; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006260; GO:0006270",0.00025742893437618,0.0364454252626284,0.00039050668720961,0.0883268371126367,0.0957422564281955,0.105458751901227,0.0841448281859483,0.0544368677210455,6.70859111500166,0.0019563913371869,0.0453231656318959,-4.58111977425499,50283,1.34367976411203,3,0,0,0.00039050668720961,0.0957422564281955,245.174435071337,7.93766474336034
"255",266,370,370,370,"Q9UH73","EBF1","COE1_HUMAN","nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; multicellular organism development [GO:0007275]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Transcription factor COE1 (O/E-1) (OE-1) (Early B-cell factor)","GO:0000981; GO:0003677; GO:0005634; GO:0006351; GO:0007275; GO:0046872; GO:0046983; GO:0070742",0.041989338878476,0.136039027562297,0.0525952820048003,0.278519648596698,0.291345676691767,0.261153141129583,0.200131605990825,0.17694035247727,6.70259458706852,0.00196338979596092,0.0453231656318959,-4.58545405315395,64464,1.34367976411203,3,0,0,0.0525952820048003,0.278519648596698,5.29552533954049,2.40477381304761
"256",267,371,371,371,"P56211","ARPP19","ARP19_HUMAN","cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; phosphatase inhibitor activity [GO:0019212]; potassium channel regulator activity [GO:0015459]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; signaling receptor binding [GO:0005102]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of glucose import [GO:0046326]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.","cAMP-regulated phosphoprotein 19 (ARPP-19)","GO:0000086; GO:0000278; GO:0004864; GO:0005102; GO:0005654; GO:0005737; GO:0015459; GO:0019212; GO:0019888; GO:0035308; GO:0045722; GO:0046326; GO:0051301; GO:0051721",0.00051281634772493,0.0130923474149059,0.00056488509492229,0.0684380736949696,0.0834441037532381,0.0526309904389385,0.0634477063431977,0.0364472027907832,6.70050736121097,0.00196583289329535,0.0453231656318959,-4.5869634465398,12323,1.34367976411203,3,0,0,0.00056488509492229,0.0684380736949696,121.153973277317,6.92069790891384
"257",268,374,374,374,"O15550","KDM6A","KDM6A_HUMAN","histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]","SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.","Lysine-specific demethylase 6A (EC 1.14.11.-) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein)","GO:0000978; GO:0001701; GO:0001843; GO:0003007; GO:0003016; GO:0005634; GO:0005654; GO:0006338; GO:0010628; GO:0031490; GO:0032452; GO:0032525; GO:0035097; GO:0035264; GO:0042802; GO:0044666; GO:0046872; GO:0048333; GO:0048570; GO:0051213; GO:0051568; GO:0060070; GO:0071558; GO:0072358",1e-07,1e-07,1.49543841835761e-05,0.399676145520226,0.399058899128122,0.620656650742113,0.473125513668759,0.236567808295774,6.65932749766493,0.00201479708741982,0.0460700506731792,-4.61682251640036,154177,1.33658131005967,3,2,0,1e-07,0.399676145520226,3996761.45520226,21.9304000380879
"258",269,375,375,375,"O94898","LRIG2","LRIG2_HUMAN","cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; innervation [GO:0060384]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15145052}; Single-pass type I membrane protein {ECO:0000269|PubMed:15145052}. Cytoplasm {ECO:0000269|PubMed:15145052}.","Leucine-rich repeats and immunoglobulin-like domains protein 2 (LIG-2)","GO:0005102; GO:0005737; GO:0005886; GO:0007605; GO:0010640; GO:0016021; GO:0030426; GO:0043025; GO:0048681; GO:0051045; GO:0060384; GO:0097708; GO:2000010; GO:2001222",1e-07,1e-07,1e-07,0.150803300861193,0.0989804601865572,0.173261686987519,0.14101504934509,0.0705076246725448,6.65646473127013,0.00201825572458437,0.0460700506731792,-4.61890392401054,118965,1.33658131005967,12,3,0,1e-07,0.150803300861193,1508033.00861193,20.5242365767368
"259",270,377,377,377,"Q9Y580","RBM7","RBM7_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; meiotic cell cycle [GO:0051321]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21855801}. Note=Excluded from the nucleolus. {ECO:0000269|PubMed:21855801}.","RNA-binding protein 7 (RNA-binding motif protein 7)","GO:0000381; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0051321",0.00011612259534837,8.95448483487561e-05,0.0213000867933512,0.0590586033862592,0.0768418813495332,0.0601189703875463,0.0581712336287634,0.0362542015600645,6.62544926039452,0.00205619269281593,0.0466870277201707,-4.64150139640601,30504,1.33080377408414,4,0,0,0.00011612259534837,0.0601189703875463,517.719830556562,9.01602776951052
"260",271,378,378,378,"P68106","FKBP1B","FKB1B_HUMAN","calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; calcium channel inhibitor activity [GO:0019855]; cyclic nucleotide binding [GO:0030551]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; signaling receptor binding [GO:0005102]; 'de novo' protein folding [GO:0006458]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; chaperone-mediated protein folding [GO:0061077]; insulin secretion [GO:0030073]; ion transmembrane transport [GO:0034220]; negative regulation of heart rate [GO:0010459]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neuronal action potential propagation [GO:0019227]; positive regulation of axon regeneration [GO:0048680]; positive regulation of sequestering of calcium ion [GO:0051284]; protein maturation by protein folding [GO:0022417]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to redox state [GO:0051775]; response to vitamin E [GO:0033197]; smooth muscle contraction [GO:0006939]; T cell proliferation [GO:0042098]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Sarcoplasmic reticulum {ECO:0000250}.","Peptidyl-prolyl cis-trans isomerase FKBP1B (PPIase FKBP1B) (EC 5.2.1.8) (12.6 kDa FK506-binding protein) (12.6 kDa FKBP) (FKBP-12.6) (FK506-binding protein 1B) (FKBP-1B) (Immunophilin FKBP12.6) (Rotamase) (h-FKBP-12)","GO:0000413; GO:0003755; GO:0005102; GO:0005528; GO:0005737; GO:0005829; GO:0006458; GO:0006939; GO:0009749; GO:0010459; GO:0010880; GO:0010881; GO:0014808; GO:0016020; GO:0019227; GO:0019855; GO:0022417; GO:0030018; GO:0030073; GO:0030551; GO:0032515; GO:0033017; GO:0033197; GO:0034220; GO:0034704; GO:0035584; GO:0042026; GO:0042098; GO:0042542; GO:0044325; GO:0048680; GO:0051280; GO:0051284; GO:0051480; GO:0051775; GO:0060314; GO:0060315; GO:0061077; GO:0061179; GO:0086064; GO:1903779",0.00426073643034016,1e-07,1e-07,0.0519210837039228,0.0600573341425173,0.0351318152641629,0.0476164322267543,0.0252285282568239,6.61382997778177,0.00207062742184019,0.0468903987591323,-4.6499894351796,11783,1.32891607397571,3,2,0,1e-07,0.0519210837039228,519210.837039228,18.9859609702153
"261",272,379,379,379,"Q15067","ACOX1","ACOX1_HUMAN","cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; PDZ domain binding [GO:0030165]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; alpha-linolenic acid metabolic process [GO:0036109]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; protein targeting to peroxisome [GO:0006625]; regulation of lipid metabolic process [GO:0019216]; spermatogenesis [GO:0007283]; very long-chain fatty acid metabolic process [GO:0000038]","SUBCELLULAR LOCATION: Peroxisome {ECO:0000250|UniProtKB:P07872}.","Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) (SCOX)","GO:0000038; GO:0003995; GO:0003997; GO:0005102; GO:0005634; GO:0005654; GO:0005730; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0005886; GO:0006091; GO:0006625; GO:0006629; GO:0006693; GO:0007283; GO:0016020; GO:0016401; GO:0016559; GO:0019216; GO:0019395; GO:0030165; GO:0033539; GO:0033540; GO:0036109; GO:0042632; GO:0043231; GO:0047485; GO:0050660; GO:0055088; GO:0071949",9.36408603173253e-05,0.00430368344250786,2.37179812619406e-05,0.0295489763572523,0.0182926087643051,0.0243198316456671,0.0225801248277125,0.0127637431752186,6.60939738632618,0.0020761664471725,0.046891780442735,-4.6532307266811,74424,1.32890327714011,12,0,0,9.36408603173253e-05,0.0243198316456671,259.713885191286,8.020779337257
"262",274,384,384,384,"A1L020","MEX3A","MEX3A_HUMAN","cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17267406}. Nucleus {ECO:0000269|PubMed:17267406}. Cytoplasm, P-body {ECO:0000269|PubMed:17267406}. Note=Predominantly expressed in the cytoplasm and shuttles between the cytoplasm and the nucleus through the CRM1 export pathway.","RNA-binding protein MEX3A (RING finger and KH domain-containing protein 4)","GO:0000932; GO:0003723; GO:0005634; GO:0005829; GO:0046872",1.42456411352409e-05,8.33554979669808e-05,8.68072050233907e-05,0.0968677804808364,0.0632139885973713,0.0609462906779271,0.0736145504706697,0.0368687446833767,6.58050441601541,0.00211271535366028,0.0470959464253438,-4.6744022299517,54173,1.3270164712334,9,0,0,8.33554979669808e-05,0.0632139885973713,758.366156272163,9.56675077206498
"263",275,385,385,385,"P61106","RAB14","RAB14_HUMAN","cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; rough endoplasmic reticulum [GO:0005791]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; defense response to bacterium [GO:0042742]; embryo development [GO:0009790]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular transport [GO:0046907]; neutrophil degranulation [GO:0043312]; phagosome maturation [GO:0090382]; phosphatidylinositol biosynthetic process [GO:0006661]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; vesicle-mediated transport [GO:0016192]","SUBCELLULAR LOCATION: Recycling endosome {ECO:0000269|PubMed:22595670}. Early endosome membrane {ECO:0000269|PubMed:16962593}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Golgi apparatus membrane {ECO:0000269|PubMed:16962593}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:16962593}; Lipid-anchor {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Cytoplasmic vesicle, phagosome {ECO:0000269|PubMed:21255211}. Note=Recruited to recycling endosomes by DENND6A (PubMed:22595670). Recruited to phagosomes containing S.aureus or M.tuberculosis (PubMed:21255211). {ECO:0000269|PubMed:21255211, ECO:0000269|PubMed:22595670}.","Ras-related protein Rab-14","GO:0000139; GO:0003924; GO:0005525; GO:0005622; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005791; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0006661; GO:0006895; GO:0008543; GO:0009790; GO:0015031; GO:0016192; GO:0019003; GO:0030100; GO:0030140; GO:0031489; GO:0031901; GO:0032456; GO:0032880; GO:0042175; GO:0042742; GO:0043231; GO:0043312; GO:0045335; GO:0046907; GO:0048471; GO:0055037; GO:0055038; GO:0070062; GO:0070821; GO:0090382",1e-07,1e-07,1e-07,0.00081812923261332,0.00053505089836121,0.00089922771788409,0.00075070261628621,0.0003754513081431,6.56358533365035,0.00213448005941384,0.0473173979803626,-4.68683516681559,23897,1.32497914557075,16,3,0,1e-07,0.00081812923261332,8181.2923261332,12.9981130355604
"264",276,387,387,387,"P98175","RBM10","RBM10_HUMAN","nuclear speck [GO:0016607]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18315527}. Note=In the extranucleolar nucleoplasm constitutes hundreds of nuclear domains, which dynamically change their structures in a reversible manner. Upon globally reducing RNA polymerase II transcription, the nuclear bodies enlarge and decrease in number. They occur closely adjacent to nuclear speckles or IGCs (interchromatin granule clusters) but coincide with TIDRs (transcription-inactivation-dependent RNA domains).","RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1)","GO:0000381; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0016607; GO:0035198; GO:0042802; GO:0042981; GO:0044877; GO:0046872",0.000156047127501,0.00020627751587558,7.9346167138892e-05,0.0504050559348383,0.0495679588807058,0.0295614876785588,0.0430309438945291,0.0216626955507697,6.55760269105522,0.00214224116026591,0.0473173979803626,-4.69123777009083,103533,1.32497914557075,16,0,0,0.000156047127501,0.0495679588807058,317.64736509096,8.31128224169803
"265",277,388,388,388,"P10586","PTPRF","PTPRF_HUMAN","extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of axon regeneration [GO:0048679]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]","SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.","Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR)","GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0007155; GO:0007185; GO:0008201; GO:0016477; GO:0031102; GO:0035335; GO:0035373; GO:0043005; GO:0043025; GO:0044877; GO:0048679; GO:0050839; GO:0070062; GO:1900121",0.00023190864602139,0.00041545716899777,0.00035716475015672,0.165054326748367,0.0967249990378093,0.162325979014201,0.141033591411734,0.0708516392275923,6.55566626088746,0.0021447605626613,0.0473173979803626,-4.69266348518594,212879,1.32497914557075,15,0,0,0.00035716475015672,0.162325979014201,454.484881117115,8.82808849233458
"266",278,391,391,391,"Q9ULI0","ATAD2B","ATD2B_HUMAN","nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; negative regulation of chromatin silencing [GO:0031936]; positive regulation of transcription by RNA polymerase II [GO:0045944]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24561620}. Note=Partially localizes to replication sites.","ATPase family AAA domain-containing protein 2B","GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0016887; GO:0031936; GO:0045944; GO:0070577",0.00028137557870955,0.00047761211992025,0.00025415916113725,0.00983697106262196,0.0132565056990571,0.016995987134592,0.013025439012168,0.00685043512600636,6.53627824130728,0.00217018463241302,0.0474142615470734,-4.70695710865933,164914,1.32409100896699,16,0,0,0.00028137557870955,0.0132565056990571,47.113206340985,5.55805961442937
"267",279,392,392,392,"Q9NRW7","VPS45","VPS45_HUMAN","endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; blood coagulation [GO:0007596]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]","SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Endosome membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=Associated with Golgi/endosomal vesicles and the trans-Golgi network. {ECO:0000250}.","Vacuolar protein sorting-associated protein 45 (h-VPS45) (hlVps45)","GO:0000139; GO:0005794; GO:0006886; GO:0006904; GO:0007596; GO:0010008; GO:0016021",0.00031015710868567,0.00046175754970963,0.00067415008323402,0.0509033960202032,0.0314973693046715,0.034025717728713,0.0383268061039861,0.0196454246325362,6.53160075829268,0.00217637299006313,0.0474142615470734,-4.71041072169687,65077,1.32409100896699,12,0,0,0.00046175754970963,0.034025717728713,73.6874096592673,6.20334623423734
"268",280,393,393,393,"Q8N2K0","ABHD12","ABD12_HUMAN","AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; protein depalmitoylation [GO:0002084]; response to auditory stimulus [GO:0010996]","SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q99LR1}; Single-pass membrane protein {ECO:0000250|UniProtKB:Q99LR1}.","Monoacylglycerol lipase ABHD12 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 12)","GO:0002084; GO:0004622; GO:0005886; GO:0006660; GO:0007628; GO:0008474; GO:0010996; GO:0016021; GO:0032281; GO:0032839; GO:0046464; GO:0046475; GO:0047372; GO:0052651",9.08575774364466e-05,0.00012612314900031,0.00010365343655635,0.0262129040508313,0.046423497030344,0.038901626854486,0.0370724645908894,0.0186431103497757,6.52626424087985,0.00218345941657023,0.0474142615470734,-4.7143533988332,45097,1.32409100896699,6,0,0,0.00010365343655635,0.038901626854486,375.304747694859,8.55191873055252
"269",281,394,394,394,"Q9BWF3","RBM4","RBM4_HUMAN","cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation [GO:0045947]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]","SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleolus. Nucleus speckle. Cytoplasm. Cytoplasmic granule. Note=Undergoes continuous nucleocytoplasmic shuttling. Upon nuclear import colocalizes with SR proteins in nuclear speckles. Arsenite stress-induced phosphorylation increases its subcellular relocalization from the nucleus to the cytoplasm and to cytoplasmic stress granules (SG) via a p38 MAPK signaling pathway. Primarily localized in nucleus and nucleoli under cell growth conditions and accumulated in the cytoplasm and cytoplasm perinuclear granules upon muscle cell differentiation.","RNA-binding protein 4 (Lark homolog) (hLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a)","GO:0000381; GO:0002190; GO:0002192; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006396; GO:0006397; GO:0008270; GO:0008380; GO:0010494; GO:0016607; GO:0017148; GO:0030154; GO:0030332; GO:0032055; GO:0035198; GO:0035278; GO:0043153; GO:0045947; GO:0046685; GO:0046822; GO:0051149; GO:0097157; GO:0097158; GO:0097167",1e-07,0.00024769432820894,7.82031383105872e-06,0.161269889518836,0.162847781304614,0.0953618557219266,0.139741303967779,0.0699558568645694,6.52437896154863,0.00218596958963931,0.0474142615470734,-4.71574689277735,40314,1.32409100896699,5,1,0,7.82031383105872e-06,0.161269889518836,20621.9204245162,14.3318910700593
"270",282,395,395,395,"P15260","IFNGR1","INGR1_HUMAN","integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine binding [GO:0019955]; interferon-gamma receptor activity [GO:0004906]; interferon-gamma-mediated signaling pathway [GO:0060333]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; response to virus [GO:0009615]; signal transduction [GO:0007165]","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10811850}; Single-pass type I membrane protein {ECO:0000255}.","Interferon gamma receptor 1 (IFN-gamma receptor 1) (IFN-gamma-R1) (CDw119) (Interferon gamma receptor alpha-chain) (IFN-gamma-R-alpha) (CD antigen CD119)","GO:0004906; GO:0005886; GO:0005887; GO:0007165; GO:0009615; GO:0019955; GO:0060333; GO:0060334",0.006973834728886,0.0310240645593302,0.0139580644993433,0.0814121693109766,0.0810892386477736,0.0636582257850437,0.0580678899854115,0.0463525995885589,6.52291256892361,0.0021879244522306,0.0474142615470734,-4.7168309961187,54405,1.32409100896699,3,0,0,0.0139580644993433,0.0810892386477736,5.8094901805038,2.53841156357284
"271",283,396,396,396,"Q9Y547","HSPB11","IFT25_HUMAN","centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; metal ion binding [GO:0046872]; heart development [GO:0007507]; intraciliary transport involved in cilium assembly [GO:0035735]; left/right axis specification [GO:0070986]; lung development [GO:0030324]; protein transport [GO:0015031]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]","SUBCELLULAR LOCATION: Cell projection, cilium {ECO:0000250}.","Intraflagellar transport protein 25 homolog (Heat shock protein beta-11) (Hspb11) (Placental protein 25) (PP25)","GO:0001501; GO:0005813; GO:0005929; GO:0007224; GO:0007507; GO:0015031; GO:0030324; GO:0030992; GO:0035735; GO:0046872; GO:0070986; GO:0097542",0.00020498752526397,0.00016065203488068,0.0001789307815554,0.0581740245922673,0.0883685329321615,0.103232689380757,0.0830768921878288,0.0417199695411477,6.50673289893041,0.00220963511691067,0.0476548160251586,-4.72880583621865,16297,1.32189320273899,3,0,0,0.0001789307815554,0.0883685329321615,493.869932070917,8.94798732659666
"272",284,397,397,397,"Q75T13","PGAP1","PGAP1_HUMAN","endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydrolase activity, acting on ester bonds [GO:0016788]; nuclease activity [GO:0004518]; phosphoric ester hydrolase activity [GO:0042578]; anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; forebrain regionalization [GO:0021871]; myo-inositol transport [GO:0015798]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.","GPI inositol-deacylase (EC 3.1.-.-) (Post-GPI attachment to proteins factor 1) (hPGAP1)","GO:0004518; GO:0005783; GO:0005789; GO:0007605; GO:0009880; GO:0009948; GO:0015031; GO:0015798; GO:0016021; GO:0016255; GO:0016788; GO:0021871; GO:0042578",9.03343179254244e-05,9.09679863606311e-05,5.71142383713598e-05,0.0254673209009587,0.0147848058039048,0.0247401559603192,0.0215846220408418,0.0108717832013067,6.50250280089154,0.00221535429198242,0.0476548160251586,-4.73194060475168,105383,1.32189320273899,16,0,0,9.03343179254244e-05,0.0247401559603192,273.873280149671,8.09736470928294
"273",285,398,398,398,"O95864","FADS2","FADS2_HUMAN","endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; linoleoyl-CoA desaturase activity [GO:0016213]; stearoyl-CoA 9-desaturase activity [GO:0004768]; alpha-linolenic acid metabolic process [GO:0036109]; linoleic acid metabolic process [GO:0043651]; unsaturated fatty acid biosynthetic process [GO:0006636]","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.","Fatty acid desaturase 2 (EC 1.14.19.3) (Acyl-CoA 6-desaturase) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase)","GO:0004768; GO:0005789; GO:0005887; GO:0006636; GO:0016020; GO:0016213; GO:0036109; GO:0043651",0.0300757104386237,0.0113921988732054,0.0195142241634737,0.118221127556069,0.155720959674127,0.102119792201186,0.10502658198536,0.0728406688177809,6.50027204616775,0.00221837754535749,0.0476548160251586,-4.73359440361306,52259,1.32189320273899,6,0,0,0.0195142241634737,0.118221127556069,6.05820280456513,2.59888987464088
"274",286,399,399,399,"Q9C0C4","SEMA4C","SEM4C_HUMAN","cell junction [GO:0030054]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synaptic vesicle membrane [GO:0030672]; cell migration in hindbrain [GO:0021535]; cerebellum development [GO:0021549]; muscle cell differentiation [GO:0042692]; negative chemotaxis [GO:0050919]; neural tube closure [GO:0001843]; positive regulation of stress-activated MAPK cascade [GO:0032874]; semaphorin-plexin signaling pathway [GO:0071526]","SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic cell membrane, postsynaptic density {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.","Semaphorin-4C","GO:0001843; GO:0005615; GO:0014069; GO:0016020; GO:0016021; GO:0021535; GO:0021549; GO:0030054; GO:0030672; GO:0032874; GO:0042692; GO:0045211; GO:0050919; GO:0071526",4.99550009407122e-06,1e-07,1e-07,0.0374321866697087,0.0632460212485758,0.0442482963286346,0.0483071029156084,0.0241552832911689,6.49362952186284,0.00222740957246353,0.0476548160251586,-4.73852166501036,92623,1.32189320273899,13,2,0,1e-07,0.0442482963286346,442482.963286346,18.7552623832924
"275",287,401,401,401,"P61247","RPS3A","RS3A_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cell differentiation [GO:0030154]; cytoplasmic translation [GO:0002181]; negative regulation of apoptotic process [GO:0043066]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03122, ECO:0000269|PubMed:17289661}. Nucleus {ECO:0000255|HAMAP-Rule:MF_03122}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs.","40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein) (Fte-1)","GO:0000184; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0006614; GO:0022627; GO:0030154; GO:0043066; GO:0048027; GO:0070062; GO:1990904",3.47272381175392e-06,1e-07,1e-07,0.00510970224171757,0.00849051727967881,0.0088844323960657,0.00749365973121677,0.00374805410687897,6.48995307393469,0.00223242771332811,0.0476548160251586,-4.74125052904754,29945,1.32189320273899,8,2,0,1e-07,0.00849051727967881,84905.1727967881,16.3735648313364
"276",288,402,402,402,"Q8NFG4","FLCN","FLCN_HUMAN","cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; cell-cell junction assembly [GO:0007043]; energy homeostasis [GO:0097009]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17028174, ECO:0000269|PubMed:18663353}. Nucleus {ECO:0000269|PubMed:17028174, ECO:0000269|PubMed:18663353}. Note=Mainly localized in the nucleus. Colocalizes with FNIP1 and FNIP2 in the cytoplasm. {ECO:0000269|PubMed:17028174, ECO:0000269|PubMed:18663353}.","Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein)","GO:0000122; GO:0001701; GO:0001932; GO:0001934; GO:0005085; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0005886; GO:0005929; GO:0007043; GO:0010508; GO:0010629; GO:0010823; GO:0030097; GO:0030308; GO:0030336; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032465; GO:0035024; GO:0035065; GO:0043065; GO:0044877; GO:0045785; GO:0045944; GO:0051898; GO:0070373; GO:0097009; GO:1900181; GO:1901723; GO:2000973; GO:2001170",9.29972229935398e-05,8.76649914745704e-05,0.00032043885281049,0.145216298149876,0.087790512343574,0.0982231954195147,0.110242968281895,0.0552885178300406,6.48043800040589,0.00224547903838975,0.0477191885311359,-4.7483189944188,64473,1.32130695015355,9,0,0,9.29972229935398e-05,0.0982231954195147,1056.1949298888,10.0446604057515
"277",289,403,403,403,"O94991","SLITRK5","SLIK5_HUMAN","integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; adult behavior [GO:0030534]; axonogenesis [GO:0007409]; cardiovascular system development [GO:0072358]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; grooming behavior [GO:0007625]; positive regulation of synapse assembly [GO:0051965]; response to xenobiotic stimulus [GO:0009410]; skin development [GO:0043588]; striatum development [GO:0021756]","SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.","SLIT and NTRK-like protein 5 (Leucine-rich repeat-containing protein 11)","GO:0005886; GO:0007268; GO:0007409; GO:0007625; GO:0009410; GO:0016021; GO:0021756; GO:0030534; GO:0043235; GO:0043588; GO:0048813; GO:0051965; GO:0072358",0.00010955659603313,0.00014287087871943,0.0110341202533386,0.0770139036762181,0.0469903238780347,0.0635115044562718,0.0587430614274778,0.0331337132897693,6.4796292368563,0.0022465926376224,0.0477191885311359,-4.74892019028531,107486,1.32130695015355,9,0,0,0.00014287087871943,0.0635115044562718,444.537788425,8.7961622519257
"278",290,404,404,404,"Q9NR46","SH3GLB2","SHLB2_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11161816}.","Endophilin-B2 (SH3 domain-containing GRB2-like protein B2)","GO:0005654; GO:0005737; GO:0005829; GO:0042802; GO:0045296",1e-07,1e-07,0.00018530655643377,0.00888956639887376,0.00912369283121499,0.0141237714372854,0.0106505080369801,0.00538708953730132,6.47129672125695,0.00225810489027247,0.0478449947047829,-4.755117738689,43974,1.32016348914719,5,2,0,1e-07,0.00912369283121499,91236.9283121499,16.4773302555789
"279",291,405,405,405,"P37837","TALDO1","TALDO_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; interleukin-12-mediated signaling pathway [GO:0035722]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; xylulose biosynthetic process [GO:0005999]","SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.","Transaldolase (EC 2.2.1.2)","GO:0004801; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005975; GO:0005999; GO:0006002; GO:0006098; GO:0009052; GO:0035722; GO:0048029; GO:0070062",3.81228343709338e-05,0.00027202690506752,2.36112791108692e-05,0.0008805155647812,0.00123704644976166,0.00091898123196123,0.00090092740931825,0.0005617173775089,6.43031188169458,0.00231578209060432,0.0489459128285752,-4.78569614183745,37540,1.31028356760151,8,0,0,3.81228343709338e-05,0.00091898123196123,24.1057950471252,4.59130810776317
"280",292,406,406,406,"Q8IUR7","ARMC8","ARMC8_HUMAN","extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; neutrophil degranulation [GO:0043312]",NA,"Armadillo repeat-containing protein 8","GO:0005576; GO:0035580; GO:0043312; GO:1904724",5.84291435837427e-05,0.00676191165149288,0.00012234931536965,0.0269173979915667,0.0419807445481161,0.0310803814624402,0.0310119446305589,0.0178202023520949,6.42445825161094,0.0023241648422235,0.0489966901524999,-4.79007638351775,75509,1.30983325664609,10,0,0,0.00012234931536965,0.0310803814624402,254.029876411961,7.98885437187702
"281",293,407,407,407,"Q96FJ0","STAMBPL1","STALP_HUMAN","cytosol [GO:0005829]; membrane [GO:0016020]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; protein deubiquitination [GO:0016579]",NA,"AMSH-like protease (AMSH-LP) (EC 3.4.19.-) (STAM-binding protein-like 1)","GO:0005829; GO:0008237; GO:0016020; GO:0016579; GO:0046872; GO:0061578",1e-07,1e-07,1e-07,0.0682886647354396,0.0438791052621602,0.0426683702337111,0.0516119467437703,0.0258060733718852,6.42065409591857,0.00232963234720414,0.0489966901524999,-4.79292474928855,49783,1.30983325664609,5,3,0,1e-07,0.0438791052621602,438791.052621602,18.743174582516
"282",294,408,408,408,"O94829","IPO13","IPO13_HUMAN","cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]","SUBCELLULAR LOCATION: Cytoplasm. Nucleus.","Importin-13 (Imp13) (Karyopherin-13) (Kap13) (Ran-binding protein 13) (RanBP13)","GO:0005737; GO:0006606; GO:0008139; GO:0008536; GO:0008565; GO:0031965",0.0256867191589329,0.0200164382095578,0.0262690821231372,0.0860944524295648,0.122593636473416,0.0875235255795357,0.0747464583302963,0.0613639756623575,6.41309343782786,0.00234054523067045,0.0491055568003408,-4.7985898640405,108195,1.30886936019525,10,0,0,0.0256867191589329,0.0875235255795357,3.4073454471938,1.76864821972341
"283",295,409,409,409,"Q9H2X9","SLC12A5","S12A5_HUMAN","dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; chloride transmembrane transporter activity [GO:0015108]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cellular chloride ion homeostasis [GO:0030644]; cellular ion homeostasis [GO:0006873]; chemical synaptic transmission [GO:0007268]; dendritic spine development [GO:0060996]; hypotonic response [GO:0006971]; ion transport [GO:0006811]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; response to drug [GO:0042493]; thermosensory behavior [GO:0040040]","SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.","Solute carrier family 12 member 5 (Electroneutral potassium-chloride cotransporter 2) (K-Cl cotransporter 2) (hKCC2) (Neuronal K-Cl cotransporter)","GO:0005886; GO:0005887; GO:0006811; GO:0006873; GO:0006971; GO:0007268; GO:0007612; GO:0015108; GO:0015379; GO:0016021; GO:0019901; GO:0030644; GO:0035264; GO:0040040; GO:0042493; GO:0043025; GO:0043198; GO:0060996",0.0109705425379654,1.16541444765158e-05,2.99163494554229e-05,0.165988781363698,0.11937953623859,0.0987784814606682,0.12437822867702,0.0658598186824756,6.38875972277531,0.00237609112836815,0.0496707225869414,-4.8168596378067,126184,1.30389952204144,6,0,0,2.99163494554229e-05,0.11937953623859,3990.44463685225,11.9623337929248
"284",296,411,411,411,"Q9BWM7","SFXN3","SFXN3_HUMAN","integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ion transmembrane transporter activity [GO:0015075]; iron ion homeostasis [GO:0055072]","SUBCELLULAR LOCATION: Mitochondrion membrane {ECO:0000269|Ref.4}; Multi-pass membrane protein {ECO:0000269|Ref.4}.","Sideroflexin-3","GO:0005739; GO:0015075; GO:0016021; GO:0031966; GO:0055072",1e-07,1e-07,1e-07,0.0491563819840879,0.0356613705782197,0.0281880625440792,0.0376685050354623,0.0188343525177311,6.37381566771466,0.00239824537034224,0.0496707225869414,-4.8281075720626,35503,1.30389952204144,9,3,0,1e-07,0.0356613705782197,356613.705782197,18.4440026257565
"285",297,413,413,413,"Q9BQI5","SGIP1","SGIP1_HUMAN","AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; SH3 domain binding [GO:0017124]; clathrin-dependent endocytosis [GO:0072583]; energy homeostasis [GO:0097009]; membrane organization [GO:0061024]; plasma membrane tubulation [GO:0097320]; positive regulation of feeding behavior [GO:2000253]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to dietary excess [GO:0002021]","SUBCELLULAR LOCATION: Membrane, clathrin-coated pit {ECO:0000305|PubMed:20946875}; Peripheral membrane protein {ECO:0000305|PubMed:20946875}; Cytoplasmic side {ECO:0000305|PubMed:20946875}.","SH3-containing GRB2-like protein 3-interacting protein 1 (Endophilin-3-interacting protein)","GO:0002021; GO:0005543; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0008017; GO:0017124; GO:0030122; GO:0030136; GO:0048260; GO:0061024; GO:0072583; GO:0097009; GO:0097320; GO:2000253",0.00013538254681537,1e-07,1e-07,0.0573613351678893,0.0341035227751847,0.0389976591929617,0.0434423115297401,0.0217663499471419,6.37086170138164,0.00240265415001102,0.0496707225869414,-4.83033345535649,89109,1.30389952204144,9,2,0,1e-07,0.0389976591929617,389976.591929617,18.5730280042564
"286",298,414,414,414,"Q9UBB4","ATXN10","ATX10_HUMAN","cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; protein homotrimerization [GO:0070207]","SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:16498633}.","Ataxin-10 (Brain protein E46 homolog) (Spinocerebellar ataxia type 10 protein)","GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0007399; GO:0016020; GO:0019899; GO:0030425; GO:0031175; GO:0042802; GO:0043025; GO:0048471; GO:0060271; GO:0070207",1e-07,1e-07,1e-07,0.0917117148380036,0.0662638315542025,0.0526547068124608,0.0702099844015556,0.0351050922007778,6.36840885485399,0.00240632247719639,0.0496707225869414,-4.83218236685645,53489,1.30389952204144,18,3,0,1e-07,0.0662638315542025,662638.315542025,19.3378621008021
"287",299,415,415,415,"Q96ST3","SIN3A","SIN3A_HUMAN","kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding transcription factor activity [GO:0003700]; protein deacetylase activity [GO:0033558]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription corepressor activity [GO:0001106]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of hormone levels [GO:0010817]; regulation of lipid metabolic process [GO:0019216]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00810, ECO:0000269|PubMed:16820529}. Nucleus, nucleolus {ECO:0000269|PubMed:16820529}. Note=Recruited to the nucleolus by SAP30L.","Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)","GO:0000122; GO:0000776; GO:0000976; GO:0001102; GO:0001103; GO:0001106; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003682; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006351; GO:0006476; GO:0007568; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0019216; GO:0031937; GO:0033558; GO:0034613; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045652; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0071333; GO:1900181; GO:1901675; GO:1903351; GO:2000678",0.00039845626386283,0.00030076051888541,0.0002587018677887,0.0249928372908449,0.0342127334265723,0.0443009935281556,0.034182881865012,0.0174107471493516,6.36474433840125,0.00241181555782626,0.0496707225869414,-4.83494568532717,145175,1.30389952204144,19,0,0,0.00030076051888541,0.0342127334265723,113.75407102422,6.82977436709799
"288",300,416,416,416,"Q96MZ0","GDAP1L1","GD1L1_HUMAN","cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]",NA,"Ganglioside-induced differentiation-associated protein 1-like 1 (GDAP1-L1)","GO:0004364; GO:0005737; GO:0006749",1e-07,1e-07,1e-07,0.0317495578915839,0.0192924662914616,0.0208983142650256,0.0239800128160237,0.0119901064080118,6.36335357709544,0.00241390427525322,0.0496707225869414,-4.83599475938531,41973,1.30389952204144,12,3,0,1e-07,0.0208983142650256,208983.142650256,17.6730270483424
